text string | url string | crawl_date timestamp[ms] | label int64 | id string |
|---|---|---|---|---|
- CARDIO-TTRansform is the largest, most comprehensive ATTR-CM study with more than 1,400 patients enrolled
- Eplontersen is currently under U.S. FDA review for ATTRv-polyneuropathy, with ATTR-CM representing a second, larger potential patient population
CARLSBAD, Calif., July 31, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the completion of enrollment in the Phase 3 CARDIO-TTRansform cardiovascular outcomes study of eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), a large and growing patient population at risk of life-threatening cardiovascular (CV) events. The study enrolled more than 1,400 patients.
Eplontersen is an investigational antisense medicine designed to inhibit the production of transthyretin and slow the progression of cardiomyopathy for people living with hereditary or wild-type ATTR-CM.
"CARDIO-TTRansform is the largest and most comprehensive ATTR-CM study ever conducted. The evaluation of eplontersen in this broad, diverse patient population will enable robust and clinically meaningful analysis of the composite endpoint of CV mortality and recurrent CV events," said Eugene Schneider, M.D., executive vice president and chief clinical development officer for Ionis. "It will also allow us to gather data from important patient subsets, including patients with or without stabilizer therapy and those with or without hereditary disease within the evolving ATTR-CM landscape. We look forward to reporting results as early as the first half of 2025."
As part of a global development and commercialization agreement, Ionis and AstraZeneca are seeking regulatory approval for eplontersen for the treatment of transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) in the U.S. and plan to seek regulatory approval in Europe and other parts of the world. The U.S. Food and Drug Administration accepted the New Drug Application for eplontersen for the treatment of ATTRv-PN with a PDUFA action date of Dec. 22, 2023. Eplontersen was granted Orphan Drug Designation in the U.S.
For more information on the CARDIO-TTRansform study, please visit www.clinicaltrials.gov (NCT04136171).
About the CARDIO-TTRansform Study
CARDIO-TTRansform is a global, double-blind, randomized, placebo-controlled Phase 3 cardiovascular outcome study in more than 1,400 patients with ATTR cardiomyopathy (ATTR-CM). It is designed to compare eplontersen to placebo in patients with both wild-type ATTRwt-CM and hereditary ATTRv-CM who are either naïve to treatment or on a currently available standard of care. The primary composite endpoint is cardiovascular (CV) mortality and recurrent CV clinical events comparing the two study arms up to week 140. Secondary endpoints include the change from baseline in the 6-minute walk test (6MWT) and the Kansas City Cardiomyopathy Questionnaire (KCCQ) scores at week 121, as well as the rates of CV mortality, CV clinical events and all-cause mortality at week 140.
About Eplontersen
Eplontersen is an investigational LIgand-Conjugated Antisense (LICA) medicine designed to inhibit the production of TTR protein. Eplontersen is being developed as a monthly self-administered subcutaneous injection to treat all types of ATTR. ATTR amyloidosis is a systemic, progressive and fatal disease in which patients experience multiple overlapping clinical manifestations caused by the inappropriate formation and aggregation of TTR amyloid deposits in various tissues and organs, including peripheral nerves, heart, intestinal tract, eyes, kidneys, central nervous system, thyroid and bone marrow. The progressive accumulation of TTR amyloid deposits in these tissues and organs leads to organ failure and eventually death.
About Transthyretin-mediated Amyloid Cardiomyopathy (ATTR-CM)
Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease. It is caused by the accumulation of misfolded TTR protein in the cardiac muscle. Patients experience ongoing debilitating heart damage resulting in progressive heart failure, which results in death within three to five years from disease onset. ATTR-CM includes both the genetic and wild-type form of the disease. Worldwide, there are an estimated 300,000 – 500,0001,2 patients with ATTR-CM.
About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
Ionis' Forward-looking Statements
This press release includes forward-looking statements regarding Ionis' business and the therapeutic and commercial potential of eplontersen, Ionis' technologies and other products in development. Any statement describing Ionis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties including those related to our commercial products and the medicines in our pipeline, and particularly those inherent in the process of discovering, developing and commercializing medicines that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such medicines. Ionis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Ionis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Ionis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Ionis' programs are described in additional detail in Ionis' annual report on Form 10-K for the year ended Dec. 31, 2022, and the most recent Form 10-Q quarterly filing, which are on file with the Securities and Exchange Commission. Copies of these and other documents are available from the Company.
In this press release, unless the context requires otherwise, "Ionis," "Company," "we," "our," and "us" all refer to Ionis Pharmaceuticals and its subsidiaries.
Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc.
1 Mohamed-Salem L, et al. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. Int J Cardiol. 2018 Nov 1;270:192-196. doi: 10.1016/j.ijcard.2018.06.006.
2 Cuscaden C, et al. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol. 2020 May 8. doi: 10.1007/s12350-020-02152-x.
View original content to download multimedia:
SOURCE Ionis Pharmaceuticals, Inc. | https://www.kswo.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ | 2023-07-31T11:50:23 | 1 | https://www.kswo.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ |
- CARDIO-TTRansform is the largest, most comprehensive ATTR-CM study with more than 1,400 patients enrolled
- Eplontersen is currently under U.S. FDA review for ATTRv-polyneuropathy, with ATTR-CM representing a second, larger potential patient population
CARLSBAD, Calif., July 31, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the completion of enrollment in the Phase 3 CARDIO-TTRansform cardiovascular outcomes study of eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), a large and growing patient population at risk of life-threatening cardiovascular (CV) events. The study enrolled more than 1,400 patients.
Eplontersen is an investigational antisense medicine designed to inhibit the production of transthyretin and slow the progression of cardiomyopathy for people living with hereditary or wild-type ATTR-CM.
"CARDIO-TTRansform is the largest and most comprehensive ATTR-CM study ever conducted. The evaluation of eplontersen in this broad, diverse patient population will enable robust and clinically meaningful analysis of the composite endpoint of CV mortality and recurrent CV events," said Eugene Schneider, M.D., executive vice president and chief clinical development officer for Ionis. "It will also allow us to gather data from important patient subsets, including patients with or without stabilizer therapy and those with or without hereditary disease within the evolving ATTR-CM landscape. We look forward to reporting results as early as the first half of 2025."
As part of a global development and commercialization agreement, Ionis and AstraZeneca are seeking regulatory approval for eplontersen for the treatment of transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) in the U.S. and plan to seek regulatory approval in Europe and other parts of the world. The U.S. Food and Drug Administration accepted the New Drug Application for eplontersen for the treatment of ATTRv-PN with a PDUFA action date of Dec. 22, 2023. Eplontersen was granted Orphan Drug Designation in the U.S.
For more information on the CARDIO-TTRansform study, please visit www.clinicaltrials.gov (NCT04136171).
About the CARDIO-TTRansform Study
CARDIO-TTRansform is a global, double-blind, randomized, placebo-controlled Phase 3 cardiovascular outcome study in more than 1,400 patients with ATTR cardiomyopathy (ATTR-CM). It is designed to compare eplontersen to placebo in patients with both wild-type ATTRwt-CM and hereditary ATTRv-CM who are either naïve to treatment or on a currently available standard of care. The primary composite endpoint is cardiovascular (CV) mortality and recurrent CV clinical events comparing the two study arms up to week 140. Secondary endpoints include the change from baseline in the 6-minute walk test (6MWT) and the Kansas City Cardiomyopathy Questionnaire (KCCQ) scores at week 121, as well as the rates of CV mortality, CV clinical events and all-cause mortality at week 140.
About Eplontersen
Eplontersen is an investigational LIgand-Conjugated Antisense (LICA) medicine designed to inhibit the production of TTR protein. Eplontersen is being developed as a monthly self-administered subcutaneous injection to treat all types of ATTR. ATTR amyloidosis is a systemic, progressive and fatal disease in which patients experience multiple overlapping clinical manifestations caused by the inappropriate formation and aggregation of TTR amyloid deposits in various tissues and organs, including peripheral nerves, heart, intestinal tract, eyes, kidneys, central nervous system, thyroid and bone marrow. The progressive accumulation of TTR amyloid deposits in these tissues and organs leads to organ failure and eventually death.
About Transthyretin-mediated Amyloid Cardiomyopathy (ATTR-CM)
Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease. It is caused by the accumulation of misfolded TTR protein in the cardiac muscle. Patients experience ongoing debilitating heart damage resulting in progressive heart failure, which results in death within three to five years from disease onset. ATTR-CM includes both the genetic and wild-type form of the disease. Worldwide, there are an estimated 300,000 – 500,0001,2 patients with ATTR-CM.
About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
Ionis' Forward-looking Statements
This press release includes forward-looking statements regarding Ionis' business and the therapeutic and commercial potential of eplontersen, Ionis' technologies and other products in development. Any statement describing Ionis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties including those related to our commercial products and the medicines in our pipeline, and particularly those inherent in the process of discovering, developing and commercializing medicines that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such medicines. Ionis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Ionis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Ionis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Ionis' programs are described in additional detail in Ionis' annual report on Form 10-K for the year ended Dec. 31, 2022, and the most recent Form 10-Q quarterly filing, which are on file with the Securities and Exchange Commission. Copies of these and other documents are available from the Company.
In this press release, unless the context requires otherwise, "Ionis," "Company," "we," "our," and "us" all refer to Ionis Pharmaceuticals and its subsidiaries.
Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc.
1 Mohamed-Salem L, et al. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. Int J Cardiol. 2018 Nov 1;270:192-196. doi: 10.1016/j.ijcard.2018.06.006.
2 Cuscaden C, et al. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol. 2020 May 8. doi: 10.1007/s12350-020-02152-x.
View original content to download multimedia:
SOURCE Ionis Pharmaceuticals, Inc. | https://www.wbrc.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ | 2023-07-31T11:50:25 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ |
Lawsuit alleges flight attendants served too much alcohol to passenger that groped woman, her daughter
(CNN) - A passenger is suing Delta Airlines, claiming flight attendants overserved alcohol to a man who became drunk while on board and groped a mother and her teenage daughter.
The alleged incident happened during an international flight last summer.
The suit claims the flight attendants ignored the mother’s pleas for them to stop serving alcohol to the man and that the passenger was making them feel unsafe.
The plaintiffs in the case said during the nine-hour flight from New York to Greece, the man made obscene gestures and sexually assaulted the 16-year-old girl sitting next to him.
When the plane landed in Greece, the man was allowed to walk free despite the mother’s request that authorities arrest him in Athens.
Delta has not commented on the suit but says the airline has zero tolerance for passengers who engage in inappropriate or unlawful behavior.
Copyright 2023 CNN Newsource. All rights reserved. | https://www.wflx.com/2023/07/31/lawsuit-alleges-flight-attendants-served-too-much-alcohol-passenger-that-groped-woman-her-daughter/ | 2023-07-31T11:50:30 | 0 | https://www.wflx.com/2023/07/31/lawsuit-alleges-flight-attendants-served-too-much-alcohol-passenger-that-groped-woman-her-daughter/ |
Trump could be indicted soon in Georgia. Here’s a look at that investigation
ATLANTA (AP) — A Georgia prosecutor is expected to seek a grand jury indictment in the coming weeks in her investigation into efforts by Donald Trump and his Republican allies to overturn the former president’s 2020 election loss.
Fulton County District Attorney Fani Willis began investigating more than two years ago, shortly after a recording was released of a January 2021 phone call Trump made to Georgia’s secretary of state.
Willis has strongly hinted that any indictment would come between July 31 and August 18. One of two grand juries seated July 11 is expected to hear the case.
If Trump is indicted by a Georgia grand jury, it would add to a growing list of legal troubles as he campaigns for president. Trump is set to go to trial in New York in March to face state charges related to hush-money payments made during the 2016 presidential campaign. And he has another trial scheduled for May on federal charges related to his handling of classified documents. He has pleaded not guilty in those cases.
The Justice Department is also investigating Trump’s role in trying to halt the certification of 2020 election results in the run-up to the Jan. 6, 2021, assault on the U.S. Capitol. Trump said he’s been told he’s a target of that investigation, which likely has some overlap with the one in Georgia.
Details of the Georgia investigation that have become public have fed speculation that Willis, a Democrat, is building a case under the Georgia Racketeer Influenced and Corrupt Organizations Act, which would allow her to charge numerous people in a potentially wide-ranging scheme.
Here are six investigative threads Willis and her team have explored:
THE PHONE CALLS
The Georgia investigation was prompted by the Jan. 2, 2021 phone call Trump made to Georgia Secretary of State Brad Raffensperger. Trump suggested the state’s top elections official could help “find” the votes needed to put him ahead of Democrat Joe Biden in the state.
“All I want to do is this: I just want to find 11,780 votes, which is one more than we have,” Trump is heard saying on a recording of the call, which was leaked to news outlets. “Because we won the state.”
Trump has insisted he did nothing wrong and has repeatedly said the call was “perfect.”
Trump also called other top state officials in his quest to overturn his 2020 election loss, including Gov. Brian Kemp, then-House Speaker David Ralston, Attorney General Chris Carr and the top investigator in the secretary of state’s office.
U.S. Sen. Lindsey Graham, a South Carolina Republican, also called Raffensperger shortly after the November election. Raffensperger said at the time that Graham asked whether he had the power to reject certain absentee ballots, which Raffensperger has said he interpreted as a suggestion to toss out legally cast votes.
Graham has denied wrongdoing, saying he just wanted to learn about the signature verification process.
FAKE ELECTORS
Biden won Georgia by a margin of fewer than 12,000 votes. Just over a month after the election, on Dec. 14, 2020, a group 16 Georgia Democratic electors met in the Senate chamber at the state Capitol to cast the state’s Electoral College votes for him. They each marked paper ballots that were counted and confirmed by a voice roll call.
That same day, in a committee meeting room at the Capitol, 16 prominent Georgia Republicans — a lawmaker, activists and party officials — met to sign a certificate falsely stating that Trump had won and declaring themselves the state’s “duly elected and qualified” electors. They sent that certificate to the National Archives and the U.S. Senate.
Georgia was one of seven battleground states that Trump lost where Republican fake electors signed and submitted similar certificates. Trump allies in the U.S. House and Senate used those certificates to argue for delaying or blocking the certification of the election during a joint session of Congress.
Prosecutors in Fulton County have said in court filings that they believe Trump associates worked with state Republicans to coordinate and execute the plan.
The multi-state effort was ultimately unsuccessful. Despite public pressure from Trump and his supporters, then-Vice President Mike Pence refused on Jan. 6, 2021, to introduce the unofficial pro-Trump electors. After the attack on the U.S. Capitol put a violent halt to the certification process, lawmakers certified Biden’s win in the early hours of Jan. 7, 2021.
At least eight of the fake electors have since reached immunity deals with Willis’ team. And a judge last summer barred Willis from prosecuting another one, Lt. Gov. Burt Jones, because of a conflict of interest.
FALSE CLAIMS OF ELECTION FRAUD
Republican state lawmakers held several hearings at the Georgia Capitol in December 2020 to examine alleged problems with the November election. During those meetings, former New York mayor Rudy Giuliani and other Trump allies made unproven claims of widespread election fraud.
They alleged that election workers tallying absentee ballots at State Farm Arena in Atlanta had told outside observers to leave and then pulled out “suitcases” of unlawful ballots and began scanning them. The Trump allies played clips of surveillance video from the arena to support their allegations. State and federal officials investigated and said there was no evidence of election fraud at the site.
Some Trump allies also said thousands of people who were ineligible — including people convicted of felonies, people younger than the age of 18, people who had voted in another state — had cast votes in Georgia. The secretary of state’s office has debunked those claims.
ALLEGED ATTEMPTS TO PRESSURE ELECTION WORKER
Two of the election workers seen in the State Farm Arena surveillance video, Ruby Freeman and her daughter Wandrea “Shaye” Moss, said they faced relentless harassment online and in person as a result of the allegations made by Trump and his allies.
Giuliani last week conceded that statements he made about the two election workers were false.
In a bizarre episode detailed by prosecutors in court filings, a woman traveled from Chicago to Georgia and met with Freeman on Jan. 4, 2021. The woman initially said she wanted to help Freeman but then warned that Freeman could go to prison and tried to pressure her into falsely confessing to committing election fraud, prosecutors wrote in court filings last year.
ELECTION EQUIPMENT ACCESSED
Trump-allied lawyer Sidney Powell and others hired a computer forensics team to copy data and software on election equipment in Coffee County, some 200 miles southeast of Atlanta, according to invoices, emails, security video and deposition testimony produced in response to subpoenas in a long-running lawsuit.
The county Republican Party chair at the time — who also served as a fake elector — greeted them when they arrived at the local elections office on Jan. 7, 2021, and some county elections officials were also on hand during the daylong visit. The secretary of state’s office has said this amounted to “alleged unauthorized access” of election equipment, and the Georgia Bureau of Investigation is looking into it at the secretary of state’s request.
Two other men who have been active in efforts to question the 2020 election results also visited Coffee County later that month and spent hours inside.
U.S. ATTORNEY RESIGNATION
U.S. Attorney BJay Pak, the top federal prosecutor in Atlanta, abruptly resigned two days after Trump called Raffensperger and a day after a recording of that call was made public. During that conversation, Trump called Pak a “never-Trumper,” implying that he didn’t support the president.
In December 2020, then-U.S. Attorney General William Barr asked Pak to investigate allegations by Giuliani and other Trump allies of widespread election fraud. Pak, who had been appointed by Trump in 2017, reported back that he had found no evidence of such fraud.
In August 2021, Pak told the U.S. Senate Judiciary Committee, which was investigating Trump’s post-election actions, that he resigned on Jan. 4, 2021, after learning from Department of Justice officials that Trump did not believe enough was being done to investigate allegations of election fraud and wanted him gone as U.S. attorney.
Copyright 2023 The Associated Press. All rights reserved. | https://www.wflx.com/2023/07/31/trump-could-be-indicted-soon-georgia-heres-look-that-investigation/ | 2023-07-31T11:50:30 | 1 | https://www.wflx.com/2023/07/31/trump-could-be-indicted-soon-georgia-heres-look-that-investigation/ |
Juggernaut and Mr. Highman will continue as substantial shareholders of Bobbie. The acquisition positions the combined company as the third largest fully integrated infant and toddler brand in the U.S., creating a more resilient industry for American families
WASHINGTON, July 31, 2023 /PRNewswire/ -- Juggernaut Capital Partners, a leading middle market private equity investor primarily in the consumer and healthcare sectors, is pleased to announce the sale of Nature's One, the pediatric nutrition company founded by Jay Highman which set the bar for quality and innovation in formula over decades. Joining forces with Bobbie Baby, Inc., the nation's fastest growing infant formula company, the combined business will be the first of its kind in pediatric nutrition.
"Nature's One is a true pioneer in the pediatric nutrition space. Juggernaut partnered with founder, Jay Highman, to accelerate product development and vertical integration initiatives. Over the past five years, the company completed the first FDA-approved clinical feeding study of an organic infant formula and designed and constructed the first newly built infant formula facility in the U.S. in 35 years," said John Shulman, Founder and Managing Partner at Juggernaut. "It has been a pleasure to partner with Jay and his team. We believe the combination with Bobbie cements the organization as a continued disruptor and a next-generation industry leader. We are proud to continue as a meaningful shareholder in the go-forward company."
Founded in 1997, Nature's One introduced the first organic baby formula to the U.S. market. Recognized for its dedication to purity and quality, all of the company's formulas have received the Clean Label Project's Purity Award and have tested best in class for purity and nutrition when compared to popular baby formulas sold in the U.S. Nature's One operates the only independent, FDA audited organic infant nutrition facility in the U.S.
Nature's One was advised by CG / Sawaya Partners (operating under Canaccord Genuity) and Morgan Lewis & Bockius LLP. Bobbie was advised by Perella Weinberg Partners LP and Goodwin Procter LLP.
About Juggernaut Capital Partners:
Juggernaut Capital Partners is a leading private equity firm focusing on lower middle market companies, primarily in the consumer and healthcare sectors. Juggernaut is currently investing out of Juggernaut Capital Partners V, L.P. For more information on Juggernaut Capital Partners, please visit www.juggernautcap.com.
About Nature's One:
Founded in 1997, Nature's One introduced the first organic formula, Baby's Only® Organic in the United States. Nature's One has dedicated 25 years to the research, development, and sourcing of pure ingredients. Recognized as the first and highest-ranked formulas for purity and nutritional superiority by the Clean Label Project, Baby's Only Formulas are preferred by parents who want to offer their child a "Better Start…for Life™." Baby's Only Formulas are sold nationally at Whole Foods, Target, Walmart, Sam's Club, and many fine natural food retailers, as well online at www.naturesone.com.
About Bobbie:
Bobbie is the mission-driven organic pediatric nutrition company that exists to build a parenting culture of confidence, not comparison. Founded in 2018, Bobbie hit the market with its flagship European-inspired formula in 2021 as the first direct-to-consumer, subscription-based infant formula in the U.S. Today, it's proud to be the only mom-founded and led infant formula brand in the world, and the fastest-growing in the U.S. since the 1980's. Bobbie is focused on providing purposefully sourced, USDA Organic products made with simple ingredients – crafted right here in America, for American families. For more information, visit www.hibobbie.com.
View original content:
SOURCE Juggernaut Capital Partners | https://www.kswo.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ | 2023-07-31T11:50:30 | 1 | https://www.kswo.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ |
BURLINGTON, N.C., July 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September 14, 2023, in New York City, beginning at 1:00 p.m. ET and is expected to conclude by approximately 4:00 p.m. ET.
This event will highlight Labcorp's go-forward strategy from Labcorp Chairman & CEO Adam Schechter, followed by business overviews and a longer-term financial outlook. Presentations will be followed by a Q&A session.
A live webcast of the event will be available through the Labcorp Investor Relations website beginning at 1:00 p.m. ET. A replay of the webcast and supporting materials will be available after the conclusion of the event.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
View original content to download multimedia:
SOURCE Labcorp | https://www.kswo.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ | 2023-07-31T11:50:31 | 0 | https://www.kswo.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ |
Juggernaut and Mr. Highman will continue as substantial shareholders of Bobbie. The acquisition positions the combined company as the third largest fully integrated infant and toddler brand in the U.S., creating a more resilient industry for American families
WASHINGTON, July 31, 2023 /PRNewswire/ -- Juggernaut Capital Partners, a leading middle market private equity investor primarily in the consumer and healthcare sectors, is pleased to announce the sale of Nature's One, the pediatric nutrition company founded by Jay Highman which set the bar for quality and innovation in formula over decades. Joining forces with Bobbie Baby, Inc., the nation's fastest growing infant formula company, the combined business will be the first of its kind in pediatric nutrition.
"Nature's One is a true pioneer in the pediatric nutrition space. Juggernaut partnered with founder, Jay Highman, to accelerate product development and vertical integration initiatives. Over the past five years, the company completed the first FDA-approved clinical feeding study of an organic infant formula and designed and constructed the first newly built infant formula facility in the U.S. in 35 years," said John Shulman, Founder and Managing Partner at Juggernaut. "It has been a pleasure to partner with Jay and his team. We believe the combination with Bobbie cements the organization as a continued disruptor and a next-generation industry leader. We are proud to continue as a meaningful shareholder in the go-forward company."
Founded in 1997, Nature's One introduced the first organic baby formula to the U.S. market. Recognized for its dedication to purity and quality, all of the company's formulas have received the Clean Label Project's Purity Award and have tested best in class for purity and nutrition when compared to popular baby formulas sold in the U.S. Nature's One operates the only independent, FDA audited organic infant nutrition facility in the U.S.
Nature's One was advised by CG / Sawaya Partners (operating under Canaccord Genuity) and Morgan Lewis & Bockius LLP. Bobbie was advised by Perella Weinberg Partners LP and Goodwin Procter LLP.
About Juggernaut Capital Partners:
Juggernaut Capital Partners is a leading private equity firm focusing on lower middle market companies, primarily in the consumer and healthcare sectors. Juggernaut is currently investing out of Juggernaut Capital Partners V, L.P. For more information on Juggernaut Capital Partners, please visit www.juggernautcap.com.
About Nature's One:
Founded in 1997, Nature's One introduced the first organic formula, Baby's Only® Organic in the United States. Nature's One has dedicated 25 years to the research, development, and sourcing of pure ingredients. Recognized as the first and highest-ranked formulas for purity and nutritional superiority by the Clean Label Project, Baby's Only Formulas are preferred by parents who want to offer their child a "Better Start…for Life™." Baby's Only Formulas are sold nationally at Whole Foods, Target, Walmart, Sam's Club, and many fine natural food retailers, as well online at www.naturesone.com.
About Bobbie:
Bobbie is the mission-driven organic pediatric nutrition company that exists to build a parenting culture of confidence, not comparison. Founded in 2018, Bobbie hit the market with its flagship European-inspired formula in 2021 as the first direct-to-consumer, subscription-based infant formula in the U.S. Today, it's proud to be the only mom-founded and led infant formula brand in the world, and the fastest-growing in the U.S. since the 1980's. Bobbie is focused on providing purposefully sourced, USDA Organic products made with simple ingredients – crafted right here in America, for American families. For more information, visit www.hibobbie.com.
View original content:
SOURCE Juggernaut Capital Partners | https://www.wbrc.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ | 2023-07-31T11:50:32 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ |
WATCH: Concertgoer throws drink at Cardi B; she hurls microphone at them
Published: Jul. 31, 2023 at 6:58 AM EDT|Updated: 51 minutes ago
LAS VEGAS (CNN) - Cardi B hurled her microphone at a fan during a concert in Las Vegas on Saturday.
The rapper was performing her song “Bodak Yellow” when a concertgoer threw a drink at her.
In seconds, Cardi B threw her microphone into the crowd as the song continued to play.
Security guards rushed to the stage.
More security guards are then seen flocking to the person in the crowd as she watched from the stage before continuing with her set.
There’s no word on what happened to the fan or if any charges will be filed.
Copyright 2023 CNN Newsource. All rights reserved. | https://www.wflx.com/2023/07/31/watch-concertgoer-throws-drink-cardi-b-she-hurls-microphone-them/ | 2023-07-31T11:50:33 | 0 | https://www.wflx.com/2023/07/31/watch-concertgoer-throws-drink-cardi-b-she-hurls-microphone-them/ |
BEIJING, July 31, 2023 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced the launch of its 36Kr Media Lab in Silicon Valley, an initiative to embrace the large language models (LLM) revolution taking place in the content creation industry and optimize the application of artificial intelligence (AI) for the new economy sector.
36Kr Silicon Valley Media Lab's first project leveraging LLM, "Empty Office," will experimentally explore scenarios where AI can think and work as humans, enhancing content production efficiency and reducing costs. Through "Empty Office," 36Kr is also building innovative media solutions that will transform traditional video, graphic and text communications into avant-garde dialogues between customized AI characters and audiences. These network-based dialogues will be naturally and seamlessly driven by real-time data generation, and available anytime, anywhere.
At the same time, 36Kr Silicon Valley Media Lab continues to focus on tailoring its LLM to the new economy sector. By utilizing dedicated financial and business datasets, including enterprises' financial results, news, market dynamics and knowledge repositories, among other resources, to train its LLM to thoroughly understand and analyze business information, 36Kr has developed a model that keenly grasps the business nuances to generate accurate analysis and interpretation. 36Kr Silicon Valley Media Lab constantly maintains its database, serving as the reference foundation to ensure that its fact-based model produces rigorous and up-to-date business and financial analysis.
Furthermore, 36Kr's professionally-training, fine-tuning capability enables its LLM-empowered "Empty Office" to quickly and efficiently create informative content for the new economy sector. For instance, in the case of a business event, such as a new product launch, an AI agent can instantly extract relevant data from the database, automatically perform a comprehensive analysis, and issue reports within just seconds. This top-speed response gives 36Kr's business and financial-focused media platform an unrivaled edge.
Mr. Dagang Feng, Co-chairman and CEO of 36Kr, commented, "The launch of 36Kr Silicon Valley Media Lab is a testament to our AI technology acumen and vision as well as our commitment to extending media's boundaries. By integrating pioneering AI technology into content creation, 36Kr will constantly elevate the efficiency and quality of content production alongside the rapid advancement of the LLM, fostering a superior content ecosystem encompassing business, finance and technology, further turbocharging the evolution of the New Economy. As we adopt and develop more AI tools amid the technology's rapid advancement, we are strategically positioning the Company to break new ground and ultimately drive long-term growth for our business."
About 36Kr Holdings Inc.
36Kr Holdings Inc. is a prominent brand and a pioneering platform dedicated to serving New Economy participants in China with the mission of empowering New Economy participants to achieve more. The Company started its business with high-quality New Economy-focused content offerings, covering a variety of industries in China's New Economy with diverse distribution channels. Leveraging traffic brought by high-quality content, the Company has expanded its offerings to business services, including online advertising services, enterprise value-added services, and subscription services, to address the evolving needs of New Economy companies and upgrading needs of traditional companies. The Company is supported by a comprehensive database and strong data analytics capabilities. Through diverse service offerings and significant brand influence, the Company is well-positioned to continuously capture the high growth potential of China's New Economy.
For more information, please visit: http://ir.36kr.com.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's goal and strategies; the Company's future business development, results of operations and financial condition; relevant government policies and regulations relating to our business and industry; the Company's expectations regarding the use of proceeds from this offering; the Company's expectations regarding demand for, and market acceptance of, its services; the Company's ability to maintain and enhance its brand; the Company's ability to provide high-quality content in a timely manner to attract and retain users; the Company's ability to retain and hire quality in-house writers and editors; the Company's ability to maintain cooperation with third-party professional content providers; the Company's ability to maintain relationships with third-party platforms; general economic and business conditions in China; possible disruptions in commercial activities caused by natural or human-induced disasters; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.
For investor and media inquiries, please contact:
In China:
36Kr Holdings Inc.
Investor Relations
Tel: +86 (10) 8965-0708
E-mail: ir@36kr.com
The Piacente Group, Inc.
Jenny Cai
Tel: +86 (10) 6508-0677
E-mail: 36Kr@tpg-ir.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: 36Kr@tpg-ir.com
View original content:
SOURCE 36Kr Holdings Inc. | https://www.wflx.com/prnewswire/2023/07/31/36kr-launches-silicon-valley-media-lab-empower-content-ecosystem-with-llm-based-ai-technology/ | 2023-07-31T11:50:35 | 0 | https://www.wflx.com/prnewswire/2023/07/31/36kr-launches-silicon-valley-media-lab-empower-content-ecosystem-with-llm-based-ai-technology/ |
Adult Males are Slightly More Likely to Live with Parents Than Their Female Counterparts
58% of Gen Z Consumers Live with Family Members
SAN FRANCISCO, July 31, 2023 /PRNewswire/ -- LendingClub Corporation (NYSE: LC), the parent company of LendingClub Bank, America's leading digital marketplace bank, today released findings from the 24th edition of the Reality Check: Paycheck-To-Paycheck research series, conducted in partnership with PYMNTS. The Household Finances Deep Dive Edition examines the impact of household composition on consumers' ability to manage expenses and put aside savings. The series draws on insights from a survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data.
The Paycheck-to-Paycheck Landscape
In June 2023, 61% of U.S. consumers lived paycheck to paycheck, unchanged from June 2022 — as is the share of those struggling to pay bills (at 21%) — even though more middle-income consumers cited living paycheck to paycheck in June 2023 than last year. Among consumers earning $50,000 to $100,000, 65% lived paycheck to paycheck as of June 2023, compared to 60% in June 2022. Meanwhile, the shares of high-income consumers — those earning more than $100,000 annually — and low-income consumers — those earning less than $50,000 annually — living paycheck to paycheck in June 2023 sit at 45% and 77%, respectively, relatively unchanged from June 2022.
This stability in the financial situation of U.S. households indicates that consumers continue to adapt to inflationary pressures, finding ways to manage their spending and live within their means.
Household Composition Determines Financial Lifestyle
Consumers living with only a partner or spouse are likely to face less financial hardship, while those with dependents and those living with friends or housemates are more likely to live paycheck to paycheck.
The research finds that 86% of consumers live with one or more people, and one-third of paycheck-to-paycheck consumers live in households of four or more people. Consumers not living paycheck to paycheck are most likely to reside in two-person households, at 41%. Meanwhile, 49% of millennials and 55% of bridge millennials live in households of four or more people, making them the age groups most likely to reside in the largest households.
There is also a direct correlation among household size, stage of life and financial lifestyle. As household size increases, the ratio of income earners to non-earners typically falls, attributable to households with dependent children. When looking at the share of paycheck-to-paycheck consumers who live in a two-member household, the data finds that 54% do so — 7 percentage points below the sample average. Meanwhile, at 66%, consumers with children under the age of 18 are 12% more likely to live paycheck to paycheck than those without children, at 59%. Among consumers living with friends or housemates, 77% live paycheck to paycheck — the most likely to do so. This suggests that those sharing expenses with a partner or spouse fare better, that is until they have children or even parents to support.
"As household size increases, the ratio of income earners to household members typically falls, creating a higher likelihood of financial distress," said Alia Dudum, LendingClub's Money Expert. "The relationship between household income and household composition explains why many families tend to struggle financially and why millennials and bridge millennials, many of whom are in their peak child-rearing years, tend to remain financially vulnerable."
Economic Considerations Top Reason to Stay in the Family Household
Economics are the main driver for consumers to live with family longer, with 43% wanting to save money and 30% unable to afford housing independently. Besides economic reasons, consumers remain at home to maintain family ties (24%), for transitional reasons (23%), and to provide care (22%).
At one-fifth (20%), adult males are slightly more likely to live with parents than their female counterparts (18%), a phenomenon that grows significantly among those financially struggling (26% of males compared to 18% of females). At 58%, Gen Z is the generation most likely to stay with family members, with 50% citing economic reasons. Members of Gen Z living with three or more people — often familial settings — spent 22% of their income on housing, compared to 30% of those living alone or with a partner.
That said, consumers living with family members to offset expenses are not planning extended stays. For example, one-third of those consumers expect to move out in the coming year, particularly millennials and bridge millennials.
Financial Transparency Determined by Relationship Status
Financial transparency within shared households is paramount to ensure bills are paid and expenses are covered, but the transparency level depends on who consumers live with. Couples living together share financial information 87% of the time and have a joint bank account 76% of the time. Parents are also likely to discuss finances with the children residing in their household, with 45% of parents sharing financial information with their children and 34% granting them access to a shared account. Bill splitting is the most common financial interaction for consumers living with friends or housemates, at 74%. Additionally, borrowing money from other household members is a financial option many use to make ends meet, with consumers mostly engaging in this practice with parents or siblings, at 47%, and friends and housemates, at 44%.
Families and couples maintain outstanding credit card balances that are significantly higher, on average, than those of consumers who live alone. Consumers with children under the age of 18 average 50% more credit card debt than those who live alone. Families represent the lion's share of credit card spending, holding average balances of $6,300 for consumers living with a partner and $7,200 for those living with children under 18. Living with a partner or children also significantly increases a consumer's likelihood of having an auto loan or mortgage.
"With today's inflationary pressures, sharing household finances has become not only common but crucial," continued Dudum. "The increasing complexity of modern lifestyles and the rising cost of living have necessitated a shift in the way consumers approach household finances. One person solely bearing the burden of managing all financial matters has become a minority practice. Instead, couples, families, and even roommates increasingly jointly navigate their economic realities, and it's a trend that is here to stay."
To view the full report, visit: https://www.pymnts.com/study/reality-check-paycheck-to-paycheck-inflation-household-spending-shared-expenses/
Methodology
New Reality Check: The Paycheck-to-Paycheck Report — The Household Finances Deep Dive Edition is based on a census-balanced survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data. The data in this report is not intended to be a representation of LendingClub's core member base. The Paycheck-to-Paycheck series expands on existing data published by government agencies, such as the Federal Reserve System and the Bureau of Labor Statistics, to provide a deep look into the core elements of American consumers' financial wellness: income, savings, debt and spending choices. Our sample was balanced to match the U.S. adult population in a set of key demographic variables: 51% of respondents identified as female, 33% were college-educated and 38% declared incomes of more than $100,000 per year.
About LendingClub
LendingClub Corporation (NYSE: LC) is the parent company of LendingClub Bank, National Association, Member FDIC. LendingClub Bank is the leading digital marketplace bank in the U.S., where members can access a broad range of financial products and services designed to help them pay less when borrowing and earn more when saving. Based on more than 150 billion cells of data and over $85 billion in loans, our advanced credit decisioning and machine-learning models are used across the customer lifecycle to expand seamless access to credit for our members while generating compelling risk-adjusted returns for our loan investors. Since 2007, more than 4.7 million members have joined the Club to help reach their financial goals. For more information about LendingClub, visit https://www.lendingclub.com.
Contact:
For Investors: IR@lendingclub.com
Media Contact: Press@lendingclub.com
PYMNTS Contact: information@PYMNTS.com
View original content to download multimedia:
SOURCE LendingClub Corporation | https://www.kswo.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ | 2023-07-31T11:50:38 | 0 | https://www.kswo.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ |
The products and services mentioned below were selected independent of sales and advertising. However, Simplemost may receive a small commission from the purchase of any products or services through an affiliate link to the retailer's website.
Do you ever have those days in the middle of winter when your skin looks a little dry and weathered as if it needs a little plumping pick-me-up? This is exactly what happened to me last February after an unusually long bout of snow in my area. I walked into Sephora and asked the sales associate what I needed to manufacture some type of dewy glow. Without hesitation, she walked me over to Saie Glowy Super Gel Illuminator.
It comes in two sizes and shades, and after sampling it, I immediately went all in on the larger size in the Starglow shade. It was exactly what I was looking for. The liquid water-based luminizer gives you a radiant finish without making you look like a ’90s pop star with glitter specs stuck to your cheeks. It’s much more subtle than that.
It’s also created with good-for-the-skin ingredients like plant-based glycerin, which plumps up the skin, and rose hip seed oil and vitamin C to nourish and brighten, which I love. I cringe thinking about all the junk makeup I’ve used over the years, but now I’ve wised up and completely cleaned up my skincare and makeup regime. I try hard to only buy products that are deemed clean.
Currently, the 0.5-ounce size sells for $15.20 on Amazon, but the 1-ounce is a slightly better deal at $26.60-$28. It comes in two shades: Starglow and Sunglow. The Starglow is whiter while the slightly-more-expensive Sunglow has a golden brown tone.
Buy Saie Glowy Super Gel Lightweight Illuminator at Amazon for $28.
A few months after purchasing, while having wine with an old friend from high school, she leaned in and asked me what I was doing to make my skin look so good.
“How so?” I asked.
She said, “I know you are happy, but you’re practically glowing!” As any good friend would, I let her behind the Saie curtain and immediately texted her a link to the product so she could buy it later.
You can mix it with your face lotion or foundation, but I use it the most as a highlighter on my cheekbones. During the summer, I blend it into my body lotion to give my legs and collarbones a little shimmer on date nights. It’s lightweight and buildable. When I use it as a highlighter, I don’t even use a full pump. It’s more like a baby drop, so a large bottle will last you a very long time.
Not only is the Saie Glowy Super Gel Illuminator amazing 365 days a year, but it makes a great gift. My teenage daughter uses it too, and I’m thinking of gifting her a bottle for the new school year.
MORE: This eye cream for dark circles has nearly 17,000 5-star reviews on Amazon
This story originally appeared on Simplemost. Check out Simplemost for additional stories. | https://www.abc15.com/glowy-gel-luminizer-will-light-your-complexion | 2023-07-31T11:50:39 | 1 | https://www.abc15.com/glowy-gel-luminizer-will-light-your-complexion |
BURLINGTON, N.C., July 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September 14, 2023, in New York City, beginning at 1:00 p.m. ET and is expected to conclude by approximately 4:00 p.m. ET.
This event will highlight Labcorp's go-forward strategy from Labcorp Chairman & CEO Adam Schechter, followed by business overviews and a longer-term financial outlook. Presentations will be followed by a Q&A session.
A live webcast of the event will be available through the Labcorp Investor Relations website beginning at 1:00 p.m. ET. A replay of the webcast and supporting materials will be available after the conclusion of the event.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
View original content to download multimedia:
SOURCE Labcorp | https://www.wbrc.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ | 2023-07-31T11:50:39 | 0 | https://www.wbrc.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ |
HOUSTON, July 31, 2023 /PRNewswire/ -- AutomationEdge, a leading Hyperautomation platform has announced strategic partnership with eAlliance Corp, a cutting-edge Hyperautomation solutions provider.
The partnership will enable eAlliance Corp to provide AutomationEdge solutions such as CogniBot - a conversational AI platform, DocEdge - an intelligent document processing platform, Intelligent Service Desk Ticket Data Analysis, IT Process Automation (ITPA) and RPA. This collaboration will empower AutomationEdge and eAlliance Corp to help customers innovate with automation to move the needle on the top and bottom line.
AutomationEdge, along with its Hyperautomation platform, has also build the ready automation solutions across industries. It will help customers achieve faster Go-To-Market for automation projects with lower cost. It is empowering 250+ customers globally in Healthcare, Banking, Insurance, Financial Services and other industries.
For over 20 years, eAlliance Corp has been delivering technology solutions to businesses worldwide across industries. It has been a trusted advisor to its customer in innovation, strategy and execution of automation solutions. Through this partnership, eAlliance will be able to offer innovative business process automation solutions to customers focusing on key enterprise domains such as finance & accounting, customer service, procurement, human resources, cash applications and more.
About AutomationEdge
AutomationEdge is a leading Hyperautomation platform across the globe with end-to-end automation capabilities. With its platforms working together as one solution, it has enabled seamless process automation for global enterprises.
AutomationEdge has already delivered its innovative solutions to large multinational organizations like American Express, Smart Dubai Government, Wipro, AccentCare, Danone, University of Maryland Medical System, Aspen Pharmacare, Oman LNG, Mashreq Bank, HDFC Bank, and Genpact, to name a few.
For more details, contact sales or request a demo.
About eAlliance Corp
eAlliance Corp is a professional services firm with big company expertise and small company relationships, taking pride in agility and real-time responsiveness. eAlliance Corp is a trusted name in the Hyperautomation industry, offering comprehensive services and solutions to help businesses achieve their automation goals with ease. Founded in 2002 in Chicago, IL, staffed with resources in the US and India possessing vast experience and leadership in business and technology.
For more details, visit website.
For media inquiries, please contact:
Rahul Wandile
Media Relations – AutomationEdge
rahul.wandile@automationedge.com
www.automationedge.com
Follow AutomationEdge on: Twitter, Facebook, LinkedIn, and YouTube
View original content:
SOURCE AutomationEdge | https://www.wflx.com/prnewswire/2023/07/31/automationedge-ealliance-corp-announced-partnership-hyperautomation-solutions/ | 2023-07-31T11:50:44 | 0 | https://www.wflx.com/prnewswire/2023/07/31/automationedge-ealliance-corp-announced-partnership-hyperautomation-solutions/ |
Many movie and TV productions are now on pause, with writers and actors on strike. So you may be wondering if it is still worth paying all that money for a half dozen streaming services or more.
The good news is that there is a growing list of streaming services out there with plenty of content that you can watch completely free.
Like many of us, Cara Nicolas feels she pays for too many TV streams.
"I think I have seven or eight streaming services now," she said. "I watch MAX and Hulu and sometimes Netflix. We have Disney Plus too."
But now, this young advertising executive wants to cut back because the writers' strike means fewer new shows. So she is checking out some free services that offer thousands of old movies and series.
Consumer Reports recently analyzed all the free streaming services available now and suggests you may want to take a look at:
- Amazon Freevee
- Crackle
- Pluto TV
- Tubi TV
- Roku channel
Click here to read the full report.
So what's the catch?
According to Consumer Reports, you won't find recently released films like Barbie or popular HBO shows, but you will get a decent variety for free. In exchange, you'll be watching more ads, according to Jim Willcox of Consumer Reports.
"You're even starting to see right now some companies promoting the fact that 'oh, we only have three ads per hour' or something like that," he said.
If you're thinking you really don't want to subscribe to another two, three, or four services, the reality is that you don't have to.
A lot of those free streaming services have a lot of the same content," Willcox said,
That means both free services, and the giants like Netflix and Hulu, have to differentiate their content while also offering affordable options.
"Clearly consumers are hitting a threshold in terms of how much money they're willing to pay each month," Willcox said.
Nicolas says those free services can keep you entertained, strike or no strike.
"There is never a shortage of content to watch," she said.
That way you don't waste your money.
__________________________
"Don't Waste Your Money" is a registered trademark of Scripps Media, Inc. ("Scripps").
Follow John:
- Facebook:John Matarese Money
- Instagram: @johnmataresemoney
- Twitter: @JohnMatarese
For more consumer news and money saving advice, go to www.dontwasteyourmoney.com | https://www.abc15.com/money/consumer/dont-waste-your-money/watch-tv-free-with-these-no-charge-streaming-services | 2023-07-31T11:50:45 | 1 | https://www.abc15.com/money/consumer/dont-waste-your-money/watch-tv-free-with-these-no-charge-streaming-services |
HOUSTON, July 31, 2023 /PRNewswire/ -- McDermott has been awarded a project management consultancy (PMC) and engineering, procurement, and construction management (EPCM) contract for the Naphtha Cracker Expansion (Phase II) polypropylene expansion and new ethylene derivative unit project from Indian Oil Corporation Limited (IOCL). The project is located at the Panipat Refinery and Petrochemical Complex, located 62 miles (100 kilometers) from New Delhi, India.
The project will increase the ethylene production capacity of the naphtha cracker unit (NCU) by approximately 20 percent. The additional ethylene and propylene production will act as feed for downstream polymer units. The polymer products will be used for the manufacture of household and industrial items, including containers, automobile parts, furniture, and heavy-duty films.
"McDermott is currently executing four other projects for IOCL, including the maleic anhydride (MAH) unit at the same site, allowing us to leverage our local resources and expertise while realizing synergies," said Vaseem Khan, Senior Vice President, Global Operations. "Furthermore, the project supports the growing demand for ethylene and propylene which will reduce imports and accelerate economic development in the area."
McDermott will provide comprehensive EPCM services and overall project management for the duration of the project, which will be executed from its Center of Excellence in Gurugram, India.
About McDermott
McDermott is a premier, fully-integrated provider of engineering and construction solutions to the energy industry. Our customers trust our technology-driven approach engineered to responsibly harness and transform global energy resources into the products the world needs. From concept to commissioning, McDermott's innovative expertise and capabilities advance the next generation of global energy infrastructure—empowering a brighter, more sustainable future for us all. Operating in over 54 countries, McDermott's locally-focused and globally-integrated resources include more than 30,000 employees, a diversified fleet of specialty marine construction vessels and fabrication facilities around the world. To learn more, visit www.mcdermott.com.
Forward-Looking Statements
McDermott cautions that statements in this press release which are forward-looking, and provide other than historical information, involve risks, contingencies and uncertainties. These forward-looking statements include, among other things, statements about the expected scope and execution of the project discussed in this press release. Although we believe that the expectations reflected in those forward-looking statements are reasonable, we can give no assurance that those expectations will prove to have been correct. Those statements are made by using various underlying assumptions and are subject to numerous risks, contingencies and uncertainties, including, among others: adverse changes in the markets in which we operate or credit or capital markets; our inability to successfully execute on contracts in backlog; changes in project design or schedules; the availability of qualified personnel; changes in the terms, scope or timing of contracts, contract cancellations, change orders and other modifications and actions by our customers and other business counterparties; changes in industry norms; actions by lenders, other creditors, customers and other business counterparties of McDermott; and adverse outcomes in legal or other dispute resolution proceedings. If one or more of these risks materialize, or if underlying assumptions prove incorrect, actual results may vary materially from those expected. You should not place undue reliance on forward-looking statements. This communication reflects the views of McDermott's management as of the date hereof. Except to the extent required by applicable law, McDermott undertakes no obligation to update or revise any forward-looking statement.
Contacts:
Global Media Relations
Reba Reid
Senior Director, Global Communications and Marketing
+1 281 588 5636
RReid@McDermott.com
Business Line Media Relations
Barbara Knight
Senior Director, Business Line Communications and Marketing
+971 56 403 2903
BBKnight@McDermott.com
View original content to download multimedia:
SOURCE McDermott International, Ltd | https://www.kswo.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ | 2023-07-31T11:50:45 | 0 | https://www.kswo.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ |
Adult Males are Slightly More Likely to Live with Parents Than Their Female Counterparts
58% of Gen Z Consumers Live with Family Members
SAN FRANCISCO, July 31, 2023 /PRNewswire/ -- LendingClub Corporation (NYSE: LC), the parent company of LendingClub Bank, America's leading digital marketplace bank, today released findings from the 24th edition of the Reality Check: Paycheck-To-Paycheck research series, conducted in partnership with PYMNTS. The Household Finances Deep Dive Edition examines the impact of household composition on consumers' ability to manage expenses and put aside savings. The series draws on insights from a survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data.
The Paycheck-to-Paycheck Landscape
In June 2023, 61% of U.S. consumers lived paycheck to paycheck, unchanged from June 2022 — as is the share of those struggling to pay bills (at 21%) — even though more middle-income consumers cited living paycheck to paycheck in June 2023 than last year. Among consumers earning $50,000 to $100,000, 65% lived paycheck to paycheck as of June 2023, compared to 60% in June 2022. Meanwhile, the shares of high-income consumers — those earning more than $100,000 annually — and low-income consumers — those earning less than $50,000 annually — living paycheck to paycheck in June 2023 sit at 45% and 77%, respectively, relatively unchanged from June 2022.
This stability in the financial situation of U.S. households indicates that consumers continue to adapt to inflationary pressures, finding ways to manage their spending and live within their means.
Household Composition Determines Financial Lifestyle
Consumers living with only a partner or spouse are likely to face less financial hardship, while those with dependents and those living with friends or housemates are more likely to live paycheck to paycheck.
The research finds that 86% of consumers live with one or more people, and one-third of paycheck-to-paycheck consumers live in households of four or more people. Consumers not living paycheck to paycheck are most likely to reside in two-person households, at 41%. Meanwhile, 49% of millennials and 55% of bridge millennials live in households of four or more people, making them the age groups most likely to reside in the largest households.
There is also a direct correlation among household size, stage of life and financial lifestyle. As household size increases, the ratio of income earners to non-earners typically falls, attributable to households with dependent children. When looking at the share of paycheck-to-paycheck consumers who live in a two-member household, the data finds that 54% do so — 7 percentage points below the sample average. Meanwhile, at 66%, consumers with children under the age of 18 are 12% more likely to live paycheck to paycheck than those without children, at 59%. Among consumers living with friends or housemates, 77% live paycheck to paycheck — the most likely to do so. This suggests that those sharing expenses with a partner or spouse fare better, that is until they have children or even parents to support.
"As household size increases, the ratio of income earners to household members typically falls, creating a higher likelihood of financial distress," said Alia Dudum, LendingClub's Money Expert. "The relationship between household income and household composition explains why many families tend to struggle financially and why millennials and bridge millennials, many of whom are in their peak child-rearing years, tend to remain financially vulnerable."
Economic Considerations Top Reason to Stay in the Family Household
Economics are the main driver for consumers to live with family longer, with 43% wanting to save money and 30% unable to afford housing independently. Besides economic reasons, consumers remain at home to maintain family ties (24%), for transitional reasons (23%), and to provide care (22%).
At one-fifth (20%), adult males are slightly more likely to live with parents than their female counterparts (18%), a phenomenon that grows significantly among those financially struggling (26% of males compared to 18% of females). At 58%, Gen Z is the generation most likely to stay with family members, with 50% citing economic reasons. Members of Gen Z living with three or more people — often familial settings — spent 22% of their income on housing, compared to 30% of those living alone or with a partner.
That said, consumers living with family members to offset expenses are not planning extended stays. For example, one-third of those consumers expect to move out in the coming year, particularly millennials and bridge millennials.
Financial Transparency Determined by Relationship Status
Financial transparency within shared households is paramount to ensure bills are paid and expenses are covered, but the transparency level depends on who consumers live with. Couples living together share financial information 87% of the time and have a joint bank account 76% of the time. Parents are also likely to discuss finances with the children residing in their household, with 45% of parents sharing financial information with their children and 34% granting them access to a shared account. Bill splitting is the most common financial interaction for consumers living with friends or housemates, at 74%. Additionally, borrowing money from other household members is a financial option many use to make ends meet, with consumers mostly engaging in this practice with parents or siblings, at 47%, and friends and housemates, at 44%.
Families and couples maintain outstanding credit card balances that are significantly higher, on average, than those of consumers who live alone. Consumers with children under the age of 18 average 50% more credit card debt than those who live alone. Families represent the lion's share of credit card spending, holding average balances of $6,300 for consumers living with a partner and $7,200 for those living with children under 18. Living with a partner or children also significantly increases a consumer's likelihood of having an auto loan or mortgage.
"With today's inflationary pressures, sharing household finances has become not only common but crucial," continued Dudum. "The increasing complexity of modern lifestyles and the rising cost of living have necessitated a shift in the way consumers approach household finances. One person solely bearing the burden of managing all financial matters has become a minority practice. Instead, couples, families, and even roommates increasingly jointly navigate their economic realities, and it's a trend that is here to stay."
To view the full report, visit: https://www.pymnts.com/study/reality-check-paycheck-to-paycheck-inflation-household-spending-shared-expenses/
Methodology
New Reality Check: The Paycheck-to-Paycheck Report — The Household Finances Deep Dive Edition is based on a census-balanced survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data. The data in this report is not intended to be a representation of LendingClub's core member base. The Paycheck-to-Paycheck series expands on existing data published by government agencies, such as the Federal Reserve System and the Bureau of Labor Statistics, to provide a deep look into the core elements of American consumers' financial wellness: income, savings, debt and spending choices. Our sample was balanced to match the U.S. adult population in a set of key demographic variables: 51% of respondents identified as female, 33% were college-educated and 38% declared incomes of more than $100,000 per year.
About LendingClub
LendingClub Corporation (NYSE: LC) is the parent company of LendingClub Bank, National Association, Member FDIC. LendingClub Bank is the leading digital marketplace bank in the U.S., where members can access a broad range of financial products and services designed to help them pay less when borrowing and earn more when saving. Based on more than 150 billion cells of data and over $85 billion in loans, our advanced credit decisioning and machine-learning models are used across the customer lifecycle to expand seamless access to credit for our members while generating compelling risk-adjusted returns for our loan investors. Since 2007, more than 4.7 million members have joined the Club to help reach their financial goals. For more information about LendingClub, visit https://www.lendingclub.com.
Contact:
For Investors: IR@lendingclub.com
Media Contact: Press@lendingclub.com
PYMNTS Contact: information@PYMNTS.com
View original content to download multimedia:
SOURCE LendingClub Corporation | https://www.wbrc.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ | 2023-07-31T11:50:46 | 0 | https://www.wbrc.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ |
President Joe Biden is set to visit Arizona on a multi-state tour over the course of several days in August.
The White House announced the president's trip Monday morning, saying he would be taking the trip from August 7-10, 2023.
Arizona is among three locations on his visit. He will also head to New Mexico and Utah on the trip.
White House officials have not provided more information on the trip. | https://www.abc15.com/news/state/president-joe-biden-set-to-visit-arizona-on-multi-state-tour-in-august | 2023-07-31T11:50:51 | 1 | https://www.abc15.com/news/state/president-joe-biden-set-to-visit-arizona-on-multi-state-tour-in-august |
Impact "much bigger than a single project"
WAYNESBORO, Ga., July 31, 2023 /PRNewswire/ -- Bechtel, the engineering, procurement, and construction company brought in to complete construction on new Units 3 and 4 at the Vogtle nuclear power plant in Georgia, today issued the following statement from Brendan Bechtel, Bechtel Chairman and CEO, marking the start of commercial operations for Unit 3:
"We are extremely proud of Bechtel's part in achieving this milestone. Our team has been 100 percent committed to Vogtle's completion since being brought in to finish the project.
"Today's start of commercial operations for Vogtle Unit 3 gives the Southeast a major new source of clean, reliable, carbon-free baseload energy. And, as the first new nuclear unit built in the U.S. in more than 30 years, it helps put America back on the map as a leader in the global nuclear industry.
"Bechtel has supported the design and construction of 150 nuclear plants worldwide. We know firsthand how Vogtle Units 3 and 4 go a long way in restoring America's muscle memory in nuclear construction, including the workforce and domestic supply chains required to build America's largest nuclear power plant. Vogtle Unit 3 comes online at a pivotal time when energy security concerns and the need to cut carbon emissions are driving growth in the world's nuclear fleet.
"Plant Vogtle will generate more carbon-free electricity yearly than any other energy facility currently operating in the country. Its completion reinforces that the United States is the responsible partner of choice for new nuclear energy around the world, and maintains U.S. interests in ensuring strong safety, security, and non-proliferation standards. This is why Vogtle's impact is much bigger than a single project.
"Thank you to the thousands of skilled craft professionals, union partners, engineers, project managers, procurement experts, suppliers, subcontractors, and everyone who made this day possible. And thank you to Georgia Power and Southern Nuclear for the opportunity to bring this project over the finish line. We look forward to doing the same with Unit 4 in the coming months."
Background
In 2017, Bechtel was brought in by Georgia Power and Southern Nuclear to take over construction of Vogtle Units 3 and 4, bringing extensive experience supporting the design and construction of 150 nuclear plants worldwide. Vogtle Units 3 and 4 are the first Westinghouse AP1000 units to ever be built in the U.S.
Bechtel has completed more than 76,000 megawatts of new nuclear generation capacity and has designed, built, or performed engineering and/or construction services on more than 80% of nuclear plants in the United States. Today, the company leads efforts in designing and constructing advanced nuclear plants, critical to global efforts to achieve net zero carbon emissions.
Bechtel partnered with North America's Building Trades Unions (NABTU) to build Plant Vogtle Units 3 and 4. At peak, Bechtel and NABTU had a combined 9,000 workers on site.
About Bechtel
Bechtel is a trusted engineering, construction, and project management partner to industry and government. Differentiated by the quality of our people and our relentless drive to deliver the most successful outcomes, we align our capabilities to our customers' objectives to create a lasting positive impact. Since 1898, we have helped customers complete more than 25,000 projects in 160 countries on all seven continents that have created jobs, grown economies, improved the resiliency of the world's infrastructure, increased access to energy, resources, and vital services, and made the world a safer, cleaner place.
Bechtel serves the Energy; Infrastructure; Manufacturing & Technology; Mining & Metals; and Nuclear, Security & Environmental markets. Our services span from initial planning and investment through start-up and operations. www.bechtel.com
Contact:
Amanda Meixel
ammeixel@bechtel.com
M: 1-706-360-5526
P: 1-703-429-6313
View original content to download multimedia:
SOURCE Bechtel | https://www.wflx.com/prnewswire/2023/07/31/bechtel-commercial-operations-vogtle-unit-3-is-an-important-milestone-us-nuclear-industry/ | 2023-07-31T11:50:50 | 0 | https://www.wflx.com/prnewswire/2023/07/31/bechtel-commercial-operations-vogtle-unit-3-is-an-important-milestone-us-nuclear-industry/ |
Forester Wilderness Ad Showcases 'A Beautiful Silence' and Partnership with the National Park Foundation
CAMDEN, N.J., July 31, 2023 /PRNewswire/ -- Subaru of America, Inc. today unveiled a new creative spot focused on the automaker's efforts to expand access to the outdoors for all. Featuring the all-new 2023 Subaru Forester Wilderness, the advertisement stars Keivonn Woodard, the Emmy-nominated, 10-year-old Deaf actor and showcases the automaker's long-standing partnership with the National Park Foundation.
In the creative, titled "A Beautiful Silence," a father and his young son, who is Deaf, drive through Yosemite National Park, with the wonders of the park's beauty surrounding them. Featuring audio elements and American Sign Language (ASL), the spot shows how the pair experience the park's natural wonders in different ways, but share the special feeling that nature brings forth.
"The outdoors are for everyone, and whether it's a trip to a national park or a walk in the woods, we believe everyone should have the opportunity to experience its beauty," said Alan Bethke, Senior Vice President, Marketing, Subaru of America, Inc. "Through our partnership with the National Park Foundation and our commitment to making safe and capable vehicles like the Forester Wilderness, we're hoping that even more people will be inspired to explore the wonders of nature, just like the father and son in our new creative."
Through the National Park Foundation's Outdoor Exploration initiative and ParkVentures program, Subaru is helping more people create life-long relationships with the outdoors. The campaign seeks to make the outdoors more accessible to communities that have been historically excluded from parks, either through a community's physical presence on public lands or through the narrative of who belongs outdoors.
Last year, with support from Subaru, ParkVentures supported the efforts of more than 55 organizations to connect more people, including those with differing abilities, to meaningful experiences in United States national parks. Subaru also developed a direct relationship with ParkVentures grantee Black People Who Hike, which aims to help address the lack of representation in parks by empowering, educating and engaging Black people in the outdoors. Subaru provided the vehicles, gear, and experiences for an enhanced retreat in Acadia National Park to help create safe, welcoming spaces and cultivate lasting relationships with the outdoors.
Subaru is the largest corporate donor to the National Park Foundation and has provided over $70 million to organizations working to conserve national parks. To learn more about the automaker's partnership with National Park Foundation and over 20 years of environmentally focused initiatives, please visit Subaru.com/earth.
The new Subaru Forester Wilderness spot, created in collaboration with agency partner Carmichael Lynch, celebrates the automaker's devotion to adventure and environmental stewardship. Beginning today, "A Beautiful Silence" will run in 30-second format on national television and be featured in 15-second format in targeted digital and social media promotions throughout August, while a 60-second version will be available on YouTube.
About Subaru of America, Inc.
Subaru of America, Inc. (SOA) is a wholly owned subsidiary of Subaru Corporation of Japan. Headquartered at a zero-landfill office in Camden, N.J., the company markets and distributes Subaru vehicles, parts and accessories through a network of more than 630 retailers across the United States. All Subaru products are manufactured in zero-landfill plants and Subaru of Indiana Automotive, Inc. is the only U.S. automobile manufacturing plant to be designated a backyard wildlife habitat by the National Wildlife Federation. SOA is guided by the Subaru Love Promise, which is the company's vision to show love and respect to everyone, and to support its communities and customers nationwide. Over the past 20 years, SOA and the SOA Foundation have donated more than $300 million to causes the Subaru family cares about, and its employees have logged nearly 88,000 volunteer hours. As a company, Subaru believes it is important to do its part in making a positive impact in the world because it is the right thing to do. For additional information visit media.subaru.com. Follow us on Facebook, Twitter, and Instagram.
Media Contacts:
Diane Anton
Corporate Communications Manager
(856) 488-5093
danton@subaru.com
Adam Leiter
Corporate Communications Specialist
(856) 488-8668
aleiter@subaru.com
View original content to download multimedia:
SOURCE Subaru of America, Inc. | https://www.kswo.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ | 2023-07-31T11:50:51 | 1 | https://www.kswo.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ |
HOUSTON, July 31, 2023 /PRNewswire/ -- McDermott has been awarded a project management consultancy (PMC) and engineering, procurement, and construction management (EPCM) contract for the Naphtha Cracker Expansion (Phase II) polypropylene expansion and new ethylene derivative unit project from Indian Oil Corporation Limited (IOCL). The project is located at the Panipat Refinery and Petrochemical Complex, located 62 miles (100 kilometers) from New Delhi, India.
The project will increase the ethylene production capacity of the naphtha cracker unit (NCU) by approximately 20 percent. The additional ethylene and propylene production will act as feed for downstream polymer units. The polymer products will be used for the manufacture of household and industrial items, including containers, automobile parts, furniture, and heavy-duty films.
"McDermott is currently executing four other projects for IOCL, including the maleic anhydride (MAH) unit at the same site, allowing us to leverage our local resources and expertise while realizing synergies," said Vaseem Khan, Senior Vice President, Global Operations. "Furthermore, the project supports the growing demand for ethylene and propylene which will reduce imports and accelerate economic development in the area."
McDermott will provide comprehensive EPCM services and overall project management for the duration of the project, which will be executed from its Center of Excellence in Gurugram, India.
About McDermott
McDermott is a premier, fully-integrated provider of engineering and construction solutions to the energy industry. Our customers trust our technology-driven approach engineered to responsibly harness and transform global energy resources into the products the world needs. From concept to commissioning, McDermott's innovative expertise and capabilities advance the next generation of global energy infrastructure—empowering a brighter, more sustainable future for us all. Operating in over 54 countries, McDermott's locally-focused and globally-integrated resources include more than 30,000 employees, a diversified fleet of specialty marine construction vessels and fabrication facilities around the world. To learn more, visit www.mcdermott.com.
Forward-Looking Statements
McDermott cautions that statements in this press release which are forward-looking, and provide other than historical information, involve risks, contingencies and uncertainties. These forward-looking statements include, among other things, statements about the expected scope and execution of the project discussed in this press release. Although we believe that the expectations reflected in those forward-looking statements are reasonable, we can give no assurance that those expectations will prove to have been correct. Those statements are made by using various underlying assumptions and are subject to numerous risks, contingencies and uncertainties, including, among others: adverse changes in the markets in which we operate or credit or capital markets; our inability to successfully execute on contracts in backlog; changes in project design or schedules; the availability of qualified personnel; changes in the terms, scope or timing of contracts, contract cancellations, change orders and other modifications and actions by our customers and other business counterparties; changes in industry norms; actions by lenders, other creditors, customers and other business counterparties of McDermott; and adverse outcomes in legal or other dispute resolution proceedings. If one or more of these risks materialize, or if underlying assumptions prove incorrect, actual results may vary materially from those expected. You should not place undue reliance on forward-looking statements. This communication reflects the views of McDermott's management as of the date hereof. Except to the extent required by applicable law, McDermott undertakes no obligation to update or revise any forward-looking statement.
Contacts:
Global Media Relations
Reba Reid
Senior Director, Global Communications and Marketing
+1 281 588 5636
RReid@McDermott.com
Business Line Media Relations
Barbara Knight
Senior Director, Business Line Communications and Marketing
+971 56 403 2903
BBKnight@McDermott.com
View original content to download multimedia:
SOURCE McDermott International, Ltd | https://www.wbrc.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ | 2023-07-31T11:50:53 | 0 | https://www.wbrc.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ |
- Cash, cash equivalents, and marketable securities totaled $349.0 million as of June 30, 2023
- Announced positive interim data from BHV-7000 EEG biomarker study demonstrating evidence of central nervous system (CNS) target engagement, confirming previously reported preclinical and clinical data, and highlighting the paradigm-changing potential of BHV-7000 in the treatment of epilepsy and mood disorders
- Brain penetrant TYK2/JAK1 inhibitor, BHV-8000, advanced into Phase 1 with projected therapeutic concentrations achieved and well-tolerated profile observed to date
- Advanced targeted extracellular protein degradation platform with potential to support numerous clinical candidates across a broad range of high unmet need indications
- Orphan drug designation (ODD) granted by the European Commission for taldefgrobep alfa a novel anti-myostatin adnectin, for the treatment of spinal muscular atrophy (SMA)
- Type A meeting planned with FDA regarding troriluzole program in Spinocerebellar Ataxia Type 3 (SCA3) and enrollment in Phase 3 obsessive compulsive disorder (OCD) trial expected to complete at end of 2023
NEW HAVEN, Conn., July 31, 2023 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the second quarter ended June 30, 2023, and provided a review of recent accomplishments and anticipated upcoming milestones.
Vlad Coric, M.D., Chairman and Chief Executive Officer of Biohaven, commented, "In less than a year since our spin-off, the Biohaven team has driven strong and consistent progress across multiple drug development platforms. We were excited to recently report positive interim data from the ongoing EEG biomarker study of our lead Kv7 activator, BHV-7000. As expected, BHV-7000 demonstrated CNS activity consistent with what has been reported in EEG studies with other Kv7 channel activators in development that are clinically effective in treating epilepsy and with other approved anti-seizure medications. Importantly, BHV-7000 demonstrates CNS target engagement but is not associated with the typical CNS adverse events associated with other ASMs, like somnolence and fatigue. We look forward to completing the higher dose groups in this EEG study and initiating Phase 2/3 studies with our once daily, extended-release oral formulation later this year."
Dr. Coric continued, "We also shared a number of equally exciting announcements across our broader pipeline this quarter. We successfully administered the first three doses in the SAD portion of our ongoing SAD/MAD study evaluating BHV-8000, an oral, brain-penetrant, dual TYK2/JAK1 inhibitor. Potential therapeutic concentrations of BHV-8000 were achieved and BHV-8000 was well tolerated with only mild adverse events reported, reinforcing our plans to start a Phase 2 clinical trial with BHV-8000 in Parkinson's disease and potentially other neuroinflammatory diseases in 2024. In addition, we have advanced IND enabling preclinical studies and remain on track to submit an IND with our IgG degrader, BHV-1300, later this year. We also anticipate submitting an IND with our IgA degrader in 2024 as we continue to advance multiple clinical degrader candidates across a wide range of indications. We also shared key updates for our taldefgrobep alfa program (an anti-myostatin) with enrollment completion in our pivotal study in SMA and a planned Phase 2 trial initiation in obesity."
"Finally, I want to reaffirm Biohaven's commitment to the SCA3 patient community in spite of the recent disappointing regulatory decision by the FDA not to review our submitted NDA. Given the seriousness of SCA3 and consistent treatment benefits observed across multiple prespecified outcome measures, including an 80% delay in disease progression over the one-year study period with substantial risk reduction in falls, we believe that full consideration of all available data is warranted for this ultra-rare disease. Biohaven has built its foundation around our patient mission and we plan to continue to work with regulatory agencies to try to advance troriluzole for individuals suffering from SCA3."
Second Quarter 2023 and Recent Business Highlights
- Announced positive interim data from EEG biomarker study with BHV-7000 - In July 2023, the Company provided a preliminary data update from the ongoing electroencephalogram (EEG) biomarker study for the Kv7 Channel Activator platform. Preliminary Phase 1 data confirmed evidence of target engagement in the central nervous system for subjects with projected therapeutic concentrations of BHV-7000 (based on the EC50 from preclinical models), measured by changes from baseline in EEG spectral power that occurred after dosing. These pharmacodynamic (PD) effects were similar to those reported in the literature for anti-seizure medicines (ASMs), including Kv7 activators in development that are clinically effective in treating epilepsy. BHV-7000's PD effects were also differentiated from those reported for other Kv7 activators including, specifically, the absence of increases in EEG spectral power in frequency bands associated with drowsiness and somnolence. Results from the low-dose group validate the preclinical hypothesis, confirm the Phase 1 SAD/MAD clinical data, and provide strong support for Biohaven's plans to initiate pivotal studies with BHV-7000 in focal epilepsy and bipolar disorder in the second half of 2023. The preliminary data highlight BHV-7000's differentiation and potentially favorable clinical profile compared to other ASMs, and the Company expects to present the complete EEG results by the end of the year. Additionally, new pharmacokinetic data from multiple clinical formulations being studied has now confirmed a once daily extended-release oral formulation that will be used in the Phase 2/3 clinical programs.
- Successfully dosed three cohorts with single ascending doses of oral, brain penetrant, dual TYK2/JAK1 agent, BHV-8000 - In July 2023, the Company announced that it successfully dosed three cohorts in the SAD portion of an ongoing SAD/MAD Phase 1 study evaluating brain penetrant TYK2/JAK1 agent, BHV-8000 in healthy volunteers. The ongoing Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics (PK) and PD of single and multiple ascending doses of BHV-8000 in healthy volunteers. Based on the preliminary data available, projected therapeutic concentrations of BHV-8000 were achieved, and BHV-8000 was well tolerated with only mild adverse events reported. These data provide support for further development of BHV-8000, and the Company anticipates beginning a Phase 2 clinical trial with BHV-8000 in Parkinson's disease and potentially other neuroinflammatory diseases in 2024. The Company had previously reported initiation of dosing with BHV-8000 in the Phase 1 study at Biohaven's R&D Day in May 2023.
- Reported on continued progress observed with Biohaven's first-in-class bispecific IgG degrader, BHV-1300, as compound advances to IND filing in 2H2023 - In July 2023, the Company shared an update on BHV-1300's highly competitive safety, manufacturable and PD profile. The Company is assembling a pipeline of partially de-risked, follow-on IgG degraders as well as antigen-specific degraders providing both optionality and a sustainable output of drug candidates for several years. An IND application for BHV-1300 is on track for submission in 2023 and an IND application for Biohaven's IgA degrader on track for submission in 2024
- Type A meeting planned to comprehensively address FDA's concerns in connection with Troriluzole program in SCA3 - In July 2023, the Company announced that the FDA informed Biohaven it would not review the recently submitted New Drug Application (NDA) for troriluzole for the treatment of spinocerebellar ataxia type 3 (SCA3), an ultra-rare, genetically-defined, neurodegenerative disease associated with progressive disability, frequent falls, loss of ambulation, speech and swallowing impairment, and premature death that is the most common SCA genotype worldwide. The FDA informed Biohaven it would not review the application given that the study's primary endpoint was not met and thus, would not permit a substantive review. Biohaven is committed to working closely with the FDA to bring troriluzole to people with SCA3 as quickly as possible given no therapy is currently approved for this ultra-rare genetic disorder. Biohaven plans to request a Type A meeting to comprehensively address FDA's concerns cited in the refusal to file letter.
- EMA orphan drug designation granted for taldefgrobep alfa for the treatment of SMA: - In July 2023, the Company announced that taldefgrobep alfa received orphan drug designation (ODD) from the European Commission for taldefgrobep for the treatment of SMA. Taldefgrobep previously received Fast-Track and ODD from the FDA. At Biohaven's R&D Day, the Company announced plans to complete randomization of approximately 180 patients in global SMA trial.
Upcoming Milestones:
Biohaven is progressing its product candidates through clinical programs in a number of common and rare disorders. The Company plans to reach significant pipeline milestones in the coming periods. Biohaven expects to:
- Announce Phase 1 EEG study results by year-end 2023: The Company expects to present complete results from its ongoing EEG study with BHV-7000 in healthy volunteers by the end of the year.
- Initiate Phase 2/3 studies with BHV-7000 in the second half of 2023: Biohaven expects to initiate pivotal trials in patients with focal epilepsy and bipolar disorder in the second half of 2023.
- Submit IND with BHV-1300, the Company's lead extracellular degrader: The Company expects to submit an IND with pan-IgG degrader BHV-1300 in the second half of 2023 and expects to initiate Phase 2 studies in 2024.
- Submit IND with selective Gd-IgA1 degrader: The Company expects to submit an IND with a Gd-IgA1 degrader indicated for IgA nephropathy in the first half of 2024.
- Initiate Phase 2 study with BHV-8000: The Company commenced Phase 1 studies with BHV-8000, an oral, brain-penetrant, dual TYK2/JAK1 inhibitor for neuroinflammatory disorders, in the first half of 2023 and expects to initiate a Phase 2 study in Parkinson's disease in 2024.
- Submit IND with BHV-2100 in chronic pain: The Company expects to submit an IND with BHV-2100, a selective TRPM3 antagonist in the Company's ion channel platform, in the second half of 2023.
- Complete enrollment in Phase 3 study of troriluzole in OCD in 2023: Two Phase 3 randomized, double-blind, placebo-controlled studies of troriluzole in OCD are expected to enroll up to 700 patients (in each trial) across nearly 200 global study sites. The Company anticipates completing enrollment in at least one Phase 3 trial by year-end 2023.
- Complete enrollment in Phase 3 clinical study of taldefgrobep alfa in SMA: The Company expects to complete enrollment in the study of taldefgrobep in SMA in the second half of 2023.
- Continue advancements across multiple neuroscience and immunoscience indications: The Company's preclinical pipeline includes a platform of bispecific degraders of extracellular proteins directed against IgG, IgA and other targets, TRPM3 and Kv7 family of ion channels, and other undisclosed targets, including those with disease-modifying potential.
Capital Position:
Cash, cash equivalents and marketable securities as of June 30, 2023 was $349.0 million, including $13.9 million of restricted cash, and excluding $40.4 million of cash payable to Biohaven Pharmaceutical Holding Company Ltd. (the Former Parent), compared to $467.9 million, including $2.5 million of restricted cash, and excluding $35.2 million of cash payable to the Former Parent, as of December 31, 20221.
Second Quarter 2023 Financial Highlights:
Research and Development (R&D) Expenses: R&D expenses, including non-cash share-based compensation costs, were $79.5 million for the three months ended June 30, 2023, compared to $177.1 million for the three months ended June 30, 2022. Non-cash share-based compensation expense was $2.5 million for the three months ended June 30, 2023, a decrease of $10.3 million as compared to the same period in 2022. Non-cash share-based compensation expense was higher in the second quarter of 2022 primarily because expense allocated from the Former Parent equity plan, prior to the spin-off, was based on equity awards with higher grant date fair values.
General and Administrative (G&A) Expenses: General and administrative expenses were $14.5 million for the three months ended June 30, 2023, compared to $20.0 million for the three months ended June 30, 2022. The decrease of $5.5 million was primarily due to decreased non-cash share-based compensation costs. Non-cash share-based compensation expense was $2.2 million for the three months ended June 30, 2023, a decrease of $5.8 million as compared to the same period in 2022. Non-cash share-based compensation expense was higher in the second quarter of 2022 primarily because expense allocated from the Former Parent equity plan, prior to the spin-off, was based on equity awards with higher grant date fair values.
Other Income (Expense), Net: Other income (expense), net was a net income of $5.8 million for the three months ended June 30, 2023, compared to net expense of $0.1 million for the three months ended June 30, 2022. The increase of $5.9 million was primarily due to an increase in net investment income and an increase of $1.7 million in other income related to our transition services provided to the Former Parent, which is largely non-recurring.
Net Loss: Biohaven reported a net loss for the three months ended June 30, 2023, of $90.3 million, or $1.32 per share, compared to $203.3 million, or $5.16 per share, for the same period in 2022. Non-GAAP adjusted net loss for the three months ended June 30, 2023 was $85.7 million, or $1.25 per share, compared to $182.5 million, or $4.63 per share for the same period in 2022. These non-GAAP adjusted net loss and non-GAAP adjusted net loss per share measures, more fully described below under "Non-GAAP Financial Measures," exclude non-cash share-based compensation charges. A reconciliation of the GAAP financial results to non-GAAP financial results is included in the tables below. For periods prior to Biohaven's spin-off from the Former Parent on October 3, 2022 (the "Spin-Off"), net loss per share and non-GAAP adjusted net loss per share were calculated based on the 39,375,944 common shares of Biohaven distributed to the Former Parent shareholders at the time of the distribution, including common shares issued in connection with the Former Parent share options that were settled on October 3, 2022 and common shares issued in connection with the Former Parent restricted share units that vested on October 3, 2022. The same number of shares is being utilized for the calculation of basic and diluted earnings per share for all periods presented prior to the Spin-Off.
Non-GAAP Financial Measures
This press release includes financial results prepared in accordance with accounting principles generally accepted in the United States (GAAP), and also certain non-GAAP financial measures. In particular, Biohaven has provided non-GAAP adjusted net loss and adjusted net loss per share, which are adjusted to exclude non-cash share-based compensation, which is substantially dependent on changes in the market price of common shares. Non-GAAP financial measures are not an alternative for financial measures prepared in accordance with GAAP. However, Biohaven believes the presentation of non-GAAP adjusted net loss and adjusted net loss per share, when viewed in conjunction with GAAP results, provides investors with a more meaningful understanding of ongoing operating performance and can assist investors in comparing Biohaven's performance between periods.
In addition, these non-GAAP financial measures are among those indicators Biohaven uses as a basis for evaluating performance, and planning and forecasting future periods. These non-GAAP financial measures are not intended to be considered in isolation or as a substitute for GAAP financial measures. A reconciliation between these non-GAAP measures and the most directly comparable GAAP measures is provided later in this news release.
About Biohaven
Biohaven is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases. Biohaven's experienced management team brings with it a track record of delivering new drug approvals for products for diseases such as migraine, depression, bipolar and schizophrenia. The company is advancing a pipeline of therapies for diseases, many of which have limited or no treatment options, leveraging its proven drug development capabilities and proprietary platforms, including Kv7 ion channel modulation for epilepsy and neuronal hyperexcitability, glutamate modulation for obsessive-compulsive disorder and spinocerebellar ataxia, myostatin inhibition for neuromuscular diseases and metabolic disorders, and brain-penetrant TYK2/JAK1 inhibition for neuroinflammatory disorders. Biohaven's portfolio of early- and late-stage product candidates also includes discovery research programs focused on TRPM3 channel activation for neuropathic pain, CD-38 antibody recruiting, bispecific molecules for multiple myeloma, antibody drug conjugates (ADCs), and targeted extracellular protein degradation platform technology (MoDE™) with potential application in neurological disorders, cancer, and autoimmune diseases.
Forward-looking Statements
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including "continue", "plan", "will", "believe", "may", "expect", "anticipate" and similar expressions, is intended to identify forward-looking statements. Investors are cautioned that any forward-looking statements, including statements regarding the future development, timing and potential marketing approval and commercialization of development candidates, are not guarantees of future performance or results and involve substantial risks and uncertainties. Actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors including: the expected timing, commencement and outcomes of Biohaven's planned and ongoing clinical trials; the timing of planned interactions and filings with the FDA; the timing and outcome of expected regulatory filings; complying with applicable U.S. regulatory requirements; the potential commercialization of Biohaven's product candidates; the potential for Biohaven's product candidates to be first in class therapies; and the effectiveness and safety of Biohaven's product candidates. Additional important factors to be considered in connection with forward-looking statements are described in Biohaven's filings with the Securities and Exchange Commission, including within the sections titled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations". The forward-looking statements are made as of the date of this new release, and Biohaven does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
MoDEs is a trademark of Biohaven Therapeutics Ltd.
Investor Contact:
Jennifer Porcelli
Vice President, Investor Relations
jennifer.porcelli@biohavenpharma.com
+1 (201) 248-0741
Media Contact:
Mike Beyer
Sam Brown Inc.
mikebeyer@sambrown.com
+1 (312) 961-2502
View original content to download multimedia:
SOURCE Biohaven Ltd. | https://www.wflx.com/prnewswire/2023/07/31/biohaven-reports-second-quarter-2023-financial-results-recent-business-developments/ | 2023-07-31T11:50:57 | 1 | https://www.wflx.com/prnewswire/2023/07/31/biohaven-reports-second-quarter-2023-financial-results-recent-business-developments/ |
Introducing the industry's first-ever utility side-by-side with a 1500cc 3-cylinder engine for more power to make tough jobs easier and the industry's only STEELDRIVE transmission for greater durability
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- Polaris Off Road, the global leader in powersports and off-road innovation, is once again breaking new ground with the industry's first extreme duty utility side-by-side: the all-new RANGER XD 1500. With its unprecedented capability, brute strength and unmatched comfort, the new extreme duty class of RANGER side-by-sides are engineered with the first-ever ProStar 1500cc 3-cylinder engine that offers an industry-leading 110 horsepower, the industry-exclusive STEELDRIVE automatic transmission for greater durability and precise control, and over 70 new accessories for enhanced customization, highlighted by Polaris' exclusive Lock & Ride MAX system. The RANGER XD 1500 establishes a new benchmark for utility side-by-sides.
"We spent over five years meeting with farmers, ranchers, large acreage property owners and big game hunters to develop an extreme duty vehicle that was missing from the market. From its ProStar 1500cc engine to the industry's only STEELDRIVE transmission, RANGER XD 1500 is unlike anything else offered today and is yet another example of our relentless commitment to advancing the industry with fresh thinking and innovative solutions that meet the real-world needs of our utility customers," said Steve Menneto, President of Polaris Off Road.
"Polaris RANGER has been the No. 1 selling utility side-by-side brand for more than 15 years and with the introduction of RANGER Extreme Duty, we've taken the industry's hardest-working lineup and expanded it," said Chris Judson, Vice President of Off Road Utility. "A segment of our utility customers said they are facing exceptionally large tasks and they simply need a machine with more power, more torque, more hauling and towing capacity, and more durability. And our team set out to deliver just that, incorporating dozens of new features and the latest engineering to make the RANGER XD 1500 more capable, stronger, and more comfortable than any other utility side-by-side out there."
Unprecedented Capability
Farmers, ranchers, and large landowners routinely haul and tow heavy loads around the property, and they've been asking for a solution when it comes to their heaviest tasks. The RANGER XD 1500 delivers unprecedented capability for hard-working customers to haul more, tow more, and get more done in less time. With the industry's only 1500cc utility engine, the RANGER XD 1500 provides over 30% more power and over 50% more torque than the next closest competitor.
- ProStar 1500cc 3-Cylinder Engine – Effortless towing, hauling, and confidence in tough terrain with an industry-leading 110HP and 105 lb-ft torque.
- 1,500 lb Cargo Box Capacity – Three-quarter ton box capacity providing nearly 50% more box volume than existing models for maximum productivity with fewer trips and bigger loads.
- 3,500 lb Towing Capacity – For those routinely towing heavy loads on the property, drive better productivity with nearly 40% more towing than existing models.
- Industry-leading Ground Clearance – All RANGER XD 1500 models get 15" of ground clearance with high-clearance arched A-arms to overcome large obstacles.
Brute Strength
Utility customers asked for a more durable, longer lasting offering to maximize their uptime and drive efficiency. Designed to last longer than any model before it, RANGER XD 1500 is the industry's most durable utility side-by-side and has been engineered from the ground up to be stronger and stand up to the demands of the longest days.
- Industry-exclusive STEELDRIVE transmission – Offers a 100 percent steel constructed belt that delivers smooth, precise operation and a fully sealed, liquid-cooled design for unmatched durability.
- High-Strength Steel Heavy Duty Frame – RANGER XD 1500 has a high-strength steel one-piece chassis featuring 160 percent more torsional stiffness for a smoother ride and better cab sealing.
- Industry-leading Service Intervals – RANGER XD 1500 offers the industry's longest service intervals so customers can maximize their uptime.
Unmatched Comfort
- From the farm to remote backcountry, utility customers work from before the sun rises to after it sets, and need something that delivers all-day comfort. Beyond industry-leading capability and durability, the RANGER XD 1500 prioritizes comfort across the entire lineup to keep customers going strong on the longest days.
- Most Spacious Interior – Equipped with the most spacious and premium cab available in utility side-by-sides, the XD 1500 offers increased leg and shoulder room, making it easy to enter and exit the vehicle. Adjustable seating and a telescopic steering wheel lets drivers find the perfect fit for height and riding preferences.
- Premium Seating – Contoured seating with added bolstering provides more rider comfort along with a center seat that flips down into an armrest with additional cup holders.
- Available Heated Seats – For comfort on the coldest days, RANGER XD 1500 NorthStar Ultimate is the first utility side-by-side that comes from the factory with heated seats.
- Drive Modes – RANGER XD 1500 comes with an intuitive and easy-to-use rotary drive mode selector that lets customers choose from four different drive modes, including:
- Heating and Air Conditioning (HVAC) – Riders can stay comfortable in harsh weather conditions in the RANGER XD 1500 NorthStar Edition, featuring an all-new HVAC system and a fully-enclosed, next generation ProShield cab that's been redesigned with improved sealing to prevent dust and water intrusion, while locking in the temperature from the climate-controlled cab.
- Sun Visors – All-new integrated sun visors provide improved visibility throughout the day for added confidence while driving.
- RIDE COMMAND – Available 7" waterproof touchscreen display powered by RIDE COMMAND technology featuring a back-up camera, GPS navigation regardless of cell service, and AM/FM radio with Bluetooth® streaming capability.
- RIDE COMMAND+ – Customers can keep tabs on their vehicle directly from the Polaris App and access critical vehicle information like vehicle location, maintenance reminders, and issue diagnostics right from the palm of their hand with the industry's only connected-vehicle technology. Available from the factory on NorthStar Ultimate.
Customization
Customers have been asking for increased versatility, durability, and ease of use for the different work applications they face throughout the day. With over 70 new Polaris Engineered Accessory options designed specifically for the RANGER XD 1500, plus options from partners brands including JBL®, Rhino Rack®, Pro Armor, Kolpin, and HD Parts, customers have more opportunity than ever before to make their vehicle fit their specific needs.
- Lock & Ride MAX – Polaris' easiest to use, most versatile, and confident accessory attachment platform ever. With customizable configurations and the ability to reconfigure on the fly with no tools required, this new accessory platform allows users to prepare for their day, their way. Customers can simply choose and place their accessory, lock it in place, and ride confidently knowing their gear is secure.
- New JBL® Audio – Polaris partnered with JBL® to create the highest performing audio system ever included in a RANGER from the factory. For customers wanting to turn it up a notch, the JBL® Trail Pro 4200 audio upgrade adds rear speakers and two subwoofers for an immersive audio experience.
- Glacier Pro HD Plow – New 84" plow designed for faster, more efficient plowing during the winter months. A hydraulic plow lift and angle kit can be paired with an all-new plow controller to manage the largest plow Polaris has ever offered, all without ever leaving the comfort of the cab.
2024 RANGER XD 1500 Premium: Starting at US $29,999 / CAN $36,199
The RANGER XD 1500 Premium commands a large presence thanks to heavy-duty components and the industry's largest bumper, providing complete front-end protection. The vehicle comes equipped with one of the most comprehensive standard packages in a side-by-side to date including 29" tires, tilt steering and seat slider for customizable comfort, four drive modes, high output LED headlights for enhanced visibility, and USB ports with multiple charging capabilities. The vehicle also comes equipped with boosted brakes and heavy-duty suspension to ensure performance across a variety of off-road environments.
2024 RANGER XD 1500 NorthStar Premium: Starting at US $39,999 / CAN $48,799
The next step up is the RANGER XD 1500 NorthStar Premium. This machine features a fully enclosed cab with HVAC temperature and five different mode controls, lockable full doors with power windows and a fixed front glass windshield. Additional features include an electronically controlled power tilt bed to dump heavy loads with ease, an overhead switch panel for easy accessorization, and an overhead rear work light to illuminate the cargo box in low-light conditions. NorthStar Premium comes stock with 30" Kenda® CrossTrail tires and available 32" tires to overcome large obstacles and tough terrain.
2024 RANGER XD 1500 NorthStar Ultimate: Starting at US $44,999 / CAN $54,499
Rounding out the lineup is the RANGER XD 1500 NorthStar Ultimate, which features everything from the NorthStar Premium trim, plus the 7" infotainment display powered by RIDE COMMAND and heated seats. The NorthStar Ultimate trim also delivers an immersive sound experience, featuring full AM/FM radio with Bluetooth® streaming capability and industry-exclusive JBL® speakers for precise audio and premium sound. Finally, the vehicle comes standard with RIDE COMMAND+, allowing for vehicle health monitoring and more.
The 2024 RANGER XD 1500 lineup is expected to begin shipping to dealers in late summer. To learn more about the 2024 RANGER family, please visit https://ranger.polaris.com/en-us/ or join the conversation and follow on Facebooksm, Instagramsm, YouTubesm and Twittersm.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
Warning: vehicle rollaway can cause serious injury or death. This vehicle can roll whenever the gear selector is not in the park position. Always shift to park when stopping the engine or leaving the vehicle. When leaving the vehicle on an incline is unavoidable, use extra care. If leaving the vehicle unattended, block the rear wheels on the downhill side and keep children, pets, and others away form the gear selector. Notice: Vehicle payload and trailer weight will affect the angle of hill on which the vehicle will hold.
Kenda® is a registered trademark of Kenda Rubber Industrial Co, Ltd.
Bluetooth® is a registered trademark of Bluetooth Sig, Inc.
JBL® is a registered trademark of Harman International Industries, Incorporated
Rhino-Rack® is a registered trademark of Rhino Rack Australia Pty Limited
Unless noted, trademarks are the property of Polaris Industries Inc.
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.kswo.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ | 2023-07-31T11:50:58 | 1 | https://www.kswo.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ |
Forester Wilderness Ad Showcases 'A Beautiful Silence' and Partnership with the National Park Foundation
CAMDEN, N.J., July 31, 2023 /PRNewswire/ -- Subaru of America, Inc. today unveiled a new creative spot focused on the automaker's efforts to expand access to the outdoors for all. Featuring the all-new 2023 Subaru Forester Wilderness, the advertisement stars Keivonn Woodard, the Emmy-nominated, 10-year-old Deaf actor and showcases the automaker's long-standing partnership with the National Park Foundation.
In the creative, titled "A Beautiful Silence," a father and his young son, who is Deaf, drive through Yosemite National Park, with the wonders of the park's beauty surrounding them. Featuring audio elements and American Sign Language (ASL), the spot shows how the pair experience the park's natural wonders in different ways, but share the special feeling that nature brings forth.
"The outdoors are for everyone, and whether it's a trip to a national park or a walk in the woods, we believe everyone should have the opportunity to experience its beauty," said Alan Bethke, Senior Vice President, Marketing, Subaru of America, Inc. "Through our partnership with the National Park Foundation and our commitment to making safe and capable vehicles like the Forester Wilderness, we're hoping that even more people will be inspired to explore the wonders of nature, just like the father and son in our new creative."
Through the National Park Foundation's Outdoor Exploration initiative and ParkVentures program, Subaru is helping more people create life-long relationships with the outdoors. The campaign seeks to make the outdoors more accessible to communities that have been historically excluded from parks, either through a community's physical presence on public lands or through the narrative of who belongs outdoors.
Last year, with support from Subaru, ParkVentures supported the efforts of more than 55 organizations to connect more people, including those with differing abilities, to meaningful experiences in United States national parks. Subaru also developed a direct relationship with ParkVentures grantee Black People Who Hike, which aims to help address the lack of representation in parks by empowering, educating and engaging Black people in the outdoors. Subaru provided the vehicles, gear, and experiences for an enhanced retreat in Acadia National Park to help create safe, welcoming spaces and cultivate lasting relationships with the outdoors.
Subaru is the largest corporate donor to the National Park Foundation and has provided over $70 million to organizations working to conserve national parks. To learn more about the automaker's partnership with National Park Foundation and over 20 years of environmentally focused initiatives, please visit Subaru.com/earth.
The new Subaru Forester Wilderness spot, created in collaboration with agency partner Carmichael Lynch, celebrates the automaker's devotion to adventure and environmental stewardship. Beginning today, "A Beautiful Silence" will run in 30-second format on national television and be featured in 15-second format in targeted digital and social media promotions throughout August, while a 60-second version will be available on YouTube.
About Subaru of America, Inc.
Subaru of America, Inc. (SOA) is a wholly owned subsidiary of Subaru Corporation of Japan. Headquartered at a zero-landfill office in Camden, N.J., the company markets and distributes Subaru vehicles, parts and accessories through a network of more than 630 retailers across the United States. All Subaru products are manufactured in zero-landfill plants and Subaru of Indiana Automotive, Inc. is the only U.S. automobile manufacturing plant to be designated a backyard wildlife habitat by the National Wildlife Federation. SOA is guided by the Subaru Love Promise, which is the company's vision to show love and respect to everyone, and to support its communities and customers nationwide. Over the past 20 years, SOA and the SOA Foundation have donated more than $300 million to causes the Subaru family cares about, and its employees have logged nearly 88,000 volunteer hours. As a company, Subaru believes it is important to do its part in making a positive impact in the world because it is the right thing to do. For additional information visit media.subaru.com. Follow us on Facebook, Twitter, and Instagram.
Media Contacts:
Diane Anton
Corporate Communications Manager
(856) 488-5093
danton@subaru.com
Adam Leiter
Corporate Communications Specialist
(856) 488-8668
aleiter@subaru.com
View original content to download multimedia:
SOURCE Subaru of America, Inc. | https://www.wbrc.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ | 2023-07-31T11:50:59 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ |
SAN FRANCISCO, July 31, 2023 /PRNewswire/ -- Today, Blitz Insurance, a specialty insurance carrier, partners with Ascend to modernize payment experiences for insurance brokers selling in specialty markets. With this partnership, Blitz Insurance will open new customer segments by offering both direct bill and premium financing into their payments workflow.
"When we looked into the market for a solution, Ascend was the right choice. Ascend meets our needs for a better payments experience for our partners while reducing everyone's operational expenses," said Brandon Murphy, Chief Distribution Officer of Blitz Insurance. "We will now have the ability to not only expand to direct bill and a premium finance option but also simplify the movement of money between us and our partners."
With Ascend, Blitz Insurance is now able to provide a direct bill in addition to their existing agency bill workflow - allowing brokers to decide what billing method works best for them. By utilizing Ascend, Blitz Insurance not only grows their footprint of appointed brokers but also gains administrative efficiency by automating what would otherwise have been a large operational undertaking.
Ascend automatically attributes incoming payments to policies in real time, speeding up the reconciliation process. By modernizing the payments experience and speeding up the reconciliation of incoming premiums, Blitz Insurance can offer a best-in-class experience to its brokers and agents.
"We find that across the insurance ecosystem - companies want to provide a seamless payment workflow for their customers and their teams," said Andrew Wynn, co-CEO of Ascend. "Ascend is built so brokers and carriers can offer this experience without shouldering the administrative resources and costs needed to support these operations."
About Ascend
Ascend is the first insurance payments platform that automates financial operations from collections and financing to carrier and commission payables. Founded by two-time insurtech entrepreneurs Andrew Wynn and Praveen Chekuri, Ascend helps insurance brokers, MGAs, and carriers improve their bottom lines by eliminating expensive and labor-intensive payment workflows. To learn more, please visit LinkedIn, Twitter or check out https://www.useascend.com/.
About Blitz Insurance
Blitz is a tech-driven insurer revolutionizing the $60B specialty market catering to SME segment. By leveraging industry knowledge and cutting-edge technology, we deliver a simpler, smarter, and faster coverage experience.
The company is led by a veteran team of insurance and technology experts and has been funded with $25M from its founder & CEO, a Forbes-listed serial entrepreneur in the real estate and insurance industries.
Contact:
Mike Nguyen
press@useascend.com
View original content to download multimedia:
SOURCE Ascend | https://www.wflx.com/prnewswire/2023/07/31/blitz-insurance-partners-with-ascend-expand-payment-financing-offerings/ | 2023-07-31T11:51:04 | 1 | https://www.wflx.com/prnewswire/2023/07/31/blitz-insurance-partners-with-ascend-expand-payment-financing-offerings/ |
Highlights Include the Return of Polaris Sportsman 570 and XP 1000 Hunt Editions, Along with a Host of
Aesthetic and Performance Upgrades Across the Lineup
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- On the heels of debuting its innovative Polaris XPEDITION and the all new Extreme Duty RANGER XD 1500, Polaris Off Road today unveiled updates for 2024 to the off-road industry's most expansive lineup. The 2024 lineup features a host of rider-inspired updates and refreshed styling and new colors. Additionally, the customer-favorite Polaris Sportsman 570 and XP 1000 Hunt editions make a return, and a Premium trim offering is now available on the 2024 GENERAL 1000 to provide customers with an upgrade in style and performance. RIDE COMMAND+ also received enhanced features for 2024, delivering unmatched connectivity and peace of mind to riders through all-new Location Bump Alerts and Check-In Messages.
"From the completely redesigned 2024 RZR XP and the industry's first "adventure side-by-side" Polaris XPEDITION, to our introduction of the all-new RANGER XD 1500, this year has been a powerful showcase of our ongoing commitment to lead the industry and innovate for our riders," said Steve Menneto, President of Polaris Off Road. "While those revolutionary product debuts are pivotal, our unwavering focus on refining and enhancing our current offerings based on customer needs and feedback remains essential, and that's what the 2024 updates represent."
From fresh new styles and colorways, to improved trim levels that appeal to a wide variety of riders, the Polaris Off Road 2024 model year lineup and RIDE COMMAND+ technology enhancements include the following:
RIDE COMMAND+:
Making its debut last fall, RIDE COMMAND+, the industry's first connected-vehicle technology, continues to roll out new enhancements to its service for 2024. With new features like Location Alerts, that will notify the owner if its vehicle has been bumped or moved from its last location, owners can now protect their vehicle more than ever before. RIDE COMMAND+ is now available as a factory option for 2024 RZR Pro R Ultimate, RANGER XD 1500 NorthStar, RANGER XP 1000 NorthStar, Polaris XPEDITION NorthStar and Sportsman XP 1000 RIDE COMMAND Edition. This service is also available on most 2024 RZR, RANGER, Sportsman and Polaris XPEDITION models as an accessory install.
Sportsman
Polaris Sportsman, the long-standing No. 1 selling automatic 4x4 ATV, is reintroducing the Sportsman 570 and XP 1000 Hunt Editions, while also implementing key improvements across the core 2024 lineup. A customer favorite, specifically designed to meet the unique needs of hunters, the Sportsman 570 and XP 1000 Hunt editions include accessories such as the 3,500 lb Polaris Winch, Kolpin Gun Scabbard & Mount, Kolpin Ratchet Claws and more.
Additionally, the 2024 Sportsman 450 and 570 lineup boasts several quality refinements for a better riding experience including a new rear brake pedal for reduced pedal effort and feel, improved sealing around the shifter, and enhanced seat fitment delivering a more comfortable ride. The 570 EPS trim and above will also include enhanced PVT clutch sealing with a higher intake location for better performance in wet conditions.
For added utility, the model year 2024 Sportsman 570 lineup will be equipped with new LED lights for the Premium and Utility HD for added visibility from dawn to dusk.
New color options also are available for the 570 Premium and Trail, 570 Ride Command Edition, Sportsman 850 Premium and Ultimate Trail, Sportsman XP 1000 Ultimate Trail, Sportsman XP 1000 High Lifter Edition, Scrambler XP 1000 S and Sportsman XP 1000 S.
The 2024 Sportsman lineup starts at $6,999 US MSRP and will begin shipping to dealers this early fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/sportsman/
GENERAL
Polaris GENERAL is the industry's most versatile crossover side-by-side, capable of tackling tough trails, while also knocking out tasks around the property. For 2024, the GENERAL 1000 receives a new Premium trim offering that provides both style and performance enhancements. Featuring 14" wheels with 27" Coronado tires, and FOX® Podium QS3® shocks that riders can adjust between soft, medium and firm based on terrain changes, the new Premium trim will deliver a smooth ride over rugged terrain, while LED headlights provide greater visibility at morning and night. These upgrades will help riders knock out more tasks and hit the trails confidently in the GENERAL 1000.
Additionally, new colorways on the GENERAL 1000 model include Ghost Gray and Volcanic Orange. The Premium and Ultimate trim levels for the GENERAL XP will feature new colors and graphics in Matte Silver Quartz and Polaris Blue.
The 2024 GENERAL lineup starts at $17,499 US MSRP and will begin shipping to dealers this summer. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/general/
RZR
Polaris RZR, the No. 1 sport side-by-side brand, receives fresh new colors and graphics across its lineup, helping riders make a bold statement when hitting the trails. The 2024 RZR Trail and RZR Trail S are now available in Storm Blue on the Sport trim and two-tone Storm Blue with White Lightning on the Ultimate. Both Sport and Ultimate trim levels now receive the same upgraded steering wheel offered in the fully-redesigned 2024 RZR XP that provides a sportier feel while driving on trails. New for 2024, the RZR Trail and Trail S Sport level feature electric power steering and LED headlights standard, providing riders easier steering input on tight trail corners and enhanced visibility. Additionally for 2024, the RZR Trail S Ultimate trim now features Walker Evans Racing® shocks, while the Sport trim moved to ZF Sachs shocks, both offering riders plush suspension performance against the rugged terrain.
For 2024, the RZR Pro XP Sport and Premium models feature Walker Evans Racing® shocks, while the Ultimate will continue to be equipped with FOX® Live Valve shocks with DYNAMIX active suspension. Both the Premium and Ultimate trim received a refresh with new graphics on the Super Graphite colorway.
Lastly and by consumer demand, the Wide Open lineup of RZR Pro R and RZR Turbo R receives refreshed color options for 2024. For the first time since launching, the RZR Pro R Ultimate is available in an all-new Matte Onyx Black with Lifted Lime accents or Matte Heavy Metal, while the Premium trim level is offered in Matte Heavy Metal. The 2024 RZR Turbo R also welcomes vibrant new colors like Velocity Blue with Green Burst accents and Military Tan with Orange Burst accents.
The 2024 RZR lineup starts at $15,999 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/rzr/
RANGER
In addition to the newly launched Extreme Duty RANGER XD 1500, the Polaris RANGER lineup receives a variety of rider-inspired upgrades and quality refinements for 2024. RANGER SP 570 gets new color options, while the NorthStar Edition gets exclusive tailgate badging and new 25" 8-ply Pro Armor X-Terrain tires for added durability and enhanced puncture resistance.
Additionally, Polaris expands the color options for the RANGER 1000 Premium which will now be offered in the sleek Granite Grey color and graphics, while the XP 1000 will be featured in two new options: Desert Sand and Super Graphite with orange burst accents. Furthermore, the RANGER XP 1000 NorthStar Ultimate model boasts connectivity features such as vehicle health, issue diagnostics, and maintenance reminders enabled by RIDE COMMAND+.
The 2024 RANGER lineup starts at $11,699 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/ranger/
Youth
Dedicated to inspiring the next generation of riders, Polaris Off Road delivers the industry's largest and most varied lineup of youth offerings. For 2024, the Polaris ORV Youth lineup receives a refresh with eye-catching new colors and graphics. This lineup continues to provide industry-leading safety features that give parents peace of mind and help instill confidence in growing riders, including pin code start, adjustable speed limiter, geofencing, helmet aware technology and industry-exclusive safety gear kit.
Specifically, the 2024 RZR 200 EFI is now offered in Storm Gray and a new graphic pattern with bright red accents. The Outlaw 70 EFI ATV is offered in Velocity Blue with either Lifted Lime or Fierce Fuchsia accents, while the Outlaw 110 EFI is now offered in both Bright White with Polaris Blue and Bright White with Radiant Green details.
The 2024 Polaris Youth lineup starts at $2,999 US MSRP and will begin shipping to dealers this winter. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/shop-by-use/youth/
Polaris XPEDITION
The Polaris XPEDITION, which recently launched in May 2023, is the first-of-its-kind adventure side-by-side, combining the all-terrain capabilities of traditional side-by-sides with comfort and cargo capabilities typically associated with overlanding at the highest level. With a host of standard features and optional configurations to accommodate the greatest range of outdoor pursuits and enable consumers to keep chasing the wild, the 2024 Polaris XPEDITION XP and ADV are the most adaptable, comfortable and capable adventure machine on the market.
The 2024 Polaris XPEDITION lineup starts at $28,999 US MSRP and is currently shipping to dealers. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/polaris-xpedition/
To learn more about the Polaris ORV 2024 lineup and to stay up to date on testing and demo opportunities, please visit https://offroad.polaris.com/en-us/ or join the conversation and follow on FacebookSM, InstagramSM, YouTubeSM and TwitterSM. Walker Evans Racing® is a registered trademark of Walker Evans Enterprises Incorporated; FOX® is a registered trademark of Fox Factory Inc.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.kswo.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ | 2023-07-31T11:51:05 | 0 | https://www.kswo.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ |
Introducing the industry's first-ever utility side-by-side with a 1500cc 3-cylinder engine for more power to make tough jobs easier and the industry's only STEELDRIVE transmission for greater durability
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- Polaris Off Road, the global leader in powersports and off-road innovation, is once again breaking new ground with the industry's first extreme duty utility side-by-side: the all-new RANGER XD 1500. With its unprecedented capability, brute strength and unmatched comfort, the new extreme duty class of RANGER side-by-sides are engineered with the first-ever ProStar 1500cc 3-cylinder engine that offers an industry-leading 110 horsepower, the industry-exclusive STEELDRIVE automatic transmission for greater durability and precise control, and over 70 new accessories for enhanced customization, highlighted by Polaris' exclusive Lock & Ride MAX system. The RANGER XD 1500 establishes a new benchmark for utility side-by-sides.
"We spent over five years meeting with farmers, ranchers, large acreage property owners and big game hunters to develop an extreme duty vehicle that was missing from the market. From its ProStar 1500cc engine to the industry's only STEELDRIVE transmission, RANGER XD 1500 is unlike anything else offered today and is yet another example of our relentless commitment to advancing the industry with fresh thinking and innovative solutions that meet the real-world needs of our utility customers," said Steve Menneto, President of Polaris Off Road.
"Polaris RANGER has been the No. 1 selling utility side-by-side brand for more than 15 years and with the introduction of RANGER Extreme Duty, we've taken the industry's hardest-working lineup and expanded it," said Chris Judson, Vice President of Off Road Utility. "A segment of our utility customers said they are facing exceptionally large tasks and they simply need a machine with more power, more torque, more hauling and towing capacity, and more durability. And our team set out to deliver just that, incorporating dozens of new features and the latest engineering to make the RANGER XD 1500 more capable, stronger, and more comfortable than any other utility side-by-side out there."
Unprecedented Capability
Farmers, ranchers, and large landowners routinely haul and tow heavy loads around the property, and they've been asking for a solution when it comes to their heaviest tasks. The RANGER XD 1500 delivers unprecedented capability for hard-working customers to haul more, tow more, and get more done in less time. With the industry's only 1500cc utility engine, the RANGER XD 1500 provides over 30% more power and over 50% more torque than the next closest competitor.
- ProStar 1500cc 3-Cylinder Engine – Effortless towing, hauling, and confidence in tough terrain with an industry-leading 110HP and 105 lb-ft torque.
- 1,500 lb Cargo Box Capacity – Three-quarter ton box capacity providing nearly 50% more box volume than existing models for maximum productivity with fewer trips and bigger loads.
- 3,500 lb Towing Capacity – For those routinely towing heavy loads on the property, drive better productivity with nearly 40% more towing than existing models.
- Industry-leading Ground Clearance – All RANGER XD 1500 models get 15" of ground clearance with high-clearance arched A-arms to overcome large obstacles.
Brute Strength
Utility customers asked for a more durable, longer lasting offering to maximize their uptime and drive efficiency. Designed to last longer than any model before it, RANGER XD 1500 is the industry's most durable utility side-by-side and has been engineered from the ground up to be stronger and stand up to the demands of the longest days.
- Industry-exclusive STEELDRIVE transmission – Offers a 100 percent steel constructed belt that delivers smooth, precise operation and a fully sealed, liquid-cooled design for unmatched durability.
- High-Strength Steel Heavy Duty Frame – RANGER XD 1500 has a high-strength steel one-piece chassis featuring 160 percent more torsional stiffness for a smoother ride and better cab sealing.
- Industry-leading Service Intervals – RANGER XD 1500 offers the industry's longest service intervals so customers can maximize their uptime.
Unmatched Comfort
- From the farm to remote backcountry, utility customers work from before the sun rises to after it sets, and need something that delivers all-day comfort. Beyond industry-leading capability and durability, the RANGER XD 1500 prioritizes comfort across the entire lineup to keep customers going strong on the longest days.
- Most Spacious Interior – Equipped with the most spacious and premium cab available in utility side-by-sides, the XD 1500 offers increased leg and shoulder room, making it easy to enter and exit the vehicle. Adjustable seating and a telescopic steering wheel lets drivers find the perfect fit for height and riding preferences.
- Premium Seating – Contoured seating with added bolstering provides more rider comfort along with a center seat that flips down into an armrest with additional cup holders.
- Available Heated Seats – For comfort on the coldest days, RANGER XD 1500 NorthStar Ultimate is the first utility side-by-side that comes from the factory with heated seats.
- Drive Modes – RANGER XD 1500 comes with an intuitive and easy-to-use rotary drive mode selector that lets customers choose from four different drive modes, including:
- Heating and Air Conditioning (HVAC) – Riders can stay comfortable in harsh weather conditions in the RANGER XD 1500 NorthStar Edition, featuring an all-new HVAC system and a fully-enclosed, next generation ProShield cab that's been redesigned with improved sealing to prevent dust and water intrusion, while locking in the temperature from the climate-controlled cab.
- Sun Visors – All-new integrated sun visors provide improved visibility throughout the day for added confidence while driving.
- RIDE COMMAND – Available 7" waterproof touchscreen display powered by RIDE COMMAND technology featuring a back-up camera, GPS navigation regardless of cell service, and AM/FM radio with Bluetooth® streaming capability.
- RIDE COMMAND+ – Customers can keep tabs on their vehicle directly from the Polaris App and access critical vehicle information like vehicle location, maintenance reminders, and issue diagnostics right from the palm of their hand with the industry's only connected-vehicle technology. Available from the factory on NorthStar Ultimate.
Customization
Customers have been asking for increased versatility, durability, and ease of use for the different work applications they face throughout the day. With over 70 new Polaris Engineered Accessory options designed specifically for the RANGER XD 1500, plus options from partners brands including JBL®, Rhino Rack®, Pro Armor, Kolpin, and HD Parts, customers have more opportunity than ever before to make their vehicle fit their specific needs.
- Lock & Ride MAX – Polaris' easiest to use, most versatile, and confident accessory attachment platform ever. With customizable configurations and the ability to reconfigure on the fly with no tools required, this new accessory platform allows users to prepare for their day, their way. Customers can simply choose and place their accessory, lock it in place, and ride confidently knowing their gear is secure.
- New JBL® Audio – Polaris partnered with JBL® to create the highest performing audio system ever included in a RANGER from the factory. For customers wanting to turn it up a notch, the JBL® Trail Pro 4200 audio upgrade adds rear speakers and two subwoofers for an immersive audio experience.
- Glacier Pro HD Plow – New 84" plow designed for faster, more efficient plowing during the winter months. A hydraulic plow lift and angle kit can be paired with an all-new plow controller to manage the largest plow Polaris has ever offered, all without ever leaving the comfort of the cab.
2024 RANGER XD 1500 Premium: Starting at US $29,999 / CAN $36,199
The RANGER XD 1500 Premium commands a large presence thanks to heavy-duty components and the industry's largest bumper, providing complete front-end protection. The vehicle comes equipped with one of the most comprehensive standard packages in a side-by-side to date including 29" tires, tilt steering and seat slider for customizable comfort, four drive modes, high output LED headlights for enhanced visibility, and USB ports with multiple charging capabilities. The vehicle also comes equipped with boosted brakes and heavy-duty suspension to ensure performance across a variety of off-road environments.
2024 RANGER XD 1500 NorthStar Premium: Starting at US $39,999 / CAN $48,799
The next step up is the RANGER XD 1500 NorthStar Premium. This machine features a fully enclosed cab with HVAC temperature and five different mode controls, lockable full doors with power windows and a fixed front glass windshield. Additional features include an electronically controlled power tilt bed to dump heavy loads with ease, an overhead switch panel for easy accessorization, and an overhead rear work light to illuminate the cargo box in low-light conditions. NorthStar Premium comes stock with 30" Kenda® CrossTrail tires and available 32" tires to overcome large obstacles and tough terrain.
2024 RANGER XD 1500 NorthStar Ultimate: Starting at US $44,999 / CAN $54,499
Rounding out the lineup is the RANGER XD 1500 NorthStar Ultimate, which features everything from the NorthStar Premium trim, plus the 7" infotainment display powered by RIDE COMMAND and heated seats. The NorthStar Ultimate trim also delivers an immersive sound experience, featuring full AM/FM radio with Bluetooth® streaming capability and industry-exclusive JBL® speakers for precise audio and premium sound. Finally, the vehicle comes standard with RIDE COMMAND+, allowing for vehicle health monitoring and more.
The 2024 RANGER XD 1500 lineup is expected to begin shipping to dealers in late summer. To learn more about the 2024 RANGER family, please visit https://ranger.polaris.com/en-us/ or join the conversation and follow on Facebooksm, Instagramsm, YouTubesm and Twittersm.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
Warning: vehicle rollaway can cause serious injury or death. This vehicle can roll whenever the gear selector is not in the park position. Always shift to park when stopping the engine or leaving the vehicle. When leaving the vehicle on an incline is unavoidable, use extra care. If leaving the vehicle unattended, block the rear wheels on the downhill side and keep children, pets, and others away form the gear selector. Notice: Vehicle payload and trailer weight will affect the angle of hill on which the vehicle will hold.
Kenda® is a registered trademark of Kenda Rubber Industrial Co, Ltd.
Bluetooth® is a registered trademark of Bluetooth Sig, Inc.
JBL® is a registered trademark of Harman International Industries, Incorporated
Rhino-Rack® is a registered trademark of Rhino Rack Australia Pty Limited
Unless noted, trademarks are the property of Polaris Industries Inc.
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.wbrc.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ | 2023-07-31T11:51:06 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ |
Georgia man electrocuted after jumping into lake
ATLANTA (WANF/Gray News) - A Georgia man is dead after jumping into Lake Lanier Thursday evening, WANF reports.
The Forsyth County Sheriff’s Office said 24-year-old Thomas Shepard Milner jumped into the lake from his family’s dock near Dove Trail and was electrocuted when he entered the water.
A family friend told investigators they heard Milner scream for help and tried to get him out of the water using a ladder.
When that didn’t work, neighbors stepped in to help and took a boat out to Milner, the sheriff’s office said. The person in the boat jumped in the water to pull Milner out but reported feeling a burning sensation, which they immediately recognized as an electric shock.
After swimming to shore and turning off the power box near the dock, the person returned to the water to pull Milner back to shore, according to investigators.
Witnesses told authorities Milner’s uncle administered CPR until emergency medical crews got to the scene. The 24-year-old was rushed to Northside Forsyth Hospital. He died from his injuries the next day.
Milner’s mother, Martha Milner, told WANF her son was gentle and kind and loved the lake.
“Shepard was known for his quirkiness, his humor and his dedication,” she said.
According to Martha Milner, the dock at their lake property was less than three years old and outfitted with electricity by a licensed electrician.
Boaters like Chris Morris were saddened to hear about the death on Sunday.
“It’s a freak accident,” he said.
It is unclear why the water was electrified.
The investigation remains ongoing.
Copyright 2023 WANF via Gray Media Group, Inc. All rights reserved. | https://www.weau.com/2023/07/31/georgia-man-electrocuted-after-jumping-into-lake/ | 2023-07-31T11:51:10 | 0 | https://www.weau.com/2023/07/31/georgia-man-electrocuted-after-jumping-into-lake/ |
MIAMI, July 31, 2023 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) today announced that Carnival Corporation (the "Company") intends to commence the marketing of a new senior secured first lien term loan B facility (the "New First Lien Term Loan") with an original principal amount of $1.0 billion, expected to mature in 2027. In conjunction with the New First Lien Term Loan, and subject to market and other conditions, the Company may raise $500 million of other secured debt maturing in 2029 (together with the New First Lien Term Loan, the "Refinancing Transactions"). The Company intends to use the proceeds from the Refinancing Transactions to repay a portion of the borrowings under the Company's existing first-priority senior secured term loan facility maturing in 2025.
After the closing of the Refinancing Transactions, the Company intends to redeem all of the Company's 10.500% second-priority senior secured notes due 2026 and 10.125% second-priority senior secured notes due 2026 (collectively, the "2026 Notes"), saving over $120 million in interest expense on an annualized basis. The $1.2 billion of redemptions will be conditioned on the closing of the Refinancing Transactions. The Company expects to use cash on hand to finance the redemptions. This press release does not constitute a notice of redemption with respect to the 2026 Notes.
The Company's Chief Financial Officer David Bernstein commented: "Given the confidence we have in our business and its cash flow generation, we plan to retire $1.2 billion of our highest cost debt. In connection with this retirement, we plan to extend some of the lowest cost public debt in our portfolio. This is yet another step forward in our deleveraging journey, building on the $1.4 billion we already early retired this year. With this debt repayment, we now expect our year end debt balance to be less than $32.0 billion, an improvement over the November 30, 2023 debt balance of less than $33.0 billion provided in our June guidance."
This press release shall not constitute an offer to sell or the solicitation of an offer to purchase any security and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offering, solicitation or sale would be unlawful.
About Carnival Corporation & plc
Carnival Corporation & plc is the largest global cruise company, and among the largest leisure travel companies, with a portfolio of world-class leading cruise lines - AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, P&O Cruises (Australia), P&O Cruises (UK), Princess Cruises and Seabourn.
Cautionary Note Concerning Forward-Looking Statements
Carnival Corporation and Carnival plc and their respective subsidiaries are referred to collectively in this press release, as "Carnival Corporation & plc," "our," "us" and "we." Some of the statements, estimates or projections contained in this press release are "forward-looking statements" that involve risks, uncertainties and assumptions with respect to us, including some statements concerning the refinancing transactions described herein, future results, operations, outlooks, plans, goals, reputation, cash flows, liquidity and other events which have not yet occurred. These statements are intended to qualify for the safe harbors from liability provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts are statements that could be deemed forward-looking. These statements are based on current expectations, estimates, forecasts and projections about our business and the industry in which we operate and the beliefs and assumptions of our management. We have tried, whenever possible, to identify these statements by using words like "will," "may," "could," "should," "would," "believe," "depends," "expect," "goal," "aspiration," "anticipate," "forecast," "project," "future," "intend," "plan," "estimate," "target," "indicate," "outlook," and similar expressions of future intent or the negative of such terms.
Forward-looking statements include those statements that relate to our outlook and financial position including, but not limited to, statements regarding:
Because forward-looking statements involve risks and uncertainties, there are many factors that could cause our actual results, performance or achievements to differ materially from those expressed or implied by our forward-looking statements. This note contains important cautionary statements of the known factors that we consider could materially affect the accuracy of our forward-looking statements and adversely affect our business, results of operations and financial position. Additionally, many of these risks and uncertainties are currently, and in the future may continue to be, amplified by our substantial debt balance as a result of the pause of our guest cruise operations. There may be additional risks that we consider immaterial or which are unknown. These factors include, but are not limited to, the following:
- events and conditions around the world, including war and other military actions, such as the invasion of Ukraine, inflation, higher fuel prices, higher interest rates and other general concerns impacting the ability or desire of people to travel have led, and may in the future lead, to a decline in demand for cruises, impacting our operating costs and profitability;
- pandemics have in the past and may in the future have a significant negative impact on our financial condition and operations;
- incidents concerning our ships, guests or the cruise industry have in the past and may, in the future, negatively impact the satisfaction of our guests and crew and lead to reputational damage;
- changes in and non-compliance with laws and regulations under which we operate, such as those relating to health, environment, safety and security, data privacy and protection, anti-corruption, economic sanctions, trade protection, labor and employment and tax have in the past and may, in the future, lead to litigation, enforcement actions, fines, penalties and reputational damage;
- factors associated with climate change, including evolving and increasing regulations, increasing global concern about climate change and the shift in climate conscious consumerism and stakeholder scrutiny, and increasing frequency and/or severity of adverse weather conditions could adversely affect our business;
- inability to meet or achieve our sustainability related goals, aspirations, initiatives, and our public statements and disclosures regarding them, may expose us to risks that may adversely impact our business;
- breaches in data security and lapses in data privacy as well as disruptions and other damages to our principal offices, information technology operations and system networks and failure to keep pace with developments in technology may adversely impact our business operations, the satisfaction of our guests and crew and may lead to reputational damage;
- the loss of key team members, our inability to recruit or retain qualified shoreside and shipboard team members and increased labor costs could have an adverse effect on our business and results of operations;
- increases in fuel prices, changes in the types of fuel consumed and availability of fuel supply may adversely impact our scheduled itineraries and costs;
- we rely on supply chain vendors who are integral to the operations of our businesses. These vendors and service providers may be unable to deliver on their commitments, which could negatively impact our business;
- fluctuations in foreign currency exchange rates may adversely impact our financial results;
- overcapacity and competition in the cruise and land-based vacation industry may negatively impact our cruise sales, pricing and destination options;
- inability to implement our shipbuilding programs and ship repairs, maintenance and refurbishments may adversely impact our business operations and the satisfaction of our guests;
- Failure to successfully implement our business strategy following our resumption of guest cruise operations would negatively impact the occupancy levels and pricing of our cruises and could have a material adverse effect on our business. We require a significant amount of cash to service our debt and sustain our operations. Our ability to generate cash depends on many factors, including those beyond our control, and we may not be able to generate cash required to service our debt and sustain our operations; and,
- the risk factors included in Carnival Corporation's and Carnival plc's Annual Report on Form 10-K filed with the SEC on January 27, 2023 and Carnival Corporation's and Carnival plc's Quarterly Reports on Form 10-Q filed with the SEC on March 29, 2023 and June 28, 2023.
The ordering of the risk factors set forth above is not intended to reflect our indication of priority or likelihood.
Forward-looking statements should not be relied upon as a prediction of actual results. Subject to any continuing obligations under applicable law or any relevant stock exchange rules, we expressly disclaim any obligation to disseminate, after the date of this document, any updates or revisions to any such forward-looking statements to reflect any change in expectations or events, conditions or circumstances on which any such statements are based.
Forward-looking and other statements in this document may also address our sustainability progress, plans and goals (including climate change and environmental-related matters). In addition, historical, current and forward-looking sustainability- and climate-related statements may be based on standards and tools for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions and predictions that are subject to change in the future and may not be generally shared.
SOURCE Carnival Corporation & plc
View original content:
SOURCE Carnival Corporation & plc | https://www.wflx.com/prnewswire/2023/07/31/carnival-corporation-amp-plc-announces-anticipated-debt-pre-payment-12b-refinancing-transaction/ | 2023-07-31T11:51:10 | 1 | https://www.wflx.com/prnewswire/2023/07/31/carnival-corporation-amp-plc-announces-anticipated-debt-pre-payment-12b-refinancing-transaction/ |
Pitstick brings product, operations, and value-based care expertise to leading behavioral health provider
SARATOGA SPRINGS, N.Y., July 31, 2023 /PRNewswire/ -- aptihealth, the leading tech-driven behavioral healthcare provider built for higher acuity care, today announced that Regina Pitstick has joined the organization as Senior Vice President of aptihealth Medical Group.
Most recently, Pitstick was VP Advocacy Product & Innovation for the Employer and Individual segment at UnitedHealth Group, where she drove the company's product strategy and vision, focused on delivering a seamless, personalized patient experience. Responsible for product development initiatives, Pitstick's leadership and experience fueled successful long-range strategies, broader market penetration and deeper engagement for over 15M consumers.
"Regina brings more than twenty years of extremely relevant experience in the healthcare industry to aptihealth—including a deep skillset in digital health start-ups, product development, operations, process improvement and value-based care," said Tim Koehler, President and Chief Operating Officer of aptihealth. "Regina's patient-centered approach, insightful understanding of the health care landscape, innovate approach, and impeccable ability to execute strategic initiatives will greatly enhance our medical group. She's ideal for this critical role at aptihealth as we continue to pursue our mission of becoming the nation's preeminent provider of behavioral health services."
Pitstick joins aptihealth at a time of significant growth, having served nearly 15,000 patients for leading national and regional health plans. aptihealth expects to more than double its patients in 2023, with a majority covered by value-based care contracts.
"The value that aptihealth is providing to health plans, physicians groups, health systems and higher-acuity patients simply can't be underestimated," indicated Pitstick. "Whether it's the company's commitment to engaging new patients at any point of care, to their proprietary screening and assessment tools, to their proven ability to improve outcomes and decrease the overall cost of care, it's not hyperbole to state that aptihealth is changing the behavioral healthcare game. I'm thrilled to have the opportunity to help aptihealth continue to improve its care model, meet its strategic goals, and intelligently achieve its considerable opportunities for growth."
About aptihealth
aptihealth is improving higher acuity behavioral healthcare for populations who need it most—one patient at a time. The company's virtual-first model and proprietary screening, assessment, and treatment programs give members fast, convenient access to precise, personalized care. Headquartered in Saratoga Springs and employing over 150, aptihealth has raised over $70 million in funding from leading international private equity firms. The company's care program and data insights are driving breakthroughs in mental health understanding, treatment, outcomes, and cost reduction. Learn more at: www.aptihealth.com.
View original content to download multimedia:
SOURCE aptihealth | https://www.kswo.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ | 2023-07-31T11:51:11 | 1 | https://www.kswo.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ |
BEIJING, July 31, 2023 /PRNewswire/ -- SANY Group ("SANY") has announced the 2023 employee stock ownership plan (ESOP). This is the fourth consecutive year that SANY has launched the ESOP, which gives employees an opportunity to own shares in the company through the setting up of incentive funds. The 2023 ESOP has set up a fund size of around 590 million yuan (USD 82 million) with a share repurchase price planned at 16.13 yuan per share (USD 2.24). The capital will be from the incentive funds accrued following relevant provisions of the group.
SANY has always focused on improving employee benefits and adhering to the principle of "growing together, pursuing common development, and sharing achievements." By establishing a comprehensive incentive and restraining mechanism, it aims to inspire employees' enthusiasm and creativity and align the interests of shareholders, the listed company, and individuals. This encourages all parties to join efforts to boost SANY's long-term development.
SANY's annual ESOP aims to share the fruits of the group's achievements with employees. The number of employees awarded with stock ownership incentives is growing annually, and the proportion of mid-level and key position employees is increasing year by year:
- 2020: SANY awarded 8.31 million shares to 2,264 employees, 71.52 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2021: SANY awarded 7.54 million shares to 4,205 employees, 91.33 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2022: SANY awarded 20.5 million shares to 6,996 employees, 94.26 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2023: SANY is awarding 36.62 million shares to 7,131 employees, 95.69 percent were employees in mid-level management, key positions, and core business (technical) positions.
The source of shares for the 2023 ESOP is the shares that have already been repurchased by SANY's special account. It does not exceed 36.62 million shares in total and is within one percent of SANY's current total capital stock.
In the meantime, SANY Renewable Energy (SH688349) released an announcement relating to exercising of the second exercise period of the 2020 stock option incentive plan, with 16.0368 million granted options to be exercised, with a three-year restricted period. The subsidiary is committed to becoming a global leader of clean energy equipment and services, and contributing to reaching the goals of carbon peaking and carbon neutrality.
View original content to download multimedia:
SOURCE SANY Group | https://www.kswo.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ | 2023-07-31T11:51:11 | 0 | https://www.kswo.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ |
Highlights Include the Return of Polaris Sportsman 570 and XP 1000 Hunt Editions, Along with a Host of
Aesthetic and Performance Upgrades Across the Lineup
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- On the heels of debuting its innovative Polaris XPEDITION and the all new Extreme Duty RANGER XD 1500, Polaris Off Road today unveiled updates for 2024 to the off-road industry's most expansive lineup. The 2024 lineup features a host of rider-inspired updates and refreshed styling and new colors. Additionally, the customer-favorite Polaris Sportsman 570 and XP 1000 Hunt editions make a return, and a Premium trim offering is now available on the 2024 GENERAL 1000 to provide customers with an upgrade in style and performance. RIDE COMMAND+ also received enhanced features for 2024, delivering unmatched connectivity and peace of mind to riders through all-new Location Bump Alerts and Check-In Messages.
"From the completely redesigned 2024 RZR XP and the industry's first "adventure side-by-side" Polaris XPEDITION, to our introduction of the all-new RANGER XD 1500, this year has been a powerful showcase of our ongoing commitment to lead the industry and innovate for our riders," said Steve Menneto, President of Polaris Off Road. "While those revolutionary product debuts are pivotal, our unwavering focus on refining and enhancing our current offerings based on customer needs and feedback remains essential, and that's what the 2024 updates represent."
From fresh new styles and colorways, to improved trim levels that appeal to a wide variety of riders, the Polaris Off Road 2024 model year lineup and RIDE COMMAND+ technology enhancements include the following:
RIDE COMMAND+:
Making its debut last fall, RIDE COMMAND+, the industry's first connected-vehicle technology, continues to roll out new enhancements to its service for 2024. With new features like Location Alerts, that will notify the owner if its vehicle has been bumped or moved from its last location, owners can now protect their vehicle more than ever before. RIDE COMMAND+ is now available as a factory option for 2024 RZR Pro R Ultimate, RANGER XD 1500 NorthStar, RANGER XP 1000 NorthStar, Polaris XPEDITION NorthStar and Sportsman XP 1000 RIDE COMMAND Edition. This service is also available on most 2024 RZR, RANGER, Sportsman and Polaris XPEDITION models as an accessory install.
Sportsman
Polaris Sportsman, the long-standing No. 1 selling automatic 4x4 ATV, is reintroducing the Sportsman 570 and XP 1000 Hunt Editions, while also implementing key improvements across the core 2024 lineup. A customer favorite, specifically designed to meet the unique needs of hunters, the Sportsman 570 and XP 1000 Hunt editions include accessories such as the 3,500 lb Polaris Winch, Kolpin Gun Scabbard & Mount, Kolpin Ratchet Claws and more.
Additionally, the 2024 Sportsman 450 and 570 lineup boasts several quality refinements for a better riding experience including a new rear brake pedal for reduced pedal effort and feel, improved sealing around the shifter, and enhanced seat fitment delivering a more comfortable ride. The 570 EPS trim and above will also include enhanced PVT clutch sealing with a higher intake location for better performance in wet conditions.
For added utility, the model year 2024 Sportsman 570 lineup will be equipped with new LED lights for the Premium and Utility HD for added visibility from dawn to dusk.
New color options also are available for the 570 Premium and Trail, 570 Ride Command Edition, Sportsman 850 Premium and Ultimate Trail, Sportsman XP 1000 Ultimate Trail, Sportsman XP 1000 High Lifter Edition, Scrambler XP 1000 S and Sportsman XP 1000 S.
The 2024 Sportsman lineup starts at $6,999 US MSRP and will begin shipping to dealers this early fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/sportsman/
GENERAL
Polaris GENERAL is the industry's most versatile crossover side-by-side, capable of tackling tough trails, while also knocking out tasks around the property. For 2024, the GENERAL 1000 receives a new Premium trim offering that provides both style and performance enhancements. Featuring 14" wheels with 27" Coronado tires, and FOX® Podium QS3® shocks that riders can adjust between soft, medium and firm based on terrain changes, the new Premium trim will deliver a smooth ride over rugged terrain, while LED headlights provide greater visibility at morning and night. These upgrades will help riders knock out more tasks and hit the trails confidently in the GENERAL 1000.
Additionally, new colorways on the GENERAL 1000 model include Ghost Gray and Volcanic Orange. The Premium and Ultimate trim levels for the GENERAL XP will feature new colors and graphics in Matte Silver Quartz and Polaris Blue.
The 2024 GENERAL lineup starts at $17,499 US MSRP and will begin shipping to dealers this summer. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/general/
RZR
Polaris RZR, the No. 1 sport side-by-side brand, receives fresh new colors and graphics across its lineup, helping riders make a bold statement when hitting the trails. The 2024 RZR Trail and RZR Trail S are now available in Storm Blue on the Sport trim and two-tone Storm Blue with White Lightning on the Ultimate. Both Sport and Ultimate trim levels now receive the same upgraded steering wheel offered in the fully-redesigned 2024 RZR XP that provides a sportier feel while driving on trails. New for 2024, the RZR Trail and Trail S Sport level feature electric power steering and LED headlights standard, providing riders easier steering input on tight trail corners and enhanced visibility. Additionally for 2024, the RZR Trail S Ultimate trim now features Walker Evans Racing® shocks, while the Sport trim moved to ZF Sachs shocks, both offering riders plush suspension performance against the rugged terrain.
For 2024, the RZR Pro XP Sport and Premium models feature Walker Evans Racing® shocks, while the Ultimate will continue to be equipped with FOX® Live Valve shocks with DYNAMIX active suspension. Both the Premium and Ultimate trim received a refresh with new graphics on the Super Graphite colorway.
Lastly and by consumer demand, the Wide Open lineup of RZR Pro R and RZR Turbo R receives refreshed color options for 2024. For the first time since launching, the RZR Pro R Ultimate is available in an all-new Matte Onyx Black with Lifted Lime accents or Matte Heavy Metal, while the Premium trim level is offered in Matte Heavy Metal. The 2024 RZR Turbo R also welcomes vibrant new colors like Velocity Blue with Green Burst accents and Military Tan with Orange Burst accents.
The 2024 RZR lineup starts at $15,999 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/rzr/
RANGER
In addition to the newly launched Extreme Duty RANGER XD 1500, the Polaris RANGER lineup receives a variety of rider-inspired upgrades and quality refinements for 2024. RANGER SP 570 gets new color options, while the NorthStar Edition gets exclusive tailgate badging and new 25" 8-ply Pro Armor X-Terrain tires for added durability and enhanced puncture resistance.
Additionally, Polaris expands the color options for the RANGER 1000 Premium which will now be offered in the sleek Granite Grey color and graphics, while the XP 1000 will be featured in two new options: Desert Sand and Super Graphite with orange burst accents. Furthermore, the RANGER XP 1000 NorthStar Ultimate model boasts connectivity features such as vehicle health, issue diagnostics, and maintenance reminders enabled by RIDE COMMAND+.
The 2024 RANGER lineup starts at $11,699 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/ranger/
Youth
Dedicated to inspiring the next generation of riders, Polaris Off Road delivers the industry's largest and most varied lineup of youth offerings. For 2024, the Polaris ORV Youth lineup receives a refresh with eye-catching new colors and graphics. This lineup continues to provide industry-leading safety features that give parents peace of mind and help instill confidence in growing riders, including pin code start, adjustable speed limiter, geofencing, helmet aware technology and industry-exclusive safety gear kit.
Specifically, the 2024 RZR 200 EFI is now offered in Storm Gray and a new graphic pattern with bright red accents. The Outlaw 70 EFI ATV is offered in Velocity Blue with either Lifted Lime or Fierce Fuchsia accents, while the Outlaw 110 EFI is now offered in both Bright White with Polaris Blue and Bright White with Radiant Green details.
The 2024 Polaris Youth lineup starts at $2,999 US MSRP and will begin shipping to dealers this winter. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/shop-by-use/youth/
Polaris XPEDITION
The Polaris XPEDITION, which recently launched in May 2023, is the first-of-its-kind adventure side-by-side, combining the all-terrain capabilities of traditional side-by-sides with comfort and cargo capabilities typically associated with overlanding at the highest level. With a host of standard features and optional configurations to accommodate the greatest range of outdoor pursuits and enable consumers to keep chasing the wild, the 2024 Polaris XPEDITION XP and ADV are the most adaptable, comfortable and capable adventure machine on the market.
The 2024 Polaris XPEDITION lineup starts at $28,999 US MSRP and is currently shipping to dealers. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/polaris-xpedition/
To learn more about the Polaris ORV 2024 lineup and to stay up to date on testing and demo opportunities, please visit https://offroad.polaris.com/en-us/ or join the conversation and follow on FacebookSM, InstagramSM, YouTubeSM and TwitterSM. Walker Evans Racing® is a registered trademark of Walker Evans Enterprises Incorporated; FOX® is a registered trademark of Fox Factory Inc.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.wbrc.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ | 2023-07-31T11:51:12 | 0 | https://www.wbrc.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ |
Lawsuit alleges flight attendants served too much alcohol to passenger that groped woman, her daughter
(CNN) - A passenger is suing Delta Airlines, claiming flight attendants overserved alcohol to a man who became drunk while on board and groped a mother and her teenage daughter.
The alleged incident happened during an international flight last summer.
The suit claims the flight attendants ignored the mother’s pleas for them to stop serving alcohol to the man and that the passenger was making them feel unsafe.
The plaintiffs in the case said during the nine-hour flight from New York to Greece, the man made obscene gestures and sexually assaulted the 16-year-old girl sitting next to him.
When the plane landed in Greece, the man was allowed to walk free despite the mother’s request that authorities arrest him in Athens.
Delta has not commented on the suit but says the airline has zero tolerance for passengers who engage in inappropriate or unlawful behavior.
Copyright 2023 CNN Newsource. All rights reserved. | https://www.weau.com/2023/07/31/lawsuit-alleges-flight-attendants-served-too-much-alcohol-passenger-that-groped-woman-her-daughter/ | 2023-07-31T11:51:17 | 1 | https://www.weau.com/2023/07/31/lawsuit-alleges-flight-attendants-served-too-much-alcohol-passenger-that-groped-woman-her-daughter/ |
LA ROMANA, Dominican Republic, July 31, 2023 /PRNewswire/ -- The international known company Hilton Hotels & Resorts opens its doors to its Hilton Garden Inn La Romana hotel project in the Dominican Republic, in collaboration with a group of important investors under the company Riverhome Capital S.A.S., whose main shareholder is the prominent Dominican former major league player, Edwin Encarnación; together with the vision of the lawyer Guillermo Estrella Ramia and the Minister of Tourism, David Collado.
The inauguration was led by Luis Abinader Corona, president of the Dominican Republic and who expressed that "This hotel has something very special, opening up the beach and the sector of La Caleta of La Romana, which for a long time was closed to the province and its visitors. Since private investment must always be accompanied by public infrastructure, we are working on creating them, so we are all part of this development of La Romana."
With an investment of 25 million united states dollars and the creation of more than 300 direct jobs, it is considered as a hotel option for the growing flows of tourists that the area is currently receiving. Located a short distance from other points of relevance, such as La Romana Airport 18 minutes away, Casa de Campo 12 minutes away and Central Romana just a few blocks away.
The new hotel facility has a privileged location on a 5,000 square meters property, located on the coast of the municipal district of La Caleta, La Romana province. With a capacity of 130 rooms, distributed in five of the seven floors of the building, it also counts with swimming pools, two bars, a restaurant, gym, event, meeting and multipurpose rooms, and outdoor areas, ideal for social and corporate celebrations.
The hotel responds to the interest of Edwin Encarnación to invest in the development of his province of origin, who expressed that "from the moment this project was presented to me, I knew that I had to be part and be the one to assume this. I joined the development of this hotel, with the only requirement that most of the workers came from here, from my town La Romana, and we achieved this."
View original content to download multimedia:
SOURCE Grupo De Valle | https://www.wflx.com/prnewswire/2023/07/31/hilton-garden-inn-la-romana-dominican-republic-celebrates-its-opening/ | 2023-07-31T11:51:17 | 0 | https://www.wflx.com/prnewswire/2023/07/31/hilton-garden-inn-la-romana-dominican-republic-celebrates-its-opening/ |
The Avocados From Mexico® Chocolate Dulce De Leche Cupcake will be available at Sprinkles bakeries nationwide for one week beginning July 31
DALLAS, July 31, 2023 /PRNewswire/ -- Talk about a perfect pairing! Avocados From Mexico®, the number one selling avocado brand in the U.S., is making National Avocado Day even better by partnering with renowned dessert bakery chain Sprinkles for a delicious collaboration – a limited-edition cupcake featuring fresh Mexican avocados.
The Avocados From Mexico® Chocolate Dulce De Leche Sprinkles cupcake is a delectable banana cupcake that's studded with pecans and generously filled with a soft dulce de leche core. And to top it all off? A zesty frosting that blends rich cream cheese and chocolate made with fresh Mexican avocados for a delightful, creamy finish.
"The new Avocados From Mexico Chocolate Dulce De Leche cupcake features the highest quality and best-tasting ingredients," said Sprinkles Vice President, Culinary, Charles Craig. "By blending fresh avocado and smooth cream cheese alongside the banana and dulce de leche cupcake, we were able to elevate all the ingredients resulting in a cupcake that is out-of-this world. We can't wait for fans to try it!"
Beginning on July 31, National Avocado Day, consumers can make their week better by enjoying Avocados From Mexico in cupcake form — available at Sprinkles nationwide through August 6.
"Avocados From Mexico make everything better, and we're so proud that our avocados will get to shine in a unique way on National Avocado Day," said Kelly Burke, Director of Brand Marketing at Avocados From Mexico. "Our brand is known for bringing the good times with great tasting avocados. We are excited to partner with a beloved brand like Sprinkles to spark good times in a new way with everyone's favorite sweet treat."
"Sprinkles Cupcakes has always taken an innovative approach to classic desserts, and this new collaboration with Avocados From Mexico is no exception," said Sprinkles CMO, Michelle Wong. "Avocados From Mexico was an obvious choice for their quality and taste, and we can't wait for our guests to discover our latest cupcake, starring this beloved fruit."
To learn more about Avocados From Mexico, visit https://avocadosfrommexico.com, Facebook (facebook.com/avocadosfrommexico), Instagram (@avocadosfrommexico) or Twitter (@AvosFromMexico). #MakeItBetter #AFMxSprinkles
About Avocados From Mexico
Avocados From Mexico is a wholly-owned subsidiary of the Mexican Hass Avocado Importers Association (MHAIA), formed for the purpose of advertising, promotion, public relations and research for all stakeholders of Avocados From Mexico. Under agreements, MHAIA and the Association of Avocado Exporting Producers & Packers of Mexico (APEAM) have combined resources to fund and manage Avocados From Mexico, with the intent to provide a focused, highly- effective and efficient marketing program in the United States. Avocados From Mexico is headquartered in Irving, Texas.
About Sprinkles
Sprinkles offers premium cupcakes, cakes and cookies that are baked fresh in small batches throughout the day and handcrafted with only the finest ingredients. Sprinkles opened its first bakery in Beverly Hills in 2005, drawing long lines of loyal cupcake fans and celebrity endorsements. Sprinkles prides themselves in being passionate innovators and since debuting the world's first Cupcake ATM, the brand has introduced layer cakes, cookies and brownies, launched a national shipping platform and has grown to over 70 bakeries and ATMs coast-to-coast. Sprinkles launched domestic and international franchising in 2022. For additional information on Sprinkles, follow @sprinklescupcakes on social and visit www.sprinkles.com.
CONTACT: Ana Ambrosi, aambrosi@avocadosfrommexico.com
View original content to download multimedia:
SOURCE Avocados From Mexico | https://www.kswo.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ | 2023-07-31T11:51:18 | 1 | https://www.kswo.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ |
Pitstick brings product, operations, and value-based care expertise to leading behavioral health provider
SARATOGA SPRINGS, N.Y., July 31, 2023 /PRNewswire/ -- aptihealth, the leading tech-driven behavioral healthcare provider built for higher acuity care, today announced that Regina Pitstick has joined the organization as Senior Vice President of aptihealth Medical Group.
Most recently, Pitstick was VP Advocacy Product & Innovation for the Employer and Individual segment at UnitedHealth Group, where she drove the company's product strategy and vision, focused on delivering a seamless, personalized patient experience. Responsible for product development initiatives, Pitstick's leadership and experience fueled successful long-range strategies, broader market penetration and deeper engagement for over 15M consumers.
"Regina brings more than twenty years of extremely relevant experience in the healthcare industry to aptihealth—including a deep skillset in digital health start-ups, product development, operations, process improvement and value-based care," said Tim Koehler, President and Chief Operating Officer of aptihealth. "Regina's patient-centered approach, insightful understanding of the health care landscape, innovate approach, and impeccable ability to execute strategic initiatives will greatly enhance our medical group. She's ideal for this critical role at aptihealth as we continue to pursue our mission of becoming the nation's preeminent provider of behavioral health services."
Pitstick joins aptihealth at a time of significant growth, having served nearly 15,000 patients for leading national and regional health plans. aptihealth expects to more than double its patients in 2023, with a majority covered by value-based care contracts.
"The value that aptihealth is providing to health plans, physicians groups, health systems and higher-acuity patients simply can't be underestimated," indicated Pitstick. "Whether it's the company's commitment to engaging new patients at any point of care, to their proprietary screening and assessment tools, to their proven ability to improve outcomes and decrease the overall cost of care, it's not hyperbole to state that aptihealth is changing the behavioral healthcare game. I'm thrilled to have the opportunity to help aptihealth continue to improve its care model, meet its strategic goals, and intelligently achieve its considerable opportunities for growth."
About aptihealth
aptihealth is improving higher acuity behavioral healthcare for populations who need it most—one patient at a time. The company's virtual-first model and proprietary screening, assessment, and treatment programs give members fast, convenient access to precise, personalized care. Headquartered in Saratoga Springs and employing over 150, aptihealth has raised over $70 million in funding from leading international private equity firms. The company's care program and data insights are driving breakthroughs in mental health understanding, treatment, outcomes, and cost reduction. Learn more at: www.aptihealth.com.
View original content to download multimedia:
SOURCE aptihealth | https://www.wbrc.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ | 2023-07-31T11:51:19 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ |
Wisconsin woman set on fire, manhunt for boyfriend is under way
Sheriff’s Department searching for Myron Faith Bowie, who is considered armed and dangerous
SALEM, Wis. (WBAY) - A manhunt is on for a man suspected of setting his girlfriend on fire Sunday morning and leaving the scene, the Kenosha County Sheriff’s Department said.
The sheriff’s department said it received a call from a Salem Lakes woman at about 4:45 a.m.
The victim told them she and Myron Faith Bowie had an argument where Bowie said he would kill her, her children, and her entire family before setting her on fire and driving away.
The victim was taken to an area hospital with severe burns. She is in critical condition.
Bowie is on the run and believed to be driving a black Cadillac SRX with Illinois license plate: DQ46996.
Bowie has a felony warrant for his arrest and should be considered armed and dangerous. Myron has been known to stay in the Chicago area -- Logan Square and Wicker Park. He is in his mid-30s, about 6 feet tall, and weighs approximately 200 pounds.
If anyone knows where Bowie is, see him or his vehicle, please contact the Kenosha County Sheriff’s Department Detective Bureau at 262-605-5102 or Kenosha Area Crime Stoppers at 262-656-7333 or 800-807-TIPS(8477). Crime Stoppers offers cash rewards of up to $1,000.
Copyright 2023 WBAY. All rights reserved. | https://www.weau.com/2023/07/31/wisconsin-woman-set-fire-manhunt-boyfriend-is-under-way/ | 2023-07-31T11:51:23 | 1 | https://www.weau.com/2023/07/31/wisconsin-woman-set-fire-manhunt-boyfriend-is-under-way/ |
- CARDIO-TTRansform is the largest, most comprehensive ATTR-CM study with more than 1,400 patients enrolled
- Eplontersen is currently under U.S. FDA review for ATTRv-polyneuropathy, with ATTR-CM representing a second, larger potential patient population
CARLSBAD, Calif., July 31, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the completion of enrollment in the Phase 3 CARDIO-TTRansform cardiovascular outcomes study of eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), a large and growing patient population at risk of life-threatening cardiovascular (CV) events. The study enrolled more than 1,400 patients.
Eplontersen is an investigational antisense medicine designed to inhibit the production of transthyretin and slow the progression of cardiomyopathy for people living with hereditary or wild-type ATTR-CM.
"CARDIO-TTRansform is the largest and most comprehensive ATTR-CM study ever conducted. The evaluation of eplontersen in this broad, diverse patient population will enable robust and clinically meaningful analysis of the composite endpoint of CV mortality and recurrent CV events," said Eugene Schneider, M.D., executive vice president and chief clinical development officer for Ionis. "It will also allow us to gather data from important patient subsets, including patients with or without stabilizer therapy and those with or without hereditary disease within the evolving ATTR-CM landscape. We look forward to reporting results as early as the first half of 2025."
As part of a global development and commercialization agreement, Ionis and AstraZeneca are seeking regulatory approval for eplontersen for the treatment of transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) in the U.S. and plan to seek regulatory approval in Europe and other parts of the world. The U.S. Food and Drug Administration accepted the New Drug Application for eplontersen for the treatment of ATTRv-PN with a PDUFA action date of Dec. 22, 2023. Eplontersen was granted Orphan Drug Designation in the U.S.
For more information on the CARDIO-TTRansform study, please visit www.clinicaltrials.gov (NCT04136171).
About the CARDIO-TTRansform Study
CARDIO-TTRansform is a global, double-blind, randomized, placebo-controlled Phase 3 cardiovascular outcome study in more than 1,400 patients with ATTR cardiomyopathy (ATTR-CM). It is designed to compare eplontersen to placebo in patients with both wild-type ATTRwt-CM and hereditary ATTRv-CM who are either naïve to treatment or on a currently available standard of care. The primary composite endpoint is cardiovascular (CV) mortality and recurrent CV clinical events comparing the two study arms up to week 140. Secondary endpoints include the change from baseline in the 6-minute walk test (6MWT) and the Kansas City Cardiomyopathy Questionnaire (KCCQ) scores at week 121, as well as the rates of CV mortality, CV clinical events and all-cause mortality at week 140.
About Eplontersen
Eplontersen is an investigational LIgand-Conjugated Antisense (LICA) medicine designed to inhibit the production of TTR protein. Eplontersen is being developed as a monthly self-administered subcutaneous injection to treat all types of ATTR. ATTR amyloidosis is a systemic, progressive and fatal disease in which patients experience multiple overlapping clinical manifestations caused by the inappropriate formation and aggregation of TTR amyloid deposits in various tissues and organs, including peripheral nerves, heart, intestinal tract, eyes, kidneys, central nervous system, thyroid and bone marrow. The progressive accumulation of TTR amyloid deposits in these tissues and organs leads to organ failure and eventually death.
About Transthyretin-mediated Amyloid Cardiomyopathy (ATTR-CM)
Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease. It is caused by the accumulation of misfolded TTR protein in the cardiac muscle. Patients experience ongoing debilitating heart damage resulting in progressive heart failure, which results in death within three to five years from disease onset. ATTR-CM includes both the genetic and wild-type form of the disease. Worldwide, there are an estimated 300,000 – 500,0001,2 patients with ATTR-CM.
About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
Ionis' Forward-looking Statements
This press release includes forward-looking statements regarding Ionis' business and the therapeutic and commercial potential of eplontersen, Ionis' technologies and other products in development. Any statement describing Ionis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties including those related to our commercial products and the medicines in our pipeline, and particularly those inherent in the process of discovering, developing and commercializing medicines that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such medicines. Ionis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Ionis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Ionis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Ionis' programs are described in additional detail in Ionis' annual report on Form 10-K for the year ended Dec. 31, 2022, and the most recent Form 10-Q quarterly filing, which are on file with the Securities and Exchange Commission. Copies of these and other documents are available from the Company.
In this press release, unless the context requires otherwise, "Ionis," "Company," "we," "our," and "us" all refer to Ionis Pharmaceuticals and its subsidiaries.
Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc.
1 Mohamed-Salem L, et al. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. Int J Cardiol. 2018 Nov 1;270:192-196. doi: 10.1016/j.ijcard.2018.06.006.
2 Cuscaden C, et al. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol. 2020 May 8. doi: 10.1007/s12350-020-02152-x.
View original content to download multimedia:
SOURCE Ionis Pharmaceuticals, Inc. | https://www.wflx.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ | 2023-07-31T11:51:24 | 0 | https://www.wflx.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ |
SHENZHEN, China, July 31, 2023 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company" or "Taoping"), today announced that the board of directors of the Company approved a one-for-ten reverse stock split of the Company's issued and outstanding ordinary shares, no par value (the "Ordinary Shares"). Beginning August 1, 2023, the Company's Ordinary Shares will be trading on a split-adjusted basis under the same symbol "TAOP" but with new CUSIP number, G8675V 127.
As a result of the share consolidation, each ten Ordinary Shares outstanding will automatically combine and convert to one issued and outstanding Ordinary Share without any action on the part of shareholders who hold their shares in brokerage accounts or "street name". Shareholders holding certificates of Ordinary Shares are expected to receive instructions from the Company's transfer agent, Transhare Corporation, regarding procedures for exchanging share certificates. All outstanding options, warrants and other rights to purchase the Company's Ordinary Shares will be adjusted proportionately as a result of the reverse stock split. No fractional shares will be issued as a result of the reverse stock split, and instead, all such fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share.
The reverse stock split is intended to increase the per share trading price of the Ordinary Shares to satisfy the $1.00 minimum bid price requirement for continued listing on the NASDAQ Stock Market. Following the reverse stock split the Company will have approximately 1.86 million Ordinary Shares issued and outstanding, exclusive of shares issuable under outstanding options and warrants. The reverse stock split will not affect the number of total authorized Ordinary Shares of the Company.
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
Safe Harbor Statement
This press release contains "forward-looking statements" that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, such as statements regarding our estimated future results of operations and financial position, our strategy and plans, and our objectives or goals, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should," or "will" or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by, these forward-looking statements. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including: our potential inability to achieve or sustain profitability or reasonably predict our future results due to our limited operating history of providing smart cloud services, the effects of the global Covid-19 pandemic, the emergence of additional competing technologies, changes in domestic and foreign laws, regulations and taxes, uncertainties related to China's legal system and economic, political and social events in China, the volatility of the securities markets; and other risks including, but not limited to, those that we discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the "SEC") available on the SEC's website at www.sec.gov, including the Company's most recent Annual Report on Form 20-F as well as in our other reports filed or furnished from time to time with the SEC. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.
View original content to download multimedia:
SOURCE Taoping Inc. | https://www.kswo.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ | 2023-07-31T11:51:25 | 1 | https://www.kswo.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ |
BEIJING, July 31, 2023 /PRNewswire/ -- SANY Group ("SANY") has announced the 2023 employee stock ownership plan (ESOP). This is the fourth consecutive year that SANY has launched the ESOP, which gives employees an opportunity to own shares in the company through the setting up of incentive funds. The 2023 ESOP has set up a fund size of around 590 million yuan (USD 82 million) with a share repurchase price planned at 16.13 yuan per share (USD 2.24). The capital will be from the incentive funds accrued following relevant provisions of the group.
SANY has always focused on improving employee benefits and adhering to the principle of "growing together, pursuing common development, and sharing achievements." By establishing a comprehensive incentive and restraining mechanism, it aims to inspire employees' enthusiasm and creativity and align the interests of shareholders, the listed company, and individuals. This encourages all parties to join efforts to boost SANY's long-term development.
SANY's annual ESOP aims to share the fruits of the group's achievements with employees. The number of employees awarded with stock ownership incentives is growing annually, and the proportion of mid-level and key position employees is increasing year by year:
- 2020: SANY awarded 8.31 million shares to 2,264 employees, 71.52 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2021: SANY awarded 7.54 million shares to 4,205 employees, 91.33 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2022: SANY awarded 20.5 million shares to 6,996 employees, 94.26 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2023: SANY is awarding 36.62 million shares to 7,131 employees, 95.69 percent were employees in mid-level management, key positions, and core business (technical) positions.
The source of shares for the 2023 ESOP is the shares that have already been repurchased by SANY's special account. It does not exceed 36.62 million shares in total and is within one percent of SANY's current total capital stock.
In the meantime, SANY Renewable Energy (SH688349) released an announcement relating to exercising of the second exercise period of the 2020 stock option incentive plan, with 16.0368 million granted options to be exercised, with a three-year restricted period. The subsidiary is committed to becoming a global leader of clean energy equipment and services, and contributing to reaching the goals of carbon peaking and carbon neutrality.
View original content to download multimedia:
SOURCE SANY Group | https://www.wbrc.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ | 2023-07-31T11:51:26 | 0 | https://www.wbrc.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ |
Elvina Kalieva 2023 Livesport Prague Open 2021 Odds
Elvina Kalieva's round of 32 match in the Livesport Prague Open 2021 will be versus Linda Noskova. Kalieva is +4000 to win this tournament at Tennis Club Sparta Praha.
Find all the latest odds for the 2023 Livesport Prague Open 2021 and place your bets with a new user bonus from BetMGM.
Kalieva at the 2023 Livesport Prague Open 2021
- Next Round: Round of 32
- Tournament Dates: July 28 - August 6
- Venue: Tennis Club Sparta Praha
- Location: Prague, Czechia
- Court Surface: Hard
Watch live sports without cable! Sign up today for a free trial to Fubo!
Kalieva's Next Match
Kalieva will meet Noskova in the round of 32 on Tuesday, August 1 at 5:00 AM ET, after getting past Tayisiya Morderger 6-2, 6-3 in the qualification final.
Kalieva is listed at +375 to win her next matchup against Noskova. Check out the latest odds for the entire field at BetMGM.
Want to bet on Kalieva? Head to BetMGM using our link for a bonus bet special offer for new players!
Kalieva Stats
- Kalieva defeated Morderger 6-2, 6-3 on Sunday in the qualifying round.
- In five tournaments over the past year, Kalieva is yet to win a title, and her overall record is 3-5.
- Kalieva has a record of 2-3 on hard courts over the last 12 months.
- In her eight matches over the past year, across all court surfaces, Kalieva has averaged 18.6 games.
- On hard courts, Kalieva has played five matches over the past 12 months, and she has totaled 20.8 games per match while winning 49.0% of games.
- Over the past year, Kalieva has been victorious in 12.5% of her return games and 28.6% of her service games.
- Kalieva has claimed 50% of her service games on hard courts and 11.1% of her return games over the past 12 months.
Not all offers available in all states, please visit BetMGM for the latest promotions for your area. Must be 21+ to gamble, please wager responsibly. If you or someone you know has a gambling problem, contact 1-800-GAMBLER.
© 2023 Data Skrive. All rights reserved. | https://www.weau.com/sports/betting/2023/07/28/elvina-kalieva-livesport-prague-open-2021-betting-odds/ | 2023-07-31T11:51:29 | 1 | https://www.weau.com/sports/betting/2023/07/28/elvina-kalieva-livesport-prague-open-2021-betting-odds/ |
Juggernaut and Mr. Highman will continue as substantial shareholders of Bobbie. The acquisition positions the combined company as the third largest fully integrated infant and toddler brand in the U.S., creating a more resilient industry for American families
WASHINGTON, July 31, 2023 /PRNewswire/ -- Juggernaut Capital Partners, a leading middle market private equity investor primarily in the consumer and healthcare sectors, is pleased to announce the sale of Nature's One, the pediatric nutrition company founded by Jay Highman which set the bar for quality and innovation in formula over decades. Joining forces with Bobbie Baby, Inc., the nation's fastest growing infant formula company, the combined business will be the first of its kind in pediatric nutrition.
"Nature's One is a true pioneer in the pediatric nutrition space. Juggernaut partnered with founder, Jay Highman, to accelerate product development and vertical integration initiatives. Over the past five years, the company completed the first FDA-approved clinical feeding study of an organic infant formula and designed and constructed the first newly built infant formula facility in the U.S. in 35 years," said John Shulman, Founder and Managing Partner at Juggernaut. "It has been a pleasure to partner with Jay and his team. We believe the combination with Bobbie cements the organization as a continued disruptor and a next-generation industry leader. We are proud to continue as a meaningful shareholder in the go-forward company."
Founded in 1997, Nature's One introduced the first organic baby formula to the U.S. market. Recognized for its dedication to purity and quality, all of the company's formulas have received the Clean Label Project's Purity Award and have tested best in class for purity and nutrition when compared to popular baby formulas sold in the U.S. Nature's One operates the only independent, FDA audited organic infant nutrition facility in the U.S.
Nature's One was advised by CG / Sawaya Partners (operating under Canaccord Genuity) and Morgan Lewis & Bockius LLP. Bobbie was advised by Perella Weinberg Partners LP and Goodwin Procter LLP.
About Juggernaut Capital Partners:
Juggernaut Capital Partners is a leading private equity firm focusing on lower middle market companies, primarily in the consumer and healthcare sectors. Juggernaut is currently investing out of Juggernaut Capital Partners V, L.P. For more information on Juggernaut Capital Partners, please visit www.juggernautcap.com.
About Nature's One:
Founded in 1997, Nature's One introduced the first organic formula, Baby's Only® Organic in the United States. Nature's One has dedicated 25 years to the research, development, and sourcing of pure ingredients. Recognized as the first and highest-ranked formulas for purity and nutritional superiority by the Clean Label Project, Baby's Only Formulas are preferred by parents who want to offer their child a "Better Start…for Life™." Baby's Only Formulas are sold nationally at Whole Foods, Target, Walmart, Sam's Club, and many fine natural food retailers, as well online at www.naturesone.com.
About Bobbie:
Bobbie is the mission-driven organic pediatric nutrition company that exists to build a parenting culture of confidence, not comparison. Founded in 2018, Bobbie hit the market with its flagship European-inspired formula in 2021 as the first direct-to-consumer, subscription-based infant formula in the U.S. Today, it's proud to be the only mom-founded and led infant formula brand in the world, and the fastest-growing in the U.S. since the 1980's. Bobbie is focused on providing purposefully sourced, USDA Organic products made with simple ingredients – crafted right here in America, for American families. For more information, visit www.hibobbie.com.
View original content:
SOURCE Juggernaut Capital Partners | https://www.wflx.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ | 2023-07-31T11:51:31 | 1 | https://www.wflx.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ |
This Launch Marks the Latest Expansion of the Brand's Complexion Offerings as it Doubles Down on The Skincare-Meets-Makeup Hybrid Category
NEW YORK, July 31, 2023 /PRNewswire/ -- TULA Skincare, the leading clinically proven probiotic extract powered skincare brand has announced the expansion of its complexion offerings to include concealer.
After learning that TULA's customers were looking for a skin brightening eye treatment along with a concealer, the brand created a state-of-the-art clean skincare-makeup hybrid that delivers skin-boosting benefits with high-performance medium-to-full coverage.
Available in a 20-shade range, the dermatologist-tested, Radiant Skin Brightening Serum Concealer is infused with TULA's unique Rainbow Seabright™ Elixir. This clinically-proven serum-like formula instantly conceals dark circles and discoloration for longwearing, crease-proof results, while brightening the appearance of skin over time. Additional ingredients include TULA's S6Pro Complex® - a US patent pending super six blend of prebiotics and probiotic extracts to help soothe skin, improve skin smoothness and maintain skin balance, along with eye peptides and tea leaf caffeine to help improve the look of dark circles, skin texture, and eye bags. The Radiant Skin Brightening Serum Concealer can be paired with the brand's Radiant Skin Brightening Serum Skin Tint or Filter Primer Blurring & Moisturizing Primer to help build one's complexion wardrobe, or spot conceal for a no-makeup, makeup look.
"Expanding our complexion category to include a concealer was a natural next step for us, especially knowing the strong desire our customers have had for an eye treatment with brightening benefits." said TULA Skincare CEO, Savannah Sachs. " We are excited to have another offering for our glow getters that will surely be a staple in their skincare and beauty routines."
To mark the launch, TULA will be executing a multi-channel launch campaign across its digital platform, and organic social, paid media, and influencer channels. Efforts will include launching a custom "shade finder" on tula.com to help customers find their perfect match concealer shade, highlighting content speaking to the "no-makeup, makeup" and makeup-skincare hybrid trends across TikTok and Instagram, and partnering with a curated set of influencers and providing them with an early access link exclusively for their followers to purchase the concealer prior to launch. In addition to tula.com, the concealer will launch in Ulta Beauty stores nationwide and online and will be featured in an upcoming issue of the Ulta Beauty Magazine, with in-store complexion events planned in the coming months in multiple doors.
TULA's Radiant Skin Brightening Serum Concealer will be available for purchase on July 31 on tula.com, and will retail for $32.
About TULA Skincare
TULA is a doctor-founded skincare brand built on clinically proven formulas powered by probiotic extracts. We believe that the same types of ingredients which are good for your body are also great for your skin. We focus on being healthy, not perfect and on empowering everyone to feel confident in their skin.
Media Contact: Zoe Jeans at Bux + Bewl Communications: zoe@buxandbewl.com
View original content to download multimedia:
SOURCE TULA Skincare | https://www.kswo.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ | 2023-07-31T11:51:31 | 0 | https://www.kswo.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ |
The Avocados From Mexico® Chocolate Dulce De Leche Cupcake will be available at Sprinkles bakeries nationwide for one week beginning July 31
DALLAS, July 31, 2023 /PRNewswire/ -- Talk about a perfect pairing! Avocados From Mexico®, the number one selling avocado brand in the U.S., is making National Avocado Day even better by partnering with renowned dessert bakery chain Sprinkles for a delicious collaboration – a limited-edition cupcake featuring fresh Mexican avocados.
The Avocados From Mexico® Chocolate Dulce De Leche Sprinkles cupcake is a delectable banana cupcake that's studded with pecans and generously filled with a soft dulce de leche core. And to top it all off? A zesty frosting that blends rich cream cheese and chocolate made with fresh Mexican avocados for a delightful, creamy finish.
"The new Avocados From Mexico Chocolate Dulce De Leche cupcake features the highest quality and best-tasting ingredients," said Sprinkles Vice President, Culinary, Charles Craig. "By blending fresh avocado and smooth cream cheese alongside the banana and dulce de leche cupcake, we were able to elevate all the ingredients resulting in a cupcake that is out-of-this world. We can't wait for fans to try it!"
Beginning on July 31, National Avocado Day, consumers can make their week better by enjoying Avocados From Mexico in cupcake form — available at Sprinkles nationwide through August 6.
"Avocados From Mexico make everything better, and we're so proud that our avocados will get to shine in a unique way on National Avocado Day," said Kelly Burke, Director of Brand Marketing at Avocados From Mexico. "Our brand is known for bringing the good times with great tasting avocados. We are excited to partner with a beloved brand like Sprinkles to spark good times in a new way with everyone's favorite sweet treat."
"Sprinkles Cupcakes has always taken an innovative approach to classic desserts, and this new collaboration with Avocados From Mexico is no exception," said Sprinkles CMO, Michelle Wong. "Avocados From Mexico was an obvious choice for their quality and taste, and we can't wait for our guests to discover our latest cupcake, starring this beloved fruit."
To learn more about Avocados From Mexico, visit https://avocadosfrommexico.com, Facebook (facebook.com/avocadosfrommexico), Instagram (@avocadosfrommexico) or Twitter (@AvosFromMexico). #MakeItBetter #AFMxSprinkles
About Avocados From Mexico
Avocados From Mexico is a wholly-owned subsidiary of the Mexican Hass Avocado Importers Association (MHAIA), formed for the purpose of advertising, promotion, public relations and research for all stakeholders of Avocados From Mexico. Under agreements, MHAIA and the Association of Avocado Exporting Producers & Packers of Mexico (APEAM) have combined resources to fund and manage Avocados From Mexico, with the intent to provide a focused, highly- effective and efficient marketing program in the United States. Avocados From Mexico is headquartered in Irving, Texas.
About Sprinkles
Sprinkles offers premium cupcakes, cakes and cookies that are baked fresh in small batches throughout the day and handcrafted with only the finest ingredients. Sprinkles opened its first bakery in Beverly Hills in 2005, drawing long lines of loyal cupcake fans and celebrity endorsements. Sprinkles prides themselves in being passionate innovators and since debuting the world's first Cupcake ATM, the brand has introduced layer cakes, cookies and brownies, launched a national shipping platform and has grown to over 70 bakeries and ATMs coast-to-coast. Sprinkles launched domestic and international franchising in 2022. For additional information on Sprinkles, follow @sprinklescupcakes on social and visit www.sprinkles.com.
CONTACT: Ana Ambrosi, aambrosi@avocadosfrommexico.com
View original content to download multimedia:
SOURCE Avocados From Mexico | https://www.wbrc.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ | 2023-07-31T11:51:32 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ |
BURLINGTON, N.C., July 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September 14, 2023, in New York City, beginning at 1:00 p.m. ET and is expected to conclude by approximately 4:00 p.m. ET.
This event will highlight Labcorp's go-forward strategy from Labcorp Chairman & CEO Adam Schechter, followed by business overviews and a longer-term financial outlook. Presentations will be followed by a Q&A session.
A live webcast of the event will be available through the Labcorp Investor Relations website beginning at 1:00 p.m. ET. A replay of the webcast and supporting materials will be available after the conclusion of the event.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
View original content to download multimedia:
SOURCE Labcorp | https://www.wflx.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ | 2023-07-31T11:51:37 | 0 | https://www.wflx.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ |
Launch demonstrates companies' commitment to bringing complex generic medicines to the market to help increase patient access
PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application (ANDA) approved by the U.S. Food and Drug Administration (FDA). Breyna, a drug-device combination product, is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD) and will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths.
Viatris Head of North America Jose Cotarelo said: "We are excited to bring Breyna to the U.S. market for the many Americans living with asthma and COPD. This launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain. Being the first to bring an FDA-approved generic version of Symbicort to patients is a true example of how access is the cornerstone of our mission to empower people worldwide to live healthier at every stage of life."
The indications for Breyna include asthma in patients six years of age and older, and the maintenance treatment of airflow obstruction and reducing exacerbations in patients with COPD, including chronic bronchitis and/or emphysema. Breyna is not indicated for the relief of acute bronchospasm. The 160 mcg/4.5 mcg is the only strength indicated for the treatment of COPD. COPD is a term used to describe a certain kind of chronic lung disease and is characterized by breathlessness; it affects more than 16 million Americans. Asthma causes swelling of the airways resulting in difficulty breathing, and approximately 25 million Americans have the chronic condition.
Milton Boyer, CEO of Kindeva Drug Delivery, added: "The launch of Breyna represents a significant milestone as it is the first FDA-approved generic version of Symbicort in the U.S., one of the most prescribed complex drug-device combination products to treat asthma and COPD. We are pleased for Viatris as well as the many Kindeva colleagues who have worked tirelessly to leverage our complex drug-delivery expertise for this important respiratory product — supporting a persistent need to continue bringing more quality medicines for asthma and COPD to patients."
To further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply. The program offers $30/month or up to $360 per year with 12 refills annually. The program will be available in August.
About Breyna
Breyna is indicated for the treatment of asthma in patients 6 years and older not adequately controlled on a long-term asthma-control medication such as an inhaled corticosteroid (ICS) or whose disease warrants initiation of treatment with both an ICS and long-acting beta2-adrenergic agonists (LABA). Breyna 160 mcg/4.5 mcg dosage is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, and Breyna 160 mcg/4.5 mcg is also indicated to reduce exacerbations of COPD. Breyna is NOT indicated for the relief of acute bronchospasm.
Important Safety Information
Breyna is contraindicated in the primary treatment of status asthmaticus or other acute episode of asthma or COPD where intensive measures are required, and in hypersensitivity to any of the ingredients in Breyna. Use of long-acting beta2-adrenergic agonists (LABA) as monotherapy (without inhaled corticosteroids [ICS]) for asthma is associated with an increased risk of asthma-related death. Available data from controlled clinial trials also suggest that use of LABA as monotherapy increases the risk of asthma-related hospitalization in pediatric and adolescent patients. These findings are considered a class effect of LABA. When LABA are used in fixed dose combination with ICS, data from large clinical trials do not show a significant increase in the risk of serious asthma-related events (hospitalizations, intubations, death) compared to ICS alone. Breyna is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms. Breyna should not be initiated in patients during rapidly deteriorating episodes of asthma or COPD. Patients who are receiving Breyna should not use additional formoterol or other LABA for any reason. Localized infections of the mouth and pharynx with Candida albicans has occurred in patients treated with Breyna. Patients should rinse the mouth after inhalation of Breyna. Lower respiratory tract infections, including pneumonia, have been reported following the administration of ICS. Due to possible immunosuppression, potential worsening of infections could occur. A more serious or even fatal course of chickenpox or measles can occur in susceptible patients. It is possible that systemic corticosteroid effects such as hypercorticism and adrenal suppression may occur, particularly at higher doses. Particular care is needed for patients who are transferred from systemically active corticosteroids to ICS. Deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available ICS. Caution should be exercised when considering administration of Breyna in patients on long-term ketoconazole and other known potent CYP3A4 inhibitors. As with other inhaled medications, paradoxical bronchospasm may occur with Breyna. Immediate hypersensitivity reactions may occur, as demonstrated by cases of urticaria, angioedema, rash, and bronchospasm. Excessive beta-adrenergic stimulation has been associated with central nervous system and cardiovascular effects. Breyna should be used with caution in patients with cardiovascular disorders especially coronary insufficiency, cardiac arrhythmias, and hypertension. Long-term use of ICS may result in a decrease in bone mineral density (BMD Assessment of BMD is recommended prior to initiating Breyna and periodically thereafter. ICS may result in a reduction in growth velocity when administered to pediatric patients. Glaucoma, increased intracolular pressure, and cataracts have been reported following the administration of ICS, including budesonide, a component of Breyna. Close monitoring for glaucoma and cataracts is warranted in patients with a change in vision or history of increased intraocular pressure. In rare cases, patients on ICS may present with systemic eosinophilic conditions. Breyna should be used with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, and in patients who are unusually responsive to sympathomimetic amines. The most common adverse reactions ≥3% reported in asthma clinical trials included nasopharyngitis, headache, upper respiratory tract infection, pharyngolaryngeal pain, sinusitis, influenza, back pain, nasal congestion, stomach discomfort, vomiting, and oral candidiasis. The most common adverse reactions ≥3% reported in COPD clinical trials included nasopharyngitis, oral candidiasis, bronchitis, sinusitis, and upper respiratory tract infection. Breyna should be administered with caution to patients being treated with MAO inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents. Beta-blockers may not only block the pulmonary effect of beta-agonists, such as formoterol, but may produce severe bronchospasm in patients with asthma. ECG changes and/or hypokalemia associated with nonpotassium-sparing diuretics may worsen with concomitant beta-agonists. Use caution with the coadministration of Breyna.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
About Kindeva Drug Delivery
Kindeva Drug Delivery is a global contract development manufacturing organization focused on drug-device combination products. Kindeva Drug Delivery develops and manufactures products across a broad range of complex drug-delivery formats, including injectables (autoinjector, intradermal, microneedle), pulmonary & nasal, and transdermal patches. Its service offering spans early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Kindeva Drug Delivery serves a global client base from its nine manufacturing and research and development facilities located in the U.S. and U.K. For more information, please visit www.kindevadd.com.
Forward-Looking Statements
This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements that the launch of Breyna demonstrates the companies' commitment to bringing complex generic medicines to the market to help increase patient access; Breyna will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths; this launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain; to further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply; and, the program will be available in August. Factors that could cause or contribute to such differences include, but are not limited to: the possibility that the Company may be unable to realize the intended benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with acquisitions, divestitures, or its global restructuring program, within the expected timeframe or at all; impairment charges or other losses related to the divestiture or sale of businesses or assets; the Company's failure to achieve expected or targeted future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by COVID-19; actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris' ability to bring new products to market, including but not limited to "at-risk" launches; Viatris' or its partners' ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings; any significant breach of data security or data privacy or disruptions to our information technology systems; risks associated with international operations; the ability to protect intellectual property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes in Viatris' or its partners' customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; failure to execute stock repurchases consistent with current expectations; stock price volatility; and the other risks described in Viatris' filings with the Securities and Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC's Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this release other than as required by law.
View original content to download multimedia:
SOURCE Viatris Inc. | https://www.kswo.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ | 2023-07-31T11:51:38 | 1 | https://www.kswo.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ |
SHENZHEN, China, July 31, 2023 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company" or "Taoping"), today announced that the board of directors of the Company approved a one-for-ten reverse stock split of the Company's issued and outstanding ordinary shares, no par value (the "Ordinary Shares"). Beginning August 1, 2023, the Company's Ordinary Shares will be trading on a split-adjusted basis under the same symbol "TAOP" but with new CUSIP number, G8675V 127.
As a result of the share consolidation, each ten Ordinary Shares outstanding will automatically combine and convert to one issued and outstanding Ordinary Share without any action on the part of shareholders who hold their shares in brokerage accounts or "street name". Shareholders holding certificates of Ordinary Shares are expected to receive instructions from the Company's transfer agent, Transhare Corporation, regarding procedures for exchanging share certificates. All outstanding options, warrants and other rights to purchase the Company's Ordinary Shares will be adjusted proportionately as a result of the reverse stock split. No fractional shares will be issued as a result of the reverse stock split, and instead, all such fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share.
The reverse stock split is intended to increase the per share trading price of the Ordinary Shares to satisfy the $1.00 minimum bid price requirement for continued listing on the NASDAQ Stock Market. Following the reverse stock split the Company will have approximately 1.86 million Ordinary Shares issued and outstanding, exclusive of shares issuable under outstanding options and warrants. The reverse stock split will not affect the number of total authorized Ordinary Shares of the Company.
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
Safe Harbor Statement
This press release contains "forward-looking statements" that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, such as statements regarding our estimated future results of operations and financial position, our strategy and plans, and our objectives or goals, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should," or "will" or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by, these forward-looking statements. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including: our potential inability to achieve or sustain profitability or reasonably predict our future results due to our limited operating history of providing smart cloud services, the effects of the global Covid-19 pandemic, the emergence of additional competing technologies, changes in domestic and foreign laws, regulations and taxes, uncertainties related to China's legal system and economic, political and social events in China, the volatility of the securities markets; and other risks including, but not limited to, those that we discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the "SEC") available on the SEC's website at www.sec.gov, including the Company's most recent Annual Report on Form 20-F as well as in our other reports filed or furnished from time to time with the SEC. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.
View original content to download multimedia:
SOURCE Taoping Inc. | https://www.wbrc.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ | 2023-07-31T11:51:39 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ |
Adult Males are Slightly More Likely to Live with Parents Than Their Female Counterparts
58% of Gen Z Consumers Live with Family Members
SAN FRANCISCO, July 31, 2023 /PRNewswire/ -- LendingClub Corporation (NYSE: LC), the parent company of LendingClub Bank, America's leading digital marketplace bank, today released findings from the 24th edition of the Reality Check: Paycheck-To-Paycheck research series, conducted in partnership with PYMNTS. The Household Finances Deep Dive Edition examines the impact of household composition on consumers' ability to manage expenses and put aside savings. The series draws on insights from a survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data.
The Paycheck-to-Paycheck Landscape
In June 2023, 61% of U.S. consumers lived paycheck to paycheck, unchanged from June 2022 — as is the share of those struggling to pay bills (at 21%) — even though more middle-income consumers cited living paycheck to paycheck in June 2023 than last year. Among consumers earning $50,000 to $100,000, 65% lived paycheck to paycheck as of June 2023, compared to 60% in June 2022. Meanwhile, the shares of high-income consumers — those earning more than $100,000 annually — and low-income consumers — those earning less than $50,000 annually — living paycheck to paycheck in June 2023 sit at 45% and 77%, respectively, relatively unchanged from June 2022.
This stability in the financial situation of U.S. households indicates that consumers continue to adapt to inflationary pressures, finding ways to manage their spending and live within their means.
Household Composition Determines Financial Lifestyle
Consumers living with only a partner or spouse are likely to face less financial hardship, while those with dependents and those living with friends or housemates are more likely to live paycheck to paycheck.
The research finds that 86% of consumers live with one or more people, and one-third of paycheck-to-paycheck consumers live in households of four or more people. Consumers not living paycheck to paycheck are most likely to reside in two-person households, at 41%. Meanwhile, 49% of millennials and 55% of bridge millennials live in households of four or more people, making them the age groups most likely to reside in the largest households.
There is also a direct correlation among household size, stage of life and financial lifestyle. As household size increases, the ratio of income earners to non-earners typically falls, attributable to households with dependent children. When looking at the share of paycheck-to-paycheck consumers who live in a two-member household, the data finds that 54% do so — 7 percentage points below the sample average. Meanwhile, at 66%, consumers with children under the age of 18 are 12% more likely to live paycheck to paycheck than those without children, at 59%. Among consumers living with friends or housemates, 77% live paycheck to paycheck — the most likely to do so. This suggests that those sharing expenses with a partner or spouse fare better, that is until they have children or even parents to support.
"As household size increases, the ratio of income earners to household members typically falls, creating a higher likelihood of financial distress," said Alia Dudum, LendingClub's Money Expert. "The relationship between household income and household composition explains why many families tend to struggle financially and why millennials and bridge millennials, many of whom are in their peak child-rearing years, tend to remain financially vulnerable."
Economic Considerations Top Reason to Stay in the Family Household
Economics are the main driver for consumers to live with family longer, with 43% wanting to save money and 30% unable to afford housing independently. Besides economic reasons, consumers remain at home to maintain family ties (24%), for transitional reasons (23%), and to provide care (22%).
At one-fifth (20%), adult males are slightly more likely to live with parents than their female counterparts (18%), a phenomenon that grows significantly among those financially struggling (26% of males compared to 18% of females). At 58%, Gen Z is the generation most likely to stay with family members, with 50% citing economic reasons. Members of Gen Z living with three or more people — often familial settings — spent 22% of their income on housing, compared to 30% of those living alone or with a partner.
That said, consumers living with family members to offset expenses are not planning extended stays. For example, one-third of those consumers expect to move out in the coming year, particularly millennials and bridge millennials.
Financial Transparency Determined by Relationship Status
Financial transparency within shared households is paramount to ensure bills are paid and expenses are covered, but the transparency level depends on who consumers live with. Couples living together share financial information 87% of the time and have a joint bank account 76% of the time. Parents are also likely to discuss finances with the children residing in their household, with 45% of parents sharing financial information with their children and 34% granting them access to a shared account. Bill splitting is the most common financial interaction for consumers living with friends or housemates, at 74%. Additionally, borrowing money from other household members is a financial option many use to make ends meet, with consumers mostly engaging in this practice with parents or siblings, at 47%, and friends and housemates, at 44%.
Families and couples maintain outstanding credit card balances that are significantly higher, on average, than those of consumers who live alone. Consumers with children under the age of 18 average 50% more credit card debt than those who live alone. Families represent the lion's share of credit card spending, holding average balances of $6,300 for consumers living with a partner and $7,200 for those living with children under 18. Living with a partner or children also significantly increases a consumer's likelihood of having an auto loan or mortgage.
"With today's inflationary pressures, sharing household finances has become not only common but crucial," continued Dudum. "The increasing complexity of modern lifestyles and the rising cost of living have necessitated a shift in the way consumers approach household finances. One person solely bearing the burden of managing all financial matters has become a minority practice. Instead, couples, families, and even roommates increasingly jointly navigate their economic realities, and it's a trend that is here to stay."
To view the full report, visit: https://www.pymnts.com/study/reality-check-paycheck-to-paycheck-inflation-household-spending-shared-expenses/
Methodology
New Reality Check: The Paycheck-to-Paycheck Report — The Household Finances Deep Dive Edition is based on a census-balanced survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data. The data in this report is not intended to be a representation of LendingClub's core member base. The Paycheck-to-Paycheck series expands on existing data published by government agencies, such as the Federal Reserve System and the Bureau of Labor Statistics, to provide a deep look into the core elements of American consumers' financial wellness: income, savings, debt and spending choices. Our sample was balanced to match the U.S. adult population in a set of key demographic variables: 51% of respondents identified as female, 33% were college-educated and 38% declared incomes of more than $100,000 per year.
About LendingClub
LendingClub Corporation (NYSE: LC) is the parent company of LendingClub Bank, National Association, Member FDIC. LendingClub Bank is the leading digital marketplace bank in the U.S., where members can access a broad range of financial products and services designed to help them pay less when borrowing and earn more when saving. Based on more than 150 billion cells of data and over $85 billion in loans, our advanced credit decisioning and machine-learning models are used across the customer lifecycle to expand seamless access to credit for our members while generating compelling risk-adjusted returns for our loan investors. Since 2007, more than 4.7 million members have joined the Club to help reach their financial goals. For more information about LendingClub, visit https://www.lendingclub.com.
Contact:
For Investors: IR@lendingclub.com
Media Contact: Press@lendingclub.com
PYMNTS Contact: information@PYMNTS.com
View original content to download multimedia:
SOURCE LendingClub Corporation | https://www.wflx.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ | 2023-07-31T11:51:43 | 0 | https://www.wflx.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ |
New nuclear unit now serving customers with clean, reliable energy 24/7
ATLANTA, July 31, 2023 /PRNewswire/ -- Georgia Power declared today that Plant Vogtle Unit 3 has entered commercial operation and is now serving customers and the State of Georgia. The new unit represents a long-term investment in the state's clean energy future and will provide reliable, emissions-free energy to customers for decades to come.
"The Plant Vogtle 3 & 4 nuclear expansion is another incredible example of how Georgia Power is building a reliable and resilient energy future for our state," said Kim Greene, chairman, president and CEO of Georgia Power. "It is important that we make these kinds of long-term investments and see them through so we can continue providing clean, safe, reliable and affordable energy to our 2.7 million customers. Today's achievement is a testament to our commitment to doing just that, and it marks the first day of the next 60 to 80 years that Vogtle Unit 3 will serve our customers with clean, reliable energy."
Vogtle Unit 3 is the first newly-constructed nuclear unit in the U.S. in over 30 years and can power an estimated 500,000 homes and businesses. Once all four units are online, the Plant Vogtle site will be the largest generator of clean energy in the nation and support continued growth in Georgia as more industries, businesses and families come to the state.
"Today is a historic day for the State of Georgia, Southern Company, and the entire energy sector, as we continue transforming the way we power the lives of millions of Americans," said Chris Womack, president and CEO of Southern Company. "With Unit 3 completed, and Unit 4 in the final stages of construction and testing, this project shows just how new nuclear can and will play a critical role in achieving a clean energy future for the United States. Bringing this unit safely into service is a credit to the hard work and dedication of our teams at Southern Company and the thousands of additional workers who have helped build that future at this site, as well as all of the partners who have helped make this day a reality."
Nuclear energy is the only zero-emission baseload energy source available today, offering high reliability, and efficient operations around the clock. Nuclear energy currently provides approximately 25% of Georgia Power's overall energy mix, including the existing units at Plant Vogtle and Georgia's other nuclear facility at Plant Hatch in Baxley, Georgia.
"The Vogtle expansion is an American energy success story and would not be possible without the support of strong public and private partners like our partners at North America's Building Trades Unions," said Tom Fanning, chairman of the Board of Directors for Southern Company. "We continue to appreciate their support and those who have stood with us at the local, state and federal levels to complete this new clean energy source to serve electric customers. Providing leadership in our industry and a commitment to safety and quality are in Southern Company's DNA. Today's milestone at the Vogtle expansion site underscores this legacy, and I couldn't be prouder of the dedication our teams have shown in seeing Unit 3 through to completion."
The final stages of construction and testing continue at Vogtle Unit 4, with the unit projected to be placed in service during the late fourth quarter 2023 or the first quarter of 2024. The unit completed hot functional testing in May, in significantly less time than Unit 3 as the team continues leveraging best practices and learnings from the earlier unit. The Vogtle site has also received nuclear fuel for Unit 4, with a total of 157 fuel assemblies necessary for the safe and reliable startup of the unit.
Also, last week, Georgia Power announced the receipt of the 103(g) finding from the Nuclear Regulatory Commission (NRC) for Vogtle Unit 4. This finding was confirmed in an official letter received by Southern Nuclear and signifies that the new unit has been constructed and will be operated in conformance with the Combined License and NRC regulations. No further NRC findings are necessary in order for Southern Nuclear to load fuel or begin the startup sequence for the new unit.
The new Vogtle units are an essential part of Georgia Power's commitment to delivering clean, safe, reliable and affordable energy to its 2.7 million customers. Southern Nuclear will operate the new units on behalf of the co-owners: Georgia Power, Oglethorpe Power, MEAG Power and Dalton Utilities.
About Georgia Power
Georgia Power is the largest electric subsidiary of Southern Company (NYSE: SO), America's premier energy company. Value, Reliability, Customer Service and Stewardship are the cornerstones of the company's promise to 2.7 million customers in all but four of Georgia's 159 counties. Committed to delivering clean, safe, reliable and affordable energy, Georgia Power maintains a diverse, innovative generation mix that includes nuclear, coal and natural gas, as well as renewables such as solar, hydroelectric and wind. Georgia Power focuses on delivering world-class service to its customers every day and the company is recognized by J.D. Power as an industry leader in customer satisfaction. For more information, visit www.GeorgiaPower.com and connect with the company on Facebook (Facebook.com/GeorgiaPower), Twitter (Twitter.com/GeorgiaPower) and Instagram (Instagram.com/ga_power).
Cautionary Note Regarding Forward-Looking Statements
Certain information contained in this release is forward-looking information based on current expectations and plans that involve risks and uncertainties. Forward-looking information includes, among other things, statements concerning the projected in-service date for Plant Vogtle Unit 4 and the future operations of Plant Vogtle Units 3 and 4. Georgia Power cautions that there are certain factors that can cause actual results to differ materially from the forward-looking information that has been provided. The reader is cautioned not to put undue reliance on this forward-looking information, which is not a guarantee of future performance and is subject to a number of uncertainties and other factors, many of which are outside the control of Georgia Power; accordingly, there can be no assurance that such suggested results will be realized. The following factors, in addition to those discussed in Georgia Power's Annual Report on Form 10-K for the year ended December 31, 2022, and subsequent securities filings, could cause actual results to differ materially from management expectations as suggested by such forward-looking information: the ability to control costs and avoid cost and schedule overruns during the development, construction, and operation of facilities or other projects, including Plant Vogtle Unit 4, which includes components based on new technology that only within the last few years began initial operation in the global nuclear industry at this scale, due to current and/or future challenges which include, but are not limited to, changes in labor costs, availability and productivity, challenges with the management of contractors or vendors, subcontractor performance, adverse weather conditions, shortages, delays, increased costs, or inconsistent quality of equipment, materials, and labor, contractor or supplier delay, the impacts of inflation, delays due to judicial or regulatory action, nonperformance under construction, operating, or other agreements, operational readiness, including specialized operator training and required site safety programs, engineering or design problems or any remediation related thereto, design and other licensing-based compliance matters, challenges with start-up activities, including major equipment failure, or system integration, and/or operational performance, continued challenges related to the COVID-19 pandemic or future pandemic health events, continued public and policymaker support for projects, environmental and geological conditions, delays or increased costs to interconnect facilities to transmission grids, and increased financing costs as a result of changes in market interest rates or as a result of project delays; the ability to overcome or mitigate the current challenges, or challenges yet to be identified, at Plant Vogtle Unit 4, that could further impact the cost and schedule for the project; legal proceedings and regulatory approvals and actions related to construction projects, such as Plant Vogtle Unit 4, including Georgia Public Service Commission approvals and U.S. Nuclear Regulatory Commission ("NRC") actions; under certain specified circumstances, a decision by holders of more than 10% of the ownership interests of Plant Vogtle Unit 3 and 4 not to proceed with construction; the notices of tender by Oglethorpe Power Corporation and the City of Dalton of a portion of their ownership interests in Plant Vogtle Units 3 and 4 to Georgia Power, including related litigation; the ability to construct facilities in accordance with the requirements of permits and licenses (including satisfaction of NRC requirements), to satisfy any environmental performance standards and the requirements of tax credits and other incentives, and to integrate facilities into the Southern Company system upon completion of construction; the inherent risks involved in operating and constructing nuclear generating facilities; the ability of counterparties of Georgia Power to make payments as and when due and to perform as required; the direct or indirect effect on Georgia Power's business resulting from cyber intrusion or physical attack and the threat of cyber and physical attacks; catastrophic events such as fires, earthquakes, explosions, floods, tornadoes, hurricanes and other storms, droughts, pandemic health events, political unrest, wars or other similar occurrences; the potential effects of the continued COVID-19 pandemic; and the direct or indirect effects on Georgia Power's business resulting from incidents affecting the U.S. electric grid or operation of generating or storage resources. Georgia Power expressly disclaim any obligation to update any forward–looking information.
View original content to download multimedia:
SOURCE Georgia Power | https://www.kswo.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ | 2023-07-31T11:51:45 | 0 | https://www.kswo.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ |
This Launch Marks the Latest Expansion of the Brand's Complexion Offerings as it Doubles Down on The Skincare-Meets-Makeup Hybrid Category
NEW YORK, July 31, 2023 /PRNewswire/ -- TULA Skincare, the leading clinically proven probiotic extract powered skincare brand has announced the expansion of its complexion offerings to include concealer.
After learning that TULA's customers were looking for a skin brightening eye treatment along with a concealer, the brand created a state-of-the-art clean skincare-makeup hybrid that delivers skin-boosting benefits with high-performance medium-to-full coverage.
Available in a 20-shade range, the dermatologist-tested, Radiant Skin Brightening Serum Concealer is infused with TULA's unique Rainbow Seabright™ Elixir. This clinically-proven serum-like formula instantly conceals dark circles and discoloration for longwearing, crease-proof results, while brightening the appearance of skin over time. Additional ingredients include TULA's S6Pro Complex® - a US patent pending super six blend of prebiotics and probiotic extracts to help soothe skin, improve skin smoothness and maintain skin balance, along with eye peptides and tea leaf caffeine to help improve the look of dark circles, skin texture, and eye bags. The Radiant Skin Brightening Serum Concealer can be paired with the brand's Radiant Skin Brightening Serum Skin Tint or Filter Primer Blurring & Moisturizing Primer to help build one's complexion wardrobe, or spot conceal for a no-makeup, makeup look.
"Expanding our complexion category to include a concealer was a natural next step for us, especially knowing the strong desire our customers have had for an eye treatment with brightening benefits." said TULA Skincare CEO, Savannah Sachs. " We are excited to have another offering for our glow getters that will surely be a staple in their skincare and beauty routines."
To mark the launch, TULA will be executing a multi-channel launch campaign across its digital platform, and organic social, paid media, and influencer channels. Efforts will include launching a custom "shade finder" on tula.com to help customers find their perfect match concealer shade, highlighting content speaking to the "no-makeup, makeup" and makeup-skincare hybrid trends across TikTok and Instagram, and partnering with a curated set of influencers and providing them with an early access link exclusively for their followers to purchase the concealer prior to launch. In addition to tula.com, the concealer will launch in Ulta Beauty stores nationwide and online and will be featured in an upcoming issue of the Ulta Beauty Magazine, with in-store complexion events planned in the coming months in multiple doors.
TULA's Radiant Skin Brightening Serum Concealer will be available for purchase on July 31 on tula.com, and will retail for $32.
About TULA Skincare
TULA is a doctor-founded skincare brand built on clinically proven formulas powered by probiotic extracts. We believe that the same types of ingredients which are good for your body are also great for your skin. We focus on being healthy, not perfect and on empowering everyone to feel confident in their skin.
Media Contact: Zoe Jeans at Bux + Bewl Communications: zoe@buxandbewl.com
View original content to download multimedia:
SOURCE TULA Skincare | https://www.wbrc.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ | 2023-07-31T11:51:46 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ |
HOUSTON, July 31, 2023 /PRNewswire/ -- McDermott has been awarded a project management consultancy (PMC) and engineering, procurement, and construction management (EPCM) contract for the Naphtha Cracker Expansion (Phase II) polypropylene expansion and new ethylene derivative unit project from Indian Oil Corporation Limited (IOCL). The project is located at the Panipat Refinery and Petrochemical Complex, located 62 miles (100 kilometers) from New Delhi, India.
The project will increase the ethylene production capacity of the naphtha cracker unit (NCU) by approximately 20 percent. The additional ethylene and propylene production will act as feed for downstream polymer units. The polymer products will be used for the manufacture of household and industrial items, including containers, automobile parts, furniture, and heavy-duty films.
"McDermott is currently executing four other projects for IOCL, including the maleic anhydride (MAH) unit at the same site, allowing us to leverage our local resources and expertise while realizing synergies," said Vaseem Khan, Senior Vice President, Global Operations. "Furthermore, the project supports the growing demand for ethylene and propylene which will reduce imports and accelerate economic development in the area."
McDermott will provide comprehensive EPCM services and overall project management for the duration of the project, which will be executed from its Center of Excellence in Gurugram, India.
About McDermott
McDermott is a premier, fully-integrated provider of engineering and construction solutions to the energy industry. Our customers trust our technology-driven approach engineered to responsibly harness and transform global energy resources into the products the world needs. From concept to commissioning, McDermott's innovative expertise and capabilities advance the next generation of global energy infrastructure—empowering a brighter, more sustainable future for us all. Operating in over 54 countries, McDermott's locally-focused and globally-integrated resources include more than 30,000 employees, a diversified fleet of specialty marine construction vessels and fabrication facilities around the world. To learn more, visit www.mcdermott.com.
Forward-Looking Statements
McDermott cautions that statements in this press release which are forward-looking, and provide other than historical information, involve risks, contingencies and uncertainties. These forward-looking statements include, among other things, statements about the expected scope and execution of the project discussed in this press release. Although we believe that the expectations reflected in those forward-looking statements are reasonable, we can give no assurance that those expectations will prove to have been correct. Those statements are made by using various underlying assumptions and are subject to numerous risks, contingencies and uncertainties, including, among others: adverse changes in the markets in which we operate or credit or capital markets; our inability to successfully execute on contracts in backlog; changes in project design or schedules; the availability of qualified personnel; changes in the terms, scope or timing of contracts, contract cancellations, change orders and other modifications and actions by our customers and other business counterparties; changes in industry norms; actions by lenders, other creditors, customers and other business counterparties of McDermott; and adverse outcomes in legal or other dispute resolution proceedings. If one or more of these risks materialize, or if underlying assumptions prove incorrect, actual results may vary materially from those expected. You should not place undue reliance on forward-looking statements. This communication reflects the views of McDermott's management as of the date hereof. Except to the extent required by applicable law, McDermott undertakes no obligation to update or revise any forward-looking statement.
Contacts:
Global Media Relations
Reba Reid
Senior Director, Global Communications and Marketing
+1 281 588 5636
RReid@McDermott.com
Business Line Media Relations
Barbara Knight
Senior Director, Business Line Communications and Marketing
+971 56 403 2903
BBKnight@McDermott.com
View original content to download multimedia:
SOURCE McDermott International, Ltd | https://www.wflx.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ | 2023-07-31T11:51:50 | 1 | https://www.wflx.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ |
- Revenue of RMB9,908 Million in the Second Quarter, Up 6.7% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 39.5% - Revenue of RMB18,871 Million in the First Half, Up 6.3% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 27.9% - Net Profit Attributable to Owners of the Company for the First Half Increased 14.6% to RMB 5,313 Million
- Diluted Earnings per Share (EPS) for the First Half Increased 20.9% to RMB1.79
- Adjusted Non-IFRS Net Profit Attributable to Owners of the Company for the First Half Increased 18.5% to RMB5,095 Million
- Adjusted Non-IFRS Diluted EPS for the First Half Increased 18.5% to RMB1.73[1]
- Free Cash Flow Achieved RMB2,926 Million for the First Half, Turned Positive and Grew Strongly
SHANGHAI, July 31, 2023 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its financial results for the first half ending June 30, 2023 ("Reporting Period").
This release provides a summary of the results and is not intended to be a comprehensive report. For additional information, please refer to the 2023 Interim Report and other relevant announcements published on the websites of the Shanghai Stock Exchange (www.sse.com.cn) and the Stock Exchange of Hong Kong (www.hkexnews.hk), and the designated media for dissemination of the relevant information. Investors are advised to exercise caution and be aware of the investment risks in trading Company shares.
All financial information disclosed in this press release is prepared based on International Financial Reporting Standards (IFRS), in currency of RMB.
The 2023 Interim Report of the Company has not been audited.
Second Quarter 2023 Financial Highlights
Revenue grew 6.7% year-over-year to RMB9,908 million, excluding COVID-19 commercial projects, revenue grew strongly by 39.5%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 2.6% year-over-year to RMB7,034 million, excluding COVID-19 commercial projects, revenue grew strongly by 51.6%. Adjusted non-IFRS gross profit grew 12.9% year-over-year to RMB3,216 million, with a gross profit margin of 45.7%.
- WuXi Testing revenue grew 23.6% year-over-year to RMB1,638 million and adjusted non-IFRS gross profit grew 36.2% year-over-year to RMB640 million, with a gross profit margin of 39.1%.
- WuXi Biology revenue grew 17.5% year-over-year to RMB656 million and adjusted non-IFRS gross profit grew 21.3% year-over-year to RMB 271 million, with a gross profit margin of 41.4%.
- WuXi ATU revenue grew 22.9% year-over-year to RMB389 million and adjusted non-IFRS gross profit was RMB(16) million, with a gross profit margin of (4.2)%
- WuXi DDSU revenue declined 17.9% year-over-year to RMB176 million and adjusted non-IFRS gross profit grew year-over-year 5.2% to RMB63 million, with a gross profit margin of 35.8%. Meanwhile, we received the first royalty income from customers in the second quarter, which is a breakthrough for DDSU.
Unit: RMB million
- IFRS gross profit increased 18.1% year-over-year to RMB4,030 million. Gross profit margin was 40.7%[2]
- Adjusted non-IFRS gross profit increased 16.4% year-over-year to RM4,177 million. Adjusted non-IFRS gross margin was 42.2%.
- Net profit attributable to owners of the Company increased 5.1% year-over-year to RMB3,145 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 22.4% year-over-year to RMB2,753 million.
First-Half 2023 Financial Highlights
Revenue grew 6.3% year-over-year to RMB18,871 million, excluding COVID-19 commercial projects, revenue grew strongly by 27.9%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 3.8% year-over-year to RMB13,467 million, excluding COVID-19 commercial projects, revenue grew strongly by 36.1%. Adjusted non-IFRS gross profit grew 14.9% year-over-year to RMB6,103 million, with a gross profit margin of 45.3%.
- WuXi Testing revenue grew 18.7% year-over-year to RMB3,091 million and adjusted non-IFRS gross profit grew 26.1% year-over-year to RMB1,168 million, with a gross profit margin of 37.8%.
- WuXi Biology revenue grew 13.0% year-over-year to RMB1,233 million and adjusted non-IFRS gross profit grew 15.1% year-over-year to RMB511 million, with a gross profit margin of 41.5%.
- WuXi ATU revenue grew 16.0% year-over-year to RMB714 million and adjusted non-IFRS gross profit was RMB(40) million, with a gross profit margin of (5.7)%.
- WuXi DDSU revenue declined 24.9% year-over-year to RMB342 million and adjusted non-IFRS gross profit declined 26.2% year-over-year to RMB103 million, with a gross profit margin of 30.1%. Meanwhile, DDSU achieved a breakthrough in receiving the first royalty income from customers.
Unit: RMB million
- IFRS gross profit increased 17.6% year-over-year to RMB7,556 million. Gross profit margin was 40.0%[3].
- Adjusted non-IFRS gross profit increased 15.7% year-over-year to RMB7,855 million. Adjusted non-IFRS gross margin was 41.6%.
- Net profit attributable to owners of the Company increased 14.6% year-over-year to RMB 5,313 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year to RMB5,095 million.
- Diluted EPS increased 20.9% year-over-year to RMB1.79, while adjusted diluted non-IFRS EPS increased by 18.5% year-over-year to RMB1.73.
- Free cash flow achieved RMB2,926 million, turned positive and grew strongly year-over-year.
First-Half 2023 Business Operation Highlights
- As an industry innovation enabler, we grow together with our customers. In the first half of 2023, we added over 600 new customers, and in total we served more than 6,000 active customers over the past 12 months. Backlog grew 25% year-over-year excluding COVID-19 commercial projects. We continued to optimize our cross-platform synergies to better serve our customers worldwide, strengthen our unique competitive advantage as a fully integrated Contract Research, Development and Manufacturing Organization (CRDMO) and Contract Testing, Development and Manufacturing Organization (CTDMO) platform, and provide one-stop services for our customers from discovery to development and manufacturing. The diversified revenue streams from customers across regions ensure the stability and resilience of the Company's financial performance.
- WuXi Chemistry: Integrated CRDMO Business Model Drives Steady Growth, with Continued Expansion in New Modalities (WuXi TIDES)
- In the past 12 months, we successfully synthesized and delivered more than 420,000 new compounds to customers, which grew 20% year-over-year. Through our chemistry drug discovery services, we enabled our customers to accelerate their research while generating opportunities for our downstream business units. In the past 12 months, 120 molecules have transitioned from R to D&M, representing a year-on-year growth of 21%. Through our "follow-the-customer" and "follow-the-molecule" strategies, we established trusted partnerships with our global customers, supporting the sustainable growth of our CRDMO business.
- We continued executing our "long-tail" strategy. Demand from "long-tail" customers in discovery services of small molecule and new modalities continued to grow, with the number of new customers growing 17% year-over-year.
- In the first half of 2023, D&M services revenue grew 2.1% year-over-year to RMB9.67 billion. Excluding COVID-19 commercial projects, D&M services revenue grew strongly by 54.5%.
- In the first half of 2023, we added 583 molecules to our D&M pipeline. To date, our D&M pipeline consists of 2,819 molecules, including 56 commercial projects, 59 in phase III, 301 in phase II and 2,403 in phase I and pre-clinical stages, among which, 8 commercial and phase III projects were added in the first half of 2023.
- In the first half of 2023, TIDES revenue grew 37.9% year-over-year to RMB1.33 billion. As of June 30, 2023, backlog of TIDES grew strongly by 188% year-over-year. We expect revenue growth from TIDES business to exceed 70% in 2023.
- The number of TIDES D&M customers increased 25% year-over-year to 121, and the number of TIDES molecules increased 46% year-over-year to 207.
- WuXi Testing: Lab Testing Services Drive Steady Growth, Clinical Business Fully Recovered
- The Company provides a full range of laboratory testing services for our customers, including drug metabolism and pharmacokinetics (DMPK), toxicology, and bioanalysis for drug development testing, as well as medical device testing. We provide customers with high-quality services, realize "one report for global submission," and enable customers to save time, reduce costs and increase efficiency.
- H1 2023 revenue from drug safety evaluation services grew 24% year-over-year. We maintained our industry leadership position in Asia Pacific for drug safety evaluation services that meet global regulatory requirements. In the first half of 2023, new lab testing facilities in Qidong and Suzhou began operations as scheduled, ensuring the business growth to accelerate in the second half of 2023.
- Moreover, we continued to enhance capabilities related to new modalities, with comprehensive coverage such as target protein degradation, nucleic acids, conjugates, and cell and gene therapies (CGT), etc.
- SMO revenue grew strongly by 53.9% in Q2 2023 and 34.3% in H1 2023, maintaining a leadership position in China. In the first half of 2023, SMO supported 25 new drug approvals for customers.
- In the first half of 2023, clinical CRO enabled our customers to obtain 8 IND approvals and submit 3 NDA filings.
- WuXi Biology: Strong Contribution from New Modalities; Early Discovery Screening Platform Continued to Generate Downstream Opportunities
- WuXi ATU: CTDMO Business Model Drives Growth
- WuXi DDSU: the First Year to Receive New Drug Application (NDA) Approval of New Drugs Developed for Customers; Breakthrough to Receive the First Royalty Income
Our Commitment to ESG
As an industry innovation enabler, a trusted partner and a contributor to the global healthcare industry, the Company is committed to environmental protection and sustainability, and to being a good global corporate citizenship.
Our outstanding ESG performance has been recognized by major global ESG rating agencies, including MSCI, S&P Global, Sustainalytics, CDP and EcoVadis. In June 2023, we received the fourth "Silver" medal recognition from EcoVadis for our Couvet site in Switzerland.
By the first half of 2023, our carbon emission intensity, energy consumption intensity and water use intensity reduced by 20.1%, 18.4%, and 31.6%, respectively, as compared to the baseline year 2020.
As we continue to advance our sustainability strategy, we embrace our shared responsibility to be good stewards of the environment.
Management Comment
Dr. Ge Li, Chairman and CEO of WuXi AppTec, said, "We continued to achieve steady growth of revenue, net profit, and free cash flow in the first half of 2023. Our revenue increased 6.3% year-over-year to RMB18.87 billion, or 27.9% if excluding COVID-19 commercial projects. Our adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year, outpacing the revenue growth rate, and our free cash flow achieved RMB2.93 billion, as a result of the Company's pursuit of operational excellence and productivity."
"The Company's performance in the first half of 2023 demonstrated that WuXi AppTec's unique CRDMO and CTDMO business models can effectively meet the growing demands from customers worldwide and continue to drive solid growth for the Company. In 2023, we aim to deliver a 5-7% revenue growth, increase adjusted non-IFRS gross profit by 13-14%, and expand free cash flow by 750-850%. We remain committed to prioritizing our customers' needs and enhancing our capacity and capabilities as we support our customers' efforts to bring groundbreaking therapies to patients around the world. Together, we can realize our vision that 'every drug can be made and every disease can be treated'."
About WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com
Forward-Looking Statements
This press release may contain certain "forward-looking statements" which are not historical facts, but instead are predictions about future events based on our beliefs as well as assumptions made by and information currently available to our management. Although we believe that our predictions are reasonable, future events are inherently uncertain and our forward-looking statements may turn out to be incorrect. Our forward-looking statements are subject to risks relating to, among other things, the ability of our service offerings to compete effectively, our ability to meet timelines for the expansion of our service offerings, our ability to protect our customers' intellectual property, unforeseeable international tension, competition, the impact of emergencies and other force majeure. Our forward-looking statements in this press release speak only as of the date on which they are made, and we assume no obligation to update any forward-looking statements except as required by applicable law or listing rules. Accordingly, you are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. All forward-looking statements contained herein are qualified by reference to the cautionary statements set forth in this section. All information provided in this press release is as of the date of this press release and are based on assumptions that we believe to be reasonable as of this date, and we do not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Use of Non-IFRS and Adjusted Non-IFRS Financial Measures
We provide non-IFRS gross profit and non-IFRS net profit attributable to owners of the Company, which exclude share-based compensation expenses, issuance expenses of convertible bonds, fair value gain or loss from derivative component of convertible bonds, foreign exchange-related gains or losses, amortization of intangible assets acquired in business combinations, non-financial assets impairment, etc. We also provide adjusted non-IFRS net profit attributable to owners of the Company and earnings per share, which further exclude realized and unrealized gains or losses from our venture capital investments and joint ventures. Neither is required by, or presented in accordance with IFRS.
We believe that the adjusted financial measures used in this press release are useful for understanding and assessing our core business performance and operating trends, and we believe that management and investors may benefit from referring to these adjusted financial measures in assessing our financial performance by eliminating the impact of certain unusual, non-recurring, non-cash and non-operating items that we do not consider indicative of the performance of our core business. Such adjusted non-IFRS net profit attributable to owners of the Company, the management of the Company believes, is widely accepted and adopted in the industry the Company is operating in. However, the presentation of these adjusted non-IFRS financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with IFRS. You should not view adjusted results on a stand-alone basis or as a substitute for results under IFRS, or as being comparable to results reported or forecasted by other companies.
For more information, please contact:
Ms. Ruijia Tang (for investors)
IR Director
Email: tang_ruijia@wuxiapptec.com
Mr. Davy Wu (for media)
PR Director
Email: davy_wu@wuxiapptec.com
View original content:
SOURCE WuXi AppTec | https://www.kswo.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ | 2023-07-31T11:51:51 | 1 | https://www.kswo.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ |
Launch demonstrates companies' commitment to bringing complex generic medicines to the market to help increase patient access
PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application (ANDA) approved by the U.S. Food and Drug Administration (FDA). Breyna, a drug-device combination product, is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD) and will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths.
Viatris Head of North America Jose Cotarelo said: "We are excited to bring Breyna to the U.S. market for the many Americans living with asthma and COPD. This launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain. Being the first to bring an FDA-approved generic version of Symbicort to patients is a true example of how access is the cornerstone of our mission to empower people worldwide to live healthier at every stage of life."
The indications for Breyna include asthma in patients six years of age and older, and the maintenance treatment of airflow obstruction and reducing exacerbations in patients with COPD, including chronic bronchitis and/or emphysema. Breyna is not indicated for the relief of acute bronchospasm. The 160 mcg/4.5 mcg is the only strength indicated for the treatment of COPD. COPD is a term used to describe a certain kind of chronic lung disease and is characterized by breathlessness; it affects more than 16 million Americans. Asthma causes swelling of the airways resulting in difficulty breathing, and approximately 25 million Americans have the chronic condition.
Milton Boyer, CEO of Kindeva Drug Delivery, added: "The launch of Breyna represents a significant milestone as it is the first FDA-approved generic version of Symbicort in the U.S., one of the most prescribed complex drug-device combination products to treat asthma and COPD. We are pleased for Viatris as well as the many Kindeva colleagues who have worked tirelessly to leverage our complex drug-delivery expertise for this important respiratory product — supporting a persistent need to continue bringing more quality medicines for asthma and COPD to patients."
To further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply. The program offers $30/month or up to $360 per year with 12 refills annually. The program will be available in August.
About Breyna
Breyna is indicated for the treatment of asthma in patients 6 years and older not adequately controlled on a long-term asthma-control medication such as an inhaled corticosteroid (ICS) or whose disease warrants initiation of treatment with both an ICS and long-acting beta2-adrenergic agonists (LABA). Breyna 160 mcg/4.5 mcg dosage is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, and Breyna 160 mcg/4.5 mcg is also indicated to reduce exacerbations of COPD. Breyna is NOT indicated for the relief of acute bronchospasm.
Important Safety Information
Breyna is contraindicated in the primary treatment of status asthmaticus or other acute episode of asthma or COPD where intensive measures are required, and in hypersensitivity to any of the ingredients in Breyna. Use of long-acting beta2-adrenergic agonists (LABA) as monotherapy (without inhaled corticosteroids [ICS]) for asthma is associated with an increased risk of asthma-related death. Available data from controlled clinial trials also suggest that use of LABA as monotherapy increases the risk of asthma-related hospitalization in pediatric and adolescent patients. These findings are considered a class effect of LABA. When LABA are used in fixed dose combination with ICS, data from large clinical trials do not show a significant increase in the risk of serious asthma-related events (hospitalizations, intubations, death) compared to ICS alone. Breyna is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms. Breyna should not be initiated in patients during rapidly deteriorating episodes of asthma or COPD. Patients who are receiving Breyna should not use additional formoterol or other LABA for any reason. Localized infections of the mouth and pharynx with Candida albicans has occurred in patients treated with Breyna. Patients should rinse the mouth after inhalation of Breyna. Lower respiratory tract infections, including pneumonia, have been reported following the administration of ICS. Due to possible immunosuppression, potential worsening of infections could occur. A more serious or even fatal course of chickenpox or measles can occur in susceptible patients. It is possible that systemic corticosteroid effects such as hypercorticism and adrenal suppression may occur, particularly at higher doses. Particular care is needed for patients who are transferred from systemically active corticosteroids to ICS. Deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available ICS. Caution should be exercised when considering administration of Breyna in patients on long-term ketoconazole and other known potent CYP3A4 inhibitors. As with other inhaled medications, paradoxical bronchospasm may occur with Breyna. Immediate hypersensitivity reactions may occur, as demonstrated by cases of urticaria, angioedema, rash, and bronchospasm. Excessive beta-adrenergic stimulation has been associated with central nervous system and cardiovascular effects. Breyna should be used with caution in patients with cardiovascular disorders especially coronary insufficiency, cardiac arrhythmias, and hypertension. Long-term use of ICS may result in a decrease in bone mineral density (BMD Assessment of BMD is recommended prior to initiating Breyna and periodically thereafter. ICS may result in a reduction in growth velocity when administered to pediatric patients. Glaucoma, increased intracolular pressure, and cataracts have been reported following the administration of ICS, including budesonide, a component of Breyna. Close monitoring for glaucoma and cataracts is warranted in patients with a change in vision or history of increased intraocular pressure. In rare cases, patients on ICS may present with systemic eosinophilic conditions. Breyna should be used with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, and in patients who are unusually responsive to sympathomimetic amines. The most common adverse reactions ≥3% reported in asthma clinical trials included nasopharyngitis, headache, upper respiratory tract infection, pharyngolaryngeal pain, sinusitis, influenza, back pain, nasal congestion, stomach discomfort, vomiting, and oral candidiasis. The most common adverse reactions ≥3% reported in COPD clinical trials included nasopharyngitis, oral candidiasis, bronchitis, sinusitis, and upper respiratory tract infection. Breyna should be administered with caution to patients being treated with MAO inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents. Beta-blockers may not only block the pulmonary effect of beta-agonists, such as formoterol, but may produce severe bronchospasm in patients with asthma. ECG changes and/or hypokalemia associated with nonpotassium-sparing diuretics may worsen with concomitant beta-agonists. Use caution with the coadministration of Breyna.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
About Kindeva Drug Delivery
Kindeva Drug Delivery is a global contract development manufacturing organization focused on drug-device combination products. Kindeva Drug Delivery develops and manufactures products across a broad range of complex drug-delivery formats, including injectables (autoinjector, intradermal, microneedle), pulmonary & nasal, and transdermal patches. Its service offering spans early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Kindeva Drug Delivery serves a global client base from its nine manufacturing and research and development facilities located in the U.S. and U.K. For more information, please visit www.kindevadd.com.
Forward-Looking Statements
This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements that the launch of Breyna demonstrates the companies' commitment to bringing complex generic medicines to the market to help increase patient access; Breyna will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths; this launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain; to further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply; and, the program will be available in August. Factors that could cause or contribute to such differences include, but are not limited to: the possibility that the Company may be unable to realize the intended benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with acquisitions, divestitures, or its global restructuring program, within the expected timeframe or at all; impairment charges or other losses related to the divestiture or sale of businesses or assets; the Company's failure to achieve expected or targeted future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by COVID-19; actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris' ability to bring new products to market, including but not limited to "at-risk" launches; Viatris' or its partners' ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings; any significant breach of data security or data privacy or disruptions to our information technology systems; risks associated with international operations; the ability to protect intellectual property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes in Viatris' or its partners' customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; failure to execute stock repurchases consistent with current expectations; stock price volatility; and the other risks described in Viatris' filings with the Securities and Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC's Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this release other than as required by law.
View original content to download multimedia:
SOURCE Viatris Inc. | https://www.wbrc.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ | 2023-07-31T11:51:52 | 0 | https://www.wbrc.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ |
GUANGZHOU, China, July 31, 2023 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that it has published its 2022 Environmental, Social and Governance ("ESG") report, outlining the Company's progress and performance in key ESG areas.
The report provides a comprehensive review of Yatsen's ESG initiatives and developments, including corporate governance, research and development, employee rights protection, human capital development, environmental sustainability and social responsibility, among others.
To view the report in full, please visit the ESG section on the Yatsen Investor Relations website. Alternatively, please click here for the English version and here for the Chinese version of the 2022 report.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the mission of creating an exciting new journey of beauty discovery for consumers around the world. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands, including Perfect Diary, Little Ondine, Abby's Choice, Galénic, DR.WU (its mainland China business), Eve Lom, Pink Bear and EANTiM. The Company's flagship brand, Perfect Diary, is one of the leading color cosmetics brands in China in terms of retail sales value. The Company primarily reaches and engages with customers directly, both online and offline, with an expansive presence across all major e-commerce, social and content platforms in China.
For more information, please visit http://ir.yatsenglobal.com/.
For investor and media inquiries, please contact:
In China:
Yatsen Holding Limited
Investor Relations
E-mail: ir@yatsenglobal.com
The Piacente Group, Inc
Hui Fan
Tel: +86-10-6508-0677
E-mail: yatsen@thepiacentegroup.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: yatsen@thepiacentegroup.com
View original content:
SOURCE Yatsen Holding Limited | https://www.kswo.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ | 2023-07-31T11:51:58 | 0 | https://www.kswo.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ |
New nuclear unit now serving customers with clean, reliable energy 24/7
ATLANTA, July 31, 2023 /PRNewswire/ -- Georgia Power declared today that Plant Vogtle Unit 3 has entered commercial operation and is now serving customers and the State of Georgia. The new unit represents a long-term investment in the state's clean energy future and will provide reliable, emissions-free energy to customers for decades to come.
"The Plant Vogtle 3 & 4 nuclear expansion is another incredible example of how Georgia Power is building a reliable and resilient energy future for our state," said Kim Greene, chairman, president and CEO of Georgia Power. "It is important that we make these kinds of long-term investments and see them through so we can continue providing clean, safe, reliable and affordable energy to our 2.7 million customers. Today's achievement is a testament to our commitment to doing just that, and it marks the first day of the next 60 to 80 years that Vogtle Unit 3 will serve our customers with clean, reliable energy."
Vogtle Unit 3 is the first newly-constructed nuclear unit in the U.S. in over 30 years and can power an estimated 500,000 homes and businesses. Once all four units are online, the Plant Vogtle site will be the largest generator of clean energy in the nation and support continued growth in Georgia as more industries, businesses and families come to the state.
"Today is a historic day for the State of Georgia, Southern Company, and the entire energy sector, as we continue transforming the way we power the lives of millions of Americans," said Chris Womack, president and CEO of Southern Company. "With Unit 3 completed, and Unit 4 in the final stages of construction and testing, this project shows just how new nuclear can and will play a critical role in achieving a clean energy future for the United States. Bringing this unit safely into service is a credit to the hard work and dedication of our teams at Southern Company and the thousands of additional workers who have helped build that future at this site, as well as all of the partners who have helped make this day a reality."
Nuclear energy is the only zero-emission baseload energy source available today, offering high reliability, and efficient operations around the clock. Nuclear energy currently provides approximately 25% of Georgia Power's overall energy mix, including the existing units at Plant Vogtle and Georgia's other nuclear facility at Plant Hatch in Baxley, Georgia.
"The Vogtle expansion is an American energy success story and would not be possible without the support of strong public and private partners like our partners at North America's Building Trades Unions," said Tom Fanning, chairman of the Board of Directors for Southern Company. "We continue to appreciate their support and those who have stood with us at the local, state and federal levels to complete this new clean energy source to serve electric customers. Providing leadership in our industry and a commitment to safety and quality are in Southern Company's DNA. Today's milestone at the Vogtle expansion site underscores this legacy, and I couldn't be prouder of the dedication our teams have shown in seeing Unit 3 through to completion."
The final stages of construction and testing continue at Vogtle Unit 4, with the unit projected to be placed in service during the late fourth quarter 2023 or the first quarter of 2024. The unit completed hot functional testing in May, in significantly less time than Unit 3 as the team continues leveraging best practices and learnings from the earlier unit. The Vogtle site has also received nuclear fuel for Unit 4, with a total of 157 fuel assemblies necessary for the safe and reliable startup of the unit.
Also, last week, Georgia Power announced the receipt of the 103(g) finding from the Nuclear Regulatory Commission (NRC) for Vogtle Unit 4. This finding was confirmed in an official letter received by Southern Nuclear and signifies that the new unit has been constructed and will be operated in conformance with the Combined License and NRC regulations. No further NRC findings are necessary in order for Southern Nuclear to load fuel or begin the startup sequence for the new unit.
The new Vogtle units are an essential part of Georgia Power's commitment to delivering clean, safe, reliable and affordable energy to its 2.7 million customers. Southern Nuclear will operate the new units on behalf of the co-owners: Georgia Power, Oglethorpe Power, MEAG Power and Dalton Utilities.
About Georgia Power
Georgia Power is the largest electric subsidiary of Southern Company (NYSE: SO), America's premier energy company. Value, Reliability, Customer Service and Stewardship are the cornerstones of the company's promise to 2.7 million customers in all but four of Georgia's 159 counties. Committed to delivering clean, safe, reliable and affordable energy, Georgia Power maintains a diverse, innovative generation mix that includes nuclear, coal and natural gas, as well as renewables such as solar, hydroelectric and wind. Georgia Power focuses on delivering world-class service to its customers every day and the company is recognized by J.D. Power as an industry leader in customer satisfaction. For more information, visit www.GeorgiaPower.com and connect with the company on Facebook (Facebook.com/GeorgiaPower), Twitter (Twitter.com/GeorgiaPower) and Instagram (Instagram.com/ga_power).
Cautionary Note Regarding Forward-Looking Statements
Certain information contained in this release is forward-looking information based on current expectations and plans that involve risks and uncertainties. Forward-looking information includes, among other things, statements concerning the projected in-service date for Plant Vogtle Unit 4 and the future operations of Plant Vogtle Units 3 and 4. Georgia Power cautions that there are certain factors that can cause actual results to differ materially from the forward-looking information that has been provided. The reader is cautioned not to put undue reliance on this forward-looking information, which is not a guarantee of future performance and is subject to a number of uncertainties and other factors, many of which are outside the control of Georgia Power; accordingly, there can be no assurance that such suggested results will be realized. The following factors, in addition to those discussed in Georgia Power's Annual Report on Form 10-K for the year ended December 31, 2022, and subsequent securities filings, could cause actual results to differ materially from management expectations as suggested by such forward-looking information: the ability to control costs and avoid cost and schedule overruns during the development, construction, and operation of facilities or other projects, including Plant Vogtle Unit 4, which includes components based on new technology that only within the last few years began initial operation in the global nuclear industry at this scale, due to current and/or future challenges which include, but are not limited to, changes in labor costs, availability and productivity, challenges with the management of contractors or vendors, subcontractor performance, adverse weather conditions, shortages, delays, increased costs, or inconsistent quality of equipment, materials, and labor, contractor or supplier delay, the impacts of inflation, delays due to judicial or regulatory action, nonperformance under construction, operating, or other agreements, operational readiness, including specialized operator training and required site safety programs, engineering or design problems or any remediation related thereto, design and other licensing-based compliance matters, challenges with start-up activities, including major equipment failure, or system integration, and/or operational performance, continued challenges related to the COVID-19 pandemic or future pandemic health events, continued public and policymaker support for projects, environmental and geological conditions, delays or increased costs to interconnect facilities to transmission grids, and increased financing costs as a result of changes in market interest rates or as a result of project delays; the ability to overcome or mitigate the current challenges, or challenges yet to be identified, at Plant Vogtle Unit 4, that could further impact the cost and schedule for the project; legal proceedings and regulatory approvals and actions related to construction projects, such as Plant Vogtle Unit 4, including Georgia Public Service Commission approvals and U.S. Nuclear Regulatory Commission ("NRC") actions; under certain specified circumstances, a decision by holders of more than 10% of the ownership interests of Plant Vogtle Unit 3 and 4 not to proceed with construction; the notices of tender by Oglethorpe Power Corporation and the City of Dalton of a portion of their ownership interests in Plant Vogtle Units 3 and 4 to Georgia Power, including related litigation; the ability to construct facilities in accordance with the requirements of permits and licenses (including satisfaction of NRC requirements), to satisfy any environmental performance standards and the requirements of tax credits and other incentives, and to integrate facilities into the Southern Company system upon completion of construction; the inherent risks involved in operating and constructing nuclear generating facilities; the ability of counterparties of Georgia Power to make payments as and when due and to perform as required; the direct or indirect effect on Georgia Power's business resulting from cyber intrusion or physical attack and the threat of cyber and physical attacks; catastrophic events such as fires, earthquakes, explosions, floods, tornadoes, hurricanes and other storms, droughts, pandemic health events, political unrest, wars or other similar occurrences; the potential effects of the continued COVID-19 pandemic; and the direct or indirect effects on Georgia Power's business resulting from incidents affecting the U.S. electric grid or operation of generating or storage resources. Georgia Power expressly disclaim any obligation to update any forward–looking information.
View original content to download multimedia:
SOURCE Georgia Power | https://www.wbrc.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ | 2023-07-31T11:51:59 | 0 | https://www.wbrc.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ |
Forester Wilderness Ad Showcases 'A Beautiful Silence' and Partnership with the National Park Foundation
CAMDEN, N.J., July 31, 2023 /PRNewswire/ -- Subaru of America, Inc. today unveiled a new creative spot focused on the automaker's efforts to expand access to the outdoors for all. Featuring the all-new 2023 Subaru Forester Wilderness, the advertisement stars Keivonn Woodard, the Emmy-nominated, 10-year-old Deaf actor and showcases the automaker's long-standing partnership with the National Park Foundation.
In the creative, titled "A Beautiful Silence," a father and his young son, who is Deaf, drive through Yosemite National Park, with the wonders of the park's beauty surrounding them. Featuring audio elements and American Sign Language (ASL), the spot shows how the pair experience the park's natural wonders in different ways, but share the special feeling that nature brings forth.
"The outdoors are for everyone, and whether it's a trip to a national park or a walk in the woods, we believe everyone should have the opportunity to experience its beauty," said Alan Bethke, Senior Vice President, Marketing, Subaru of America, Inc. "Through our partnership with the National Park Foundation and our commitment to making safe and capable vehicles like the Forester Wilderness, we're hoping that even more people will be inspired to explore the wonders of nature, just like the father and son in our new creative."
Through the National Park Foundation's Outdoor Exploration initiative and ParkVentures program, Subaru is helping more people create life-long relationships with the outdoors. The campaign seeks to make the outdoors more accessible to communities that have been historically excluded from parks, either through a community's physical presence on public lands or through the narrative of who belongs outdoors.
Last year, with support from Subaru, ParkVentures supported the efforts of more than 55 organizations to connect more people, including those with differing abilities, to meaningful experiences in United States national parks. Subaru also developed a direct relationship with ParkVentures grantee Black People Who Hike, which aims to help address the lack of representation in parks by empowering, educating and engaging Black people in the outdoors. Subaru provided the vehicles, gear, and experiences for an enhanced retreat in Acadia National Park to help create safe, welcoming spaces and cultivate lasting relationships with the outdoors.
Subaru is the largest corporate donor to the National Park Foundation and has provided over $70 million to organizations working to conserve national parks. To learn more about the automaker's partnership with National Park Foundation and over 20 years of environmentally focused initiatives, please visit Subaru.com/earth.
The new Subaru Forester Wilderness spot, created in collaboration with agency partner Carmichael Lynch, celebrates the automaker's devotion to adventure and environmental stewardship. Beginning today, "A Beautiful Silence" will run in 30-second format on national television and be featured in 15-second format in targeted digital and social media promotions throughout August, while a 60-second version will be available on YouTube.
About Subaru of America, Inc.
Subaru of America, Inc. (SOA) is a wholly owned subsidiary of Subaru Corporation of Japan. Headquartered at a zero-landfill office in Camden, N.J., the company markets and distributes Subaru vehicles, parts and accessories through a network of more than 630 retailers across the United States. All Subaru products are manufactured in zero-landfill plants and Subaru of Indiana Automotive, Inc. is the only U.S. automobile manufacturing plant to be designated a backyard wildlife habitat by the National Wildlife Federation. SOA is guided by the Subaru Love Promise, which is the company's vision to show love and respect to everyone, and to support its communities and customers nationwide. Over the past 20 years, SOA and the SOA Foundation have donated more than $300 million to causes the Subaru family cares about, and its employees have logged nearly 88,000 volunteer hours. As a company, Subaru believes it is important to do its part in making a positive impact in the world because it is the right thing to do. For additional information visit media.subaru.com. Follow us on Facebook, Twitter, and Instagram.
Media Contacts:
Diane Anton
Corporate Communications Manager
(856) 488-5093
danton@subaru.com
Adam Leiter
Corporate Communications Specialist
(856) 488-8668
aleiter@subaru.com
View original content to download multimedia:
SOURCE Subaru of America, Inc. | https://www.wflx.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ | 2023-07-31T11:52:02 | 0 | https://www.wflx.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ |
Leveraging artificial intelligence, Mumbai-based IT services firm Yodaplus is catalyzing industry transformations, from nutraceuticals to retail, by streamlining business operations and boosting decision-making capabilities.
MUMBAI, India, July 31, 2023 /PRNewswire/ -- Yodaplus, a Mumbai-based IT services firm, is at the forefront of empowering organizations worldwide with advanced technological capabilities. Today, the company sheds light on the evolving global landscape of Artificial Intelligence (AI) and its growing adoption within its service portfolio.
With its wide range of services and deep industry knowledge, Yodaplus has been a game changer – enabling organizations to focus on their core operations and achieve sustainable growth. And now, by integrating AI into services, Yodaplus helps businesses navigate the complex digital transformation landscape more efficiently, creating a competitive edge.
AI continues to transform business operations globally, powering automation, analytics, decision-making, and enhancing user experiences. This ultimately delivers safer and more effective products to meet the growing global demand.
Yodaplus is known for its expansive roster of clients - from development banks and blockchain companies to EdTech startups and HRMS providers. With such a diverse clientele, embracing AI is more necessary than a choice, and Yodaplus has promptly addressed this need.
"As we navigate the digital age, the integration of AI into our service offerings has become an undeniable necessity," commented Vishrut Srivastava, MD, Yodaplus. "AI is here to stay, poised to make our lives more efficient and free mankind from the burden of mundane tasks. At Yodaplus, we are committed to embracing AI to drive growth and innovation for our clients while we continue to explore new horizons in this transformative technological landscape."
In line with this commitment, Yodaplus has developed an AI engine transforming the global nutraceutical supply chain. Addressing the complexities of generating differentiated nutraceutical label claims necessitates a well-mapped global database and the application of AI. To solve this problem, Yodaplus developed an AI-driven smart labels function via the NutrifyGenie AI engine.
NutrifyGenie uses sophisticated algorithms that facilitate simplified and precise decision-making, authenticating label claim validation and enabling real-time regulatory compliance. This feature provides users with pre-made labels, including correct dosage values for nutraceutical products, significantly expediting product development.
Enabling companies to effortlessly commercialize their innovations in essential markets fulfills the continuously increasing demand for nutraceutical products. As the nutraceutical industry continues to grow, Yodaplus's AI engine will play a crucial role in accelerating the new product development process and helping businesses bring innovative and differentiated products to market faster than ever before.
Not just that, the company has also recently deployed advanced invoice parsing for a retail giant. This smart solution facilitates operations by accurately extracting and collating relevant information from invoices, thus automating a previously laborious task. Furthermore, Yodaplus uses sophisticated AI tools to assist an asset management client in conducting comprehensive financial records analysis, rendering them outstanding financial decision-making capabilities.
About Yodaplus
An ever-evolving, highly specialized technology solutions company, Yodaplus offers an array of services designed to address the unique needs of businesses globally, extending beyond its Mumbai base to the US, UK, UAE, and Singapore. The company's mission, steered by MD Vishrut Srivastava, is dedicated to providing top-tier IT services and aims to propel businesses toward unprecedented growth and success. With this commitment, Yodaplus becomes your duly trusted tech partner.
For more information about Yodaplus, please visit www.yodaplus.com.
Press Contact:
Amit Pareek
Senior Marketing Manager
amitp@yodaplus.com
Photo: https://mma.prnewswire.com/media/2163861/Vishrut_Srivatava_MD_Yodaplus.jpg
Logo: https://mma.prnewswire.com/media/2144978/4185052/Yodaplus_Logo.jpg
View original content:
SOURCE Yodaplus Technologies | https://www.kswo.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ | 2023-07-31T11:52:04 | 0 | https://www.kswo.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ |
- Revenue of RMB9,908 Million in the Second Quarter, Up 6.7% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 39.5% - Revenue of RMB18,871 Million in the First Half, Up 6.3% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 27.9% - Net Profit Attributable to Owners of the Company for the First Half Increased 14.6% to RMB 5,313 Million
- Diluted Earnings per Share (EPS) for the First Half Increased 20.9% to RMB1.79
- Adjusted Non-IFRS Net Profit Attributable to Owners of the Company for the First Half Increased 18.5% to RMB5,095 Million
- Adjusted Non-IFRS Diluted EPS for the First Half Increased 18.5% to RMB1.73[1]
- Free Cash Flow Achieved RMB2,926 Million for the First Half, Turned Positive and Grew Strongly
SHANGHAI, July 31, 2023 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its financial results for the first half ending June 30, 2023 ("Reporting Period").
This release provides a summary of the results and is not intended to be a comprehensive report. For additional information, please refer to the 2023 Interim Report and other relevant announcements published on the websites of the Shanghai Stock Exchange (www.sse.com.cn) and the Stock Exchange of Hong Kong (www.hkexnews.hk), and the designated media for dissemination of the relevant information. Investors are advised to exercise caution and be aware of the investment risks in trading Company shares.
All financial information disclosed in this press release is prepared based on International Financial Reporting Standards (IFRS), in currency of RMB.
The 2023 Interim Report of the Company has not been audited.
Second Quarter 2023 Financial Highlights
Revenue grew 6.7% year-over-year to RMB9,908 million, excluding COVID-19 commercial projects, revenue grew strongly by 39.5%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 2.6% year-over-year to RMB7,034 million, excluding COVID-19 commercial projects, revenue grew strongly by 51.6%. Adjusted non-IFRS gross profit grew 12.9% year-over-year to RMB3,216 million, with a gross profit margin of 45.7%.
- WuXi Testing revenue grew 23.6% year-over-year to RMB1,638 million and adjusted non-IFRS gross profit grew 36.2% year-over-year to RMB640 million, with a gross profit margin of 39.1%.
- WuXi Biology revenue grew 17.5% year-over-year to RMB656 million and adjusted non-IFRS gross profit grew 21.3% year-over-year to RMB 271 million, with a gross profit margin of 41.4%.
- WuXi ATU revenue grew 22.9% year-over-year to RMB389 million and adjusted non-IFRS gross profit was RMB(16) million, with a gross profit margin of (4.2)%
- WuXi DDSU revenue declined 17.9% year-over-year to RMB176 million and adjusted non-IFRS gross profit grew year-over-year 5.2% to RMB63 million, with a gross profit margin of 35.8%. Meanwhile, we received the first royalty income from customers in the second quarter, which is a breakthrough for DDSU.
Unit: RMB million
- IFRS gross profit increased 18.1% year-over-year to RMB4,030 million. Gross profit margin was 40.7%[2]
- Adjusted non-IFRS gross profit increased 16.4% year-over-year to RM4,177 million. Adjusted non-IFRS gross margin was 42.2%.
- Net profit attributable to owners of the Company increased 5.1% year-over-year to RMB3,145 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 22.4% year-over-year to RMB2,753 million.
First-Half 2023 Financial Highlights
Revenue grew 6.3% year-over-year to RMB18,871 million, excluding COVID-19 commercial projects, revenue grew strongly by 27.9%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 3.8% year-over-year to RMB13,467 million, excluding COVID-19 commercial projects, revenue grew strongly by 36.1%. Adjusted non-IFRS gross profit grew 14.9% year-over-year to RMB6,103 million, with a gross profit margin of 45.3%.
- WuXi Testing revenue grew 18.7% year-over-year to RMB3,091 million and adjusted non-IFRS gross profit grew 26.1% year-over-year to RMB1,168 million, with a gross profit margin of 37.8%.
- WuXi Biology revenue grew 13.0% year-over-year to RMB1,233 million and adjusted non-IFRS gross profit grew 15.1% year-over-year to RMB511 million, with a gross profit margin of 41.5%.
- WuXi ATU revenue grew 16.0% year-over-year to RMB714 million and adjusted non-IFRS gross profit was RMB(40) million, with a gross profit margin of (5.7)%.
- WuXi DDSU revenue declined 24.9% year-over-year to RMB342 million and adjusted non-IFRS gross profit declined 26.2% year-over-year to RMB103 million, with a gross profit margin of 30.1%. Meanwhile, DDSU achieved a breakthrough in receiving the first royalty income from customers.
Unit: RMB million
- IFRS gross profit increased 17.6% year-over-year to RMB7,556 million. Gross profit margin was 40.0%[3].
- Adjusted non-IFRS gross profit increased 15.7% year-over-year to RMB7,855 million. Adjusted non-IFRS gross margin was 41.6%.
- Net profit attributable to owners of the Company increased 14.6% year-over-year to RMB 5,313 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year to RMB5,095 million.
- Diluted EPS increased 20.9% year-over-year to RMB1.79, while adjusted diluted non-IFRS EPS increased by 18.5% year-over-year to RMB1.73.
- Free cash flow achieved RMB2,926 million, turned positive and grew strongly year-over-year.
First-Half 2023 Business Operation Highlights
- As an industry innovation enabler, we grow together with our customers. In the first half of 2023, we added over 600 new customers, and in total we served more than 6,000 active customers over the past 12 months. Backlog grew 25% year-over-year excluding COVID-19 commercial projects. We continued to optimize our cross-platform synergies to better serve our customers worldwide, strengthen our unique competitive advantage as a fully integrated Contract Research, Development and Manufacturing Organization (CRDMO) and Contract Testing, Development and Manufacturing Organization (CTDMO) platform, and provide one-stop services for our customers from discovery to development and manufacturing. The diversified revenue streams from customers across regions ensure the stability and resilience of the Company's financial performance.
- WuXi Chemistry: Integrated CRDMO Business Model Drives Steady Growth, with Continued Expansion in New Modalities (WuXi TIDES)
- In the past 12 months, we successfully synthesized and delivered more than 420,000 new compounds to customers, which grew 20% year-over-year. Through our chemistry drug discovery services, we enabled our customers to accelerate their research while generating opportunities for our downstream business units. In the past 12 months, 120 molecules have transitioned from R to D&M, representing a year-on-year growth of 21%. Through our "follow-the-customer" and "follow-the-molecule" strategies, we established trusted partnerships with our global customers, supporting the sustainable growth of our CRDMO business.
- We continued executing our "long-tail" strategy. Demand from "long-tail" customers in discovery services of small molecule and new modalities continued to grow, with the number of new customers growing 17% year-over-year.
- In the first half of 2023, D&M services revenue grew 2.1% year-over-year to RMB9.67 billion. Excluding COVID-19 commercial projects, D&M services revenue grew strongly by 54.5%.
- In the first half of 2023, we added 583 molecules to our D&M pipeline. To date, our D&M pipeline consists of 2,819 molecules, including 56 commercial projects, 59 in phase III, 301 in phase II and 2,403 in phase I and pre-clinical stages, among which, 8 commercial and phase III projects were added in the first half of 2023.
- In the first half of 2023, TIDES revenue grew 37.9% year-over-year to RMB1.33 billion. As of June 30, 2023, backlog of TIDES grew strongly by 188% year-over-year. We expect revenue growth from TIDES business to exceed 70% in 2023.
- The number of TIDES D&M customers increased 25% year-over-year to 121, and the number of TIDES molecules increased 46% year-over-year to 207.
- WuXi Testing: Lab Testing Services Drive Steady Growth, Clinical Business Fully Recovered
- The Company provides a full range of laboratory testing services for our customers, including drug metabolism and pharmacokinetics (DMPK), toxicology, and bioanalysis for drug development testing, as well as medical device testing. We provide customers with high-quality services, realize "one report for global submission," and enable customers to save time, reduce costs and increase efficiency.
- H1 2023 revenue from drug safety evaluation services grew 24% year-over-year. We maintained our industry leadership position in Asia Pacific for drug safety evaluation services that meet global regulatory requirements. In the first half of 2023, new lab testing facilities in Qidong and Suzhou began operations as scheduled, ensuring the business growth to accelerate in the second half of 2023.
- Moreover, we continued to enhance capabilities related to new modalities, with comprehensive coverage such as target protein degradation, nucleic acids, conjugates, and cell and gene therapies (CGT), etc.
- SMO revenue grew strongly by 53.9% in Q2 2023 and 34.3% in H1 2023, maintaining a leadership position in China. In the first half of 2023, SMO supported 25 new drug approvals for customers.
- In the first half of 2023, clinical CRO enabled our customers to obtain 8 IND approvals and submit 3 NDA filings.
- WuXi Biology: Strong Contribution from New Modalities; Early Discovery Screening Platform Continued to Generate Downstream Opportunities
- WuXi ATU: CTDMO Business Model Drives Growth
- WuXi DDSU: the First Year to Receive New Drug Application (NDA) Approval of New Drugs Developed for Customers; Breakthrough to Receive the First Royalty Income
Our Commitment to ESG
As an industry innovation enabler, a trusted partner and a contributor to the global healthcare industry, the Company is committed to environmental protection and sustainability, and to being a good global corporate citizenship.
Our outstanding ESG performance has been recognized by major global ESG rating agencies, including MSCI, S&P Global, Sustainalytics, CDP and EcoVadis. In June 2023, we received the fourth "Silver" medal recognition from EcoVadis for our Couvet site in Switzerland.
By the first half of 2023, our carbon emission intensity, energy consumption intensity and water use intensity reduced by 20.1%, 18.4%, and 31.6%, respectively, as compared to the baseline year 2020.
As we continue to advance our sustainability strategy, we embrace our shared responsibility to be good stewards of the environment.
Management Comment
Dr. Ge Li, Chairman and CEO of WuXi AppTec, said, "We continued to achieve steady growth of revenue, net profit, and free cash flow in the first half of 2023. Our revenue increased 6.3% year-over-year to RMB18.87 billion, or 27.9% if excluding COVID-19 commercial projects. Our adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year, outpacing the revenue growth rate, and our free cash flow achieved RMB2.93 billion, as a result of the Company's pursuit of operational excellence and productivity."
"The Company's performance in the first half of 2023 demonstrated that WuXi AppTec's unique CRDMO and CTDMO business models can effectively meet the growing demands from customers worldwide and continue to drive solid growth for the Company. In 2023, we aim to deliver a 5-7% revenue growth, increase adjusted non-IFRS gross profit by 13-14%, and expand free cash flow by 750-850%. We remain committed to prioritizing our customers' needs and enhancing our capacity and capabilities as we support our customers' efforts to bring groundbreaking therapies to patients around the world. Together, we can realize our vision that 'every drug can be made and every disease can be treated'."
About WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com
Forward-Looking Statements
This press release may contain certain "forward-looking statements" which are not historical facts, but instead are predictions about future events based on our beliefs as well as assumptions made by and information currently available to our management. Although we believe that our predictions are reasonable, future events are inherently uncertain and our forward-looking statements may turn out to be incorrect. Our forward-looking statements are subject to risks relating to, among other things, the ability of our service offerings to compete effectively, our ability to meet timelines for the expansion of our service offerings, our ability to protect our customers' intellectual property, unforeseeable international tension, competition, the impact of emergencies and other force majeure. Our forward-looking statements in this press release speak only as of the date on which they are made, and we assume no obligation to update any forward-looking statements except as required by applicable law or listing rules. Accordingly, you are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. All forward-looking statements contained herein are qualified by reference to the cautionary statements set forth in this section. All information provided in this press release is as of the date of this press release and are based on assumptions that we believe to be reasonable as of this date, and we do not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Use of Non-IFRS and Adjusted Non-IFRS Financial Measures
We provide non-IFRS gross profit and non-IFRS net profit attributable to owners of the Company, which exclude share-based compensation expenses, issuance expenses of convertible bonds, fair value gain or loss from derivative component of convertible bonds, foreign exchange-related gains or losses, amortization of intangible assets acquired in business combinations, non-financial assets impairment, etc. We also provide adjusted non-IFRS net profit attributable to owners of the Company and earnings per share, which further exclude realized and unrealized gains or losses from our venture capital investments and joint ventures. Neither is required by, or presented in accordance with IFRS.
We believe that the adjusted financial measures used in this press release are useful for understanding and assessing our core business performance and operating trends, and we believe that management and investors may benefit from referring to these adjusted financial measures in assessing our financial performance by eliminating the impact of certain unusual, non-recurring, non-cash and non-operating items that we do not consider indicative of the performance of our core business. Such adjusted non-IFRS net profit attributable to owners of the Company, the management of the Company believes, is widely accepted and adopted in the industry the Company is operating in. However, the presentation of these adjusted non-IFRS financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with IFRS. You should not view adjusted results on a stand-alone basis or as a substitute for results under IFRS, or as being comparable to results reported or forecasted by other companies.
For more information, please contact:
Ms. Ruijia Tang (for investors)
IR Director
Email: tang_ruijia@wuxiapptec.com
Mr. Davy Wu (for media)
PR Director
Email: davy_wu@wuxiapptec.com
View original content:
SOURCE WuXi AppTec | https://www.wbrc.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ | 2023-07-31T11:52:05 | 0 | https://www.wbrc.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ |
Introducing the industry's first-ever utility side-by-side with a 1500cc 3-cylinder engine for more power to make tough jobs easier and the industry's only STEELDRIVE transmission for greater durability
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- Polaris Off Road, the global leader in powersports and off-road innovation, is once again breaking new ground with the industry's first extreme duty utility side-by-side: the all-new RANGER XD 1500. With its unprecedented capability, brute strength and unmatched comfort, the new extreme duty class of RANGER side-by-sides are engineered with the first-ever ProStar 1500cc 3-cylinder engine that offers an industry-leading 110 horsepower, the industry-exclusive STEELDRIVE automatic transmission for greater durability and precise control, and over 70 new accessories for enhanced customization, highlighted by Polaris' exclusive Lock & Ride MAX system. The RANGER XD 1500 establishes a new benchmark for utility side-by-sides.
"We spent over five years meeting with farmers, ranchers, large acreage property owners and big game hunters to develop an extreme duty vehicle that was missing from the market. From its ProStar 1500cc engine to the industry's only STEELDRIVE transmission, RANGER XD 1500 is unlike anything else offered today and is yet another example of our relentless commitment to advancing the industry with fresh thinking and innovative solutions that meet the real-world needs of our utility customers," said Steve Menneto, President of Polaris Off Road.
"Polaris RANGER has been the No. 1 selling utility side-by-side brand for more than 15 years and with the introduction of RANGER Extreme Duty, we've taken the industry's hardest-working lineup and expanded it," said Chris Judson, Vice President of Off Road Utility. "A segment of our utility customers said they are facing exceptionally large tasks and they simply need a machine with more power, more torque, more hauling and towing capacity, and more durability. And our team set out to deliver just that, incorporating dozens of new features and the latest engineering to make the RANGER XD 1500 more capable, stronger, and more comfortable than any other utility side-by-side out there."
Unprecedented Capability
Farmers, ranchers, and large landowners routinely haul and tow heavy loads around the property, and they've been asking for a solution when it comes to their heaviest tasks. The RANGER XD 1500 delivers unprecedented capability for hard-working customers to haul more, tow more, and get more done in less time. With the industry's only 1500cc utility engine, the RANGER XD 1500 provides over 30% more power and over 50% more torque than the next closest competitor.
- ProStar 1500cc 3-Cylinder Engine – Effortless towing, hauling, and confidence in tough terrain with an industry-leading 110HP and 105 lb-ft torque.
- 1,500 lb Cargo Box Capacity – Three-quarter ton box capacity providing nearly 50% more box volume than existing models for maximum productivity with fewer trips and bigger loads.
- 3,500 lb Towing Capacity – For those routinely towing heavy loads on the property, drive better productivity with nearly 40% more towing than existing models.
- Industry-leading Ground Clearance – All RANGER XD 1500 models get 15" of ground clearance with high-clearance arched A-arms to overcome large obstacles.
Brute Strength
Utility customers asked for a more durable, longer lasting offering to maximize their uptime and drive efficiency. Designed to last longer than any model before it, RANGER XD 1500 is the industry's most durable utility side-by-side and has been engineered from the ground up to be stronger and stand up to the demands of the longest days.
- Industry-exclusive STEELDRIVE transmission – Offers a 100 percent steel constructed belt that delivers smooth, precise operation and a fully sealed, liquid-cooled design for unmatched durability.
- High-Strength Steel Heavy Duty Frame – RANGER XD 1500 has a high-strength steel one-piece chassis featuring 160 percent more torsional stiffness for a smoother ride and better cab sealing.
- Industry-leading Service Intervals – RANGER XD 1500 offers the industry's longest service intervals so customers can maximize their uptime.
Unmatched Comfort
- From the farm to remote backcountry, utility customers work from before the sun rises to after it sets, and need something that delivers all-day comfort. Beyond industry-leading capability and durability, the RANGER XD 1500 prioritizes comfort across the entire lineup to keep customers going strong on the longest days.
- Most Spacious Interior – Equipped with the most spacious and premium cab available in utility side-by-sides, the XD 1500 offers increased leg and shoulder room, making it easy to enter and exit the vehicle. Adjustable seating and a telescopic steering wheel lets drivers find the perfect fit for height and riding preferences.
- Premium Seating – Contoured seating with added bolstering provides more rider comfort along with a center seat that flips down into an armrest with additional cup holders.
- Available Heated Seats – For comfort on the coldest days, RANGER XD 1500 NorthStar Ultimate is the first utility side-by-side that comes from the factory with heated seats.
- Drive Modes – RANGER XD 1500 comes with an intuitive and easy-to-use rotary drive mode selector that lets customers choose from four different drive modes, including:
- Heating and Air Conditioning (HVAC) – Riders can stay comfortable in harsh weather conditions in the RANGER XD 1500 NorthStar Edition, featuring an all-new HVAC system and a fully-enclosed, next generation ProShield cab that's been redesigned with improved sealing to prevent dust and water intrusion, while locking in the temperature from the climate-controlled cab.
- Sun Visors – All-new integrated sun visors provide improved visibility throughout the day for added confidence while driving.
- RIDE COMMAND – Available 7" waterproof touchscreen display powered by RIDE COMMAND technology featuring a back-up camera, GPS navigation regardless of cell service, and AM/FM radio with Bluetooth® streaming capability.
- RIDE COMMAND+ – Customers can keep tabs on their vehicle directly from the Polaris App and access critical vehicle information like vehicle location, maintenance reminders, and issue diagnostics right from the palm of their hand with the industry's only connected-vehicle technology. Available from the factory on NorthStar Ultimate.
Customization
Customers have been asking for increased versatility, durability, and ease of use for the different work applications they face throughout the day. With over 70 new Polaris Engineered Accessory options designed specifically for the RANGER XD 1500, plus options from partners brands including JBL®, Rhino Rack®, Pro Armor, Kolpin, and HD Parts, customers have more opportunity than ever before to make their vehicle fit their specific needs.
- Lock & Ride MAX – Polaris' easiest to use, most versatile, and confident accessory attachment platform ever. With customizable configurations and the ability to reconfigure on the fly with no tools required, this new accessory platform allows users to prepare for their day, their way. Customers can simply choose and place their accessory, lock it in place, and ride confidently knowing their gear is secure.
- New JBL® Audio – Polaris partnered with JBL® to create the highest performing audio system ever included in a RANGER from the factory. For customers wanting to turn it up a notch, the JBL® Trail Pro 4200 audio upgrade adds rear speakers and two subwoofers for an immersive audio experience.
- Glacier Pro HD Plow – New 84" plow designed for faster, more efficient plowing during the winter months. A hydraulic plow lift and angle kit can be paired with an all-new plow controller to manage the largest plow Polaris has ever offered, all without ever leaving the comfort of the cab.
2024 RANGER XD 1500 Premium: Starting at US $29,999 / CAN $36,199
The RANGER XD 1500 Premium commands a large presence thanks to heavy-duty components and the industry's largest bumper, providing complete front-end protection. The vehicle comes equipped with one of the most comprehensive standard packages in a side-by-side to date including 29" tires, tilt steering and seat slider for customizable comfort, four drive modes, high output LED headlights for enhanced visibility, and USB ports with multiple charging capabilities. The vehicle also comes equipped with boosted brakes and heavy-duty suspension to ensure performance across a variety of off-road environments.
2024 RANGER XD 1500 NorthStar Premium: Starting at US $39,999 / CAN $48,799
The next step up is the RANGER XD 1500 NorthStar Premium. This machine features a fully enclosed cab with HVAC temperature and five different mode controls, lockable full doors with power windows and a fixed front glass windshield. Additional features include an electronically controlled power tilt bed to dump heavy loads with ease, an overhead switch panel for easy accessorization, and an overhead rear work light to illuminate the cargo box in low-light conditions. NorthStar Premium comes stock with 30" Kenda® CrossTrail tires and available 32" tires to overcome large obstacles and tough terrain.
2024 RANGER XD 1500 NorthStar Ultimate: Starting at US $44,999 / CAN $54,499
Rounding out the lineup is the RANGER XD 1500 NorthStar Ultimate, which features everything from the NorthStar Premium trim, plus the 7" infotainment display powered by RIDE COMMAND and heated seats. The NorthStar Ultimate trim also delivers an immersive sound experience, featuring full AM/FM radio with Bluetooth® streaming capability and industry-exclusive JBL® speakers for precise audio and premium sound. Finally, the vehicle comes standard with RIDE COMMAND+, allowing for vehicle health monitoring and more.
The 2024 RANGER XD 1500 lineup is expected to begin shipping to dealers in late summer. To learn more about the 2024 RANGER family, please visit https://ranger.polaris.com/en-us/ or join the conversation and follow on Facebooksm, Instagramsm, YouTubesm and Twittersm.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
Warning: vehicle rollaway can cause serious injury or death. This vehicle can roll whenever the gear selector is not in the park position. Always shift to park when stopping the engine or leaving the vehicle. When leaving the vehicle on an incline is unavoidable, use extra care. If leaving the vehicle unattended, block the rear wheels on the downhill side and keep children, pets, and others away form the gear selector. Notice: Vehicle payload and trailer weight will affect the angle of hill on which the vehicle will hold.
Kenda® is a registered trademark of Kenda Rubber Industrial Co, Ltd.
Bluetooth® is a registered trademark of Bluetooth Sig, Inc.
JBL® is a registered trademark of Harman International Industries, Incorporated
Rhino-Rack® is a registered trademark of Rhino Rack Australia Pty Limited
Unless noted, trademarks are the property of Polaris Industries Inc.
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.wflx.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ | 2023-07-31T11:52:09 | 0 | https://www.wflx.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ |
(The Hill) – Dozens of former Cabinet officials under former President Trump’s administration declined to publicly support the former president’s third bid for the White House, NBC News reported.
NBC News reached out to 44 people who previously served in Trump’s Cabinet during his four years in office to gauge whether they would support the former president during the 2024 presidential election. The outlet reported that most of the people declined to comment or ignored the requests and that only four said publicly they would support Trump for the presidency.
Trump’s Cabinet saw a higher rate of turnover compared with many of his predecessors, with many new officials rotating in and out of his administration over the four years. The only four former Cabinet members who NBC News reached out to who said they would support Trump are former acting Attorney General Matthew Whitaker, former chief of staff Mark Meadows, former Office of Management and Budget (OMB) director Russell Vought and former acting director of national intelligence Richard Grenell.
A spokesperson for Meadows told NBC News that he “fully” supports Trump. In May, Vought posted on X, the site formerly known as Twitter, that the former president is “the only person I trust to take a wrecking ball to the Deep State.”
Other former administration officials were reluctant to support Trump or have publicly said they will not support him. Former Attorney General Bill Barr told NBC News that he opposes Trump getting the 2024 GOP nomination but declined whether to say he would support him in the general election if pitted against President Biden.
Top Stories from The Hill
- White House takes the gloves off ahead of 2024
- Trump attorney calls him ‘the most ethical American I know’ in wake of superseding indictment
- Murphy says Alito’s Supreme Court seat ‘exists only because of an act passed by Congress’
- Trump attorney calls him ‘the most ethical American I know’ in wake of superseding indictment
Former chief of staff Mick Mulvaney also said that he does not want Trump to get the Republican nomination for president.
“I am working hard to make sure that someone else is the nominee,” Mulvaney told NBC News. “I think he’s the Republican who is most likely to lose in a general election, of all our leading candidates. If anyone can lose to Joe Biden, it would be him.”
Other former officials who have not endorsed Trump yet include former Secretary of State Mike Pompeo, former Defense Secretary Patrick Shanahan, former chief of staff John Kelly and Joseph Maguire and Dan Coats, who each once served as director of national intelligence. Coats told NBC News that he would be supporting former Vice President Mike Pence for the GOP primary.
The Hill has reached out to Trump’s campaign for comment. | https://www.ksn.com/hill-politics/dozens-of-former-trump-cabinet-officials-wont-publicly-support-his-2024-bid/ | 2023-07-31T11:52:10 | 1 | https://www.ksn.com/hill-politics/dozens-of-former-trump-cabinet-officials-wont-publicly-support-his-2024-bid/ |
ATLANTA - For more than two years, people here and across the country have watched and waited for clues that the high-profile Georgia investigation into whether former president Donald Trump and his allies broke the law in their attempts to overturn his 2020 election loss in the state was winding to an end.
That speculation hit fever pitch in recent days with the installation of orange security barriers near the main entrance of the Fulton County Courthouse in downtown Atlanta. It was the most visible sign yet of the looming charging decision in a case that has ensnared not only Trump but several high-profile Republicans who could either face charges or stand witness in a potential trial unlike anything seen before in this Southern metropolis.
Advertisement
It is one of several investigations into attempts to reverse Trump’s loss in 2020, including a sprawling Justice Department probe overseen by special counsel Jack Smith that has sparked its own intensifying waiting game in recent days. Smith and his team have interviewed or sought information from several witnesses also key to the Georgia investigation. Trump has said he received a letter from the Justice Department saying he could face criminal charges for his efforts after the election that preceded the Jan. 6, 2021, attack on the U.S. Capitol.
While the pace of Smith's investigation has been unpredictable, Fulton County District Attorney Fani T. Willis took the unusual step of publicly telegraphing that she plans to announce a charging decision in the Georgia case during the first three weeks of August, a period that opens Monday.
In Atlanta, local, state and federal law enforcement officials have been privately meeting for months to plan enhanced security measures in anticipation of that decision.
All eyes are now on two criminal grand jury panels sworn in on July 11 - one group that meets on Mondays and Tuesdays, the other that meets on Thursdays and Fridays. One of the panels is likely to decide whether charges should be filed in the closely watched election interference case - a decision that could put Trump, who is now under indictment in two other criminal cases, in even more legal peril.
Advertisement
Willis (D) has strongly hinted for months that she will seek multiple indictments in the case, using Georgia's expansive anti-racketeering statutes that allow prosecutors not only to charge in-state wrongdoing but to use activities in other states to prove criminal intent in Georgia. In court filings, Willis has described her probe as an investigation of "multi-state, coordinated efforts to influence the results of the November 2020 elections in Georgia and elsewhere."
At least 18 people were informed by prosecutors last year that they were targets of the investigation. That list that includes former New York mayor Rudy Giuliani, who acted as Trump's personal attorney after the election, and several Georgia Republicans who served as alternate Trump electors and falsely signed documents claiming Trump won Georgia - though some have since been granted immunity.
But Willis's scope is believed to be larger than that. Georgia law does not require individuals to be formally notified they are targets of an investigation.
Behind the scenes, law enforcement officials have already been discussing how it could all play out - including the anticipated crush of media and curious onlookers and potential protests that officials fear could be disruptive in a key part of downtown Atlanta.
Advertisement
Officials are also considering the logistics of how potential high-profile defendants might surrender for arrest, according to a person familiar with the preparations who, like others interviewed, spoke on the condition of anonymity to discuss private meetings or sensitive plans. People who are indicted in Fulton County usually are arrested and processed for fingerprints at the Fulton County Jail before making their first court appearance.
But the decrepit condition of the jail - including crowding and unsanitary conditions - recently sparked a Justice Department civil rights investigation into the facility. That has led to speculation that Trump, if indicted, could be processed at the courthouse or another location for security reasons - a request that could come from his attorneys or the Secret Service.
The Fulton County Courthouse sits directly across the street from the Georgia Capitol building, where hundreds of Trump supporters, some armed, gathered in anger in the aftermath of his 2020 election loss. State officials at the time received death threats related to the fraud claims posed by Trump and his allies. Atlanta City Hall sits adjacent to both buildings, while the Richard B. Russell Federal Building and U.S. Courthouse is located a few blocks away.
The county courthouse has already been subject to enhanced security because of ongoing threats to Willis and her staff - including racist, threatening phone calls related to the election investigation, according to two people familiar with the threats. It's an issue that Willis, who is often accompanied by armed bodyguards during public appearances, has raised both privately and publicly.
Advertisement
In January 2022, just days after she received approval to impanel a special grand jury to investigate the case, Willis, the first Black woman elected as Fulton County district attorney, sent a letter to the head of the FBI's Atlanta field office requesting a risk assessment of the courthouse, citing "alarming" rhetoric from Trump.
In the letter, Willis pointed to remarks Trump had made at a Texas rally the previous weekend, where he attacked unnamed prosecutors investigating him in cities including Atlanta as "racist" and "mentally sick." Willis also cited "communications" she and her staff had received from "persons unhappy" with the investigation.
Since then, Trump has escalated his attacks, describing Willis's probe as a "political witch hunt" and repeatedly referring to her as the "racist D.A. from Atlanta." Willis has largely declined to comment on Trump's remarks. "It's ridiculous in nature," Willis told Atlanta's WSB-TV in April. "But I respect his right to be protected by the First Amendment and say what he likes."
But Willis has continued to raise concerns about security, which some have read as a hint that Trump may be among those who are charged in her investigation.
In an April letter to Fulton County Sheriff Patrick Labat, Willis offered her appreciation for additional security at the courthouse - including increased officers and new metal detectors that were installed amid jury selection in another high profile case involving rapper Jeffery Lamar Williams, known as Young Thug. But Willis said "the need for vigilance will increase" and urged "heightened security and preparedness" ahead of her announcement in the election case.
Advertisement
"Open-source intelligence has indicated the announcement of decisions in this case may provoke a significant public reaction," Willis wrote in her letter. "We have seen in recent years that some may go outside of public expressions of opinion that are protected by the First Amendment to engage in acts of violence that will engage the safety [of] our community. As leaders, it is incumbent for us to prepare."
Similar letters were also sent to the chief of the Atlanta Police Department and other top law enforcement officials in the region - prompting meetings between local, state and federal law enforcement and other local officials about security around potential indictments and possible arraignments, according to two people familiar with the preparations.
Labat, who oversees security at the courthouse and the jail, has spearheaded much of the planning process, according to two people familiar with those plans. In April, the sheriff dispatched two deputies to observe proceedings in New York, where Trump was indicted on charges related to hush money payments made to an adult film actress. Fulton County deputies also traveled to Miami, where Trump was arraigned in June on federal charges tied to his handling of classified documents.
Labat, who could not be reached for comment, told Atlanta's WXIA-TV in June that he dispatched deputies to New York and Miami understand "the gravity of it" as the agency made its own preparations in advance of Willis's announcement.
The Atlanta Police Department, which has jurisdiction over the city streets around the courthouse, also sent an officer to Miami during the Trump arraignment, according to a spokeswoman who otherwise declined to comment on the department's planning.
Those agencies have been coordinating with the Georgia State Patrol, which oversees security on the capitol grounds. Officials with the Georgia Bureau of Investigation, the FBI and Secret Service have attended security meetings, according to a person familiar with the plans. All agencies declined to comment - though a spokeswoman for the sheriff's office confirmed the coordinated efforts.
"The Fulton County Sheriff's Office is proactively coordinating with local, state and federal agencies to enhance security during . . . high profile legal proceedings at the Fulton County Courthouse," Natalie Ammons, a spokeswoman for the sheriff's office, said in an email. "Some of the measures we are deploying, such as barriers that will limit parking near the courthouse, will be obvious to the public. For security reasons, other measures being deployed will not be as obvious."
Under Georgia law, a defendant does not have to be present when an indictment is unsealed - meaning the grand jury's decision could be made public as soon as it is delivered to a presiding judge, who will read the charges in open court.
Anyone charged in an indictment would then negotiate with the sheriff's office on when to surrender to authorities for processing. An initial court date could occur immediately upon surrender or at a later date. If Willis does charge multiple defendants as part of an anti-racketeering case, it is not expected they would make their first appearance in court together but would likely have joint hearings at a later date.
In her letters to Labat and other law enforcement officials in April, Willis initially presented a seven-week period beginning in mid-July of when she would announce her charging decision in the election case.
She later narrowed that window even further, announcing in a letter to the chief judge in Fulton County and copied to other top county officials that much of her staff would work remotely during the first three weeks of August. Noting that many judges were already scheduled to be at a conference the first week of August, Willis asked that no trials or in-person proceedings be held at the courthouse between Aug. 7 and 18 - though the courthouse remains open to the public.
Willis's suggested charging window opens as Trump's attorneys are still seeking to disqualify Willis and her office from investigating the former president and block prosecutors from using evidence gathered by a special grand jury that investigated the case.
On July 20, Fulton County Superior Court Judge Ural Glanville recused the entire judicial bench in Fulton County from hearing Trump’s motion, asking an administrative court to assign a judge outside the division to hear the case. Judge J. Stephen Schuster, a senior judge in Cobb County Superior Court, north of Atlanta, was assigned last week to the case. Schuster has scheduled a hearing for Aug. 10 - in the middle of Willis’s charging window. | https://www.bostonglobe.com/2023/07/31/nation/georgia-2020-election-investigation/ | 2023-07-31T11:52:10 | 0 | https://www.bostonglobe.com/2023/07/31/nation/georgia-2020-election-investigation/ |
The cutting-edge platform empowers B2B SaaS start-ups to reduce churn, increase upsell, and boost NRR
WILMINGTON, Del., July 31, 2023 /PRNewswire/ -- ZapScale, a new-age customer success platform, is making waves in the industry by offering an unrivalled one-day onboarding experience along with the ability to track 150 customer data points for a comprehensive 360-degree view of customer health. This ground-breaking feature sets ZapScale apart from its competitors.
The secret behind ZapScale's lightning-fast onboarding lies in its comprehensive toolkit. With a robust framework of 40 pre-built KPI-based health frameworks, 60 pre-designed playbooks to automate CS ops, and seamless native integrations with all popular tools, ZapScale empowers businesses to gain complete visibility over customer data. With deep customer health insights, ZapScale's customers have seen an improvement in retention and increase in upsell opportunities.
Manasij Ganguli, Founder and CEO of ZapScale, shares his personal motivation for creating this game-changing platform: "ZapScale was born out of my passion to empower B2B SaaS start-ups with an efficient and effective CS platform. Having faced numerous customer success challenges in my previous start-up, which I successfully sold in 2019, I realized the critical need for a solution that could streamline, optimize, and accelerate CS operations.
For small to mid-sized businesses that have limited time and resources, implementing a CS platform has historically been a daunting task, taking weeks, if not months, to set up essential elements like customer health, playbooks, and integrations. ZapScale has addressed this challenge by offering a user-friendly and efficient implementation process, eliminating waste of time and resources. Now, businesses can seamlessly focus on their customers right from day 1."
ZapScale eliminates the traditional barriers and time-consuming processes associated with implementing CS platforms using key in-built features that facilitate custom mapping, support custom fields, and require no unique key to integrate applications, ensuring a tailored yet quick integration experience.
ZapScale is swiftly gaining traction in the market, with 30+ global companies already using the customer success platform. Starting at $249 per month, with a one-month free trial, ZapScale is helping businesses significantly improve their customer success initiatives.
For more information about ZapScale and to schedule a demo, visit www.zapscale.com.
Contact:
Nikita Kalra
Marketing Head, ZapScale
nikita@zapscale.com
Logo: https://mma.prnewswire.com/media/2097823/ZS_Logo.jpg
View original content:
SOURCE ZapScale | https://www.kswo.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ | 2023-07-31T11:52:10 | 0 | https://www.kswo.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ |
GUANGZHOU, China, July 31, 2023 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that it has published its 2022 Environmental, Social and Governance ("ESG") report, outlining the Company's progress and performance in key ESG areas.
The report provides a comprehensive review of Yatsen's ESG initiatives and developments, including corporate governance, research and development, employee rights protection, human capital development, environmental sustainability and social responsibility, among others.
To view the report in full, please visit the ESG section on the Yatsen Investor Relations website. Alternatively, please click here for the English version and here for the Chinese version of the 2022 report.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the mission of creating an exciting new journey of beauty discovery for consumers around the world. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands, including Perfect Diary, Little Ondine, Abby's Choice, Galénic, DR.WU (its mainland China business), Eve Lom, Pink Bear and EANTiM. The Company's flagship brand, Perfect Diary, is one of the leading color cosmetics brands in China in terms of retail sales value. The Company primarily reaches and engages with customers directly, both online and offline, with an expansive presence across all major e-commerce, social and content platforms in China.
For more information, please visit http://ir.yatsenglobal.com/.
For investor and media inquiries, please contact:
In China:
Yatsen Holding Limited
Investor Relations
E-mail: ir@yatsenglobal.com
The Piacente Group, Inc
Hui Fan
Tel: +86-10-6508-0677
E-mail: yatsen@thepiacentegroup.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: yatsen@thepiacentegroup.com
View original content:
SOURCE Yatsen Holding Limited | https://www.wbrc.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ | 2023-07-31T11:52:12 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ |
Leveraging artificial intelligence, Mumbai-based IT services firm Yodaplus is catalyzing industry transformations, from nutraceuticals to retail, by streamlining business operations and boosting decision-making capabilities.
MUMBAI, India, July 31, 2023 /PRNewswire/ -- Yodaplus, a Mumbai-based IT services firm, is at the forefront of empowering organizations worldwide with advanced technological capabilities. Today, the company sheds light on the evolving global landscape of Artificial Intelligence (AI) and its growing adoption within its service portfolio.
With its wide range of services and deep industry knowledge, Yodaplus has been a game changer – enabling organizations to focus on their core operations and achieve sustainable growth. And now, by integrating AI into services, Yodaplus helps businesses navigate the complex digital transformation landscape more efficiently, creating a competitive edge.
AI continues to transform business operations globally, powering automation, analytics, decision-making, and enhancing user experiences. This ultimately delivers safer and more effective products to meet the growing global demand.
Yodaplus is known for its expansive roster of clients - from development banks and blockchain companies to EdTech startups and HRMS providers. With such a diverse clientele, embracing AI is more necessary than a choice, and Yodaplus has promptly addressed this need.
"As we navigate the digital age, the integration of AI into our service offerings has become an undeniable necessity," commented Vishrut Srivastava, MD, Yodaplus. "AI is here to stay, poised to make our lives more efficient and free mankind from the burden of mundane tasks. At Yodaplus, we are committed to embracing AI to drive growth and innovation for our clients while we continue to explore new horizons in this transformative technological landscape."
In line with this commitment, Yodaplus has developed an AI engine transforming the global nutraceutical supply chain. Addressing the complexities of generating differentiated nutraceutical label claims necessitates a well-mapped global database and the application of AI. To solve this problem, Yodaplus developed an AI-driven smart labels function via the NutrifyGenie AI engine.
NutrifyGenie uses sophisticated algorithms that facilitate simplified and precise decision-making, authenticating label claim validation and enabling real-time regulatory compliance. This feature provides users with pre-made labels, including correct dosage values for nutraceutical products, significantly expediting product development.
Enabling companies to effortlessly commercialize their innovations in essential markets fulfills the continuously increasing demand for nutraceutical products. As the nutraceutical industry continues to grow, Yodaplus's AI engine will play a crucial role in accelerating the new product development process and helping businesses bring innovative and differentiated products to market faster than ever before.
Not just that, the company has also recently deployed advanced invoice parsing for a retail giant. This smart solution facilitates operations by accurately extracting and collating relevant information from invoices, thus automating a previously laborious task. Furthermore, Yodaplus uses sophisticated AI tools to assist an asset management client in conducting comprehensive financial records analysis, rendering them outstanding financial decision-making capabilities.
About Yodaplus
An ever-evolving, highly specialized technology solutions company, Yodaplus offers an array of services designed to address the unique needs of businesses globally, extending beyond its Mumbai base to the US, UK, UAE, and Singapore. The company's mission, steered by MD Vishrut Srivastava, is dedicated to providing top-tier IT services and aims to propel businesses toward unprecedented growth and success. With this commitment, Yodaplus becomes your duly trusted tech partner.
For more information about Yodaplus, please visit www.yodaplus.com.
Press Contact:
Amit Pareek
Senior Marketing Manager
amitp@yodaplus.com
Photo: https://mma.prnewswire.com/media/2163861/Vishrut_Srivatava_MD_Yodaplus.jpg
Logo: https://mma.prnewswire.com/media/2144978/4185052/Yodaplus_Logo.jpg
View original content:
SOURCE Yodaplus Technologies | https://www.wbrc.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ | 2023-07-31T11:52:19 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ |
Highlights Include the Return of Polaris Sportsman 570 and XP 1000 Hunt Editions, Along with a Host of
Aesthetic and Performance Upgrades Across the Lineup
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- On the heels of debuting its innovative Polaris XPEDITION and the all new Extreme Duty RANGER XD 1500, Polaris Off Road today unveiled updates for 2024 to the off-road industry's most expansive lineup. The 2024 lineup features a host of rider-inspired updates and refreshed styling and new colors. Additionally, the customer-favorite Polaris Sportsman 570 and XP 1000 Hunt editions make a return, and a Premium trim offering is now available on the 2024 GENERAL 1000 to provide customers with an upgrade in style and performance. RIDE COMMAND+ also received enhanced features for 2024, delivering unmatched connectivity and peace of mind to riders through all-new Location Bump Alerts and Check-In Messages.
"From the completely redesigned 2024 RZR XP and the industry's first "adventure side-by-side" Polaris XPEDITION, to our introduction of the all-new RANGER XD 1500, this year has been a powerful showcase of our ongoing commitment to lead the industry and innovate for our riders," said Steve Menneto, President of Polaris Off Road. "While those revolutionary product debuts are pivotal, our unwavering focus on refining and enhancing our current offerings based on customer needs and feedback remains essential, and that's what the 2024 updates represent."
From fresh new styles and colorways, to improved trim levels that appeal to a wide variety of riders, the Polaris Off Road 2024 model year lineup and RIDE COMMAND+ technology enhancements include the following:
RIDE COMMAND+:
Making its debut last fall, RIDE COMMAND+, the industry's first connected-vehicle technology, continues to roll out new enhancements to its service for 2024. With new features like Location Alerts, that will notify the owner if its vehicle has been bumped or moved from its last location, owners can now protect their vehicle more than ever before. RIDE COMMAND+ is now available as a factory option for 2024 RZR Pro R Ultimate, RANGER XD 1500 NorthStar, RANGER XP 1000 NorthStar, Polaris XPEDITION NorthStar and Sportsman XP 1000 RIDE COMMAND Edition. This service is also available on most 2024 RZR, RANGER, Sportsman and Polaris XPEDITION models as an accessory install.
Sportsman
Polaris Sportsman, the long-standing No. 1 selling automatic 4x4 ATV, is reintroducing the Sportsman 570 and XP 1000 Hunt Editions, while also implementing key improvements across the core 2024 lineup. A customer favorite, specifically designed to meet the unique needs of hunters, the Sportsman 570 and XP 1000 Hunt editions include accessories such as the 3,500 lb Polaris Winch, Kolpin Gun Scabbard & Mount, Kolpin Ratchet Claws and more.
Additionally, the 2024 Sportsman 450 and 570 lineup boasts several quality refinements for a better riding experience including a new rear brake pedal for reduced pedal effort and feel, improved sealing around the shifter, and enhanced seat fitment delivering a more comfortable ride. The 570 EPS trim and above will also include enhanced PVT clutch sealing with a higher intake location for better performance in wet conditions.
For added utility, the model year 2024 Sportsman 570 lineup will be equipped with new LED lights for the Premium and Utility HD for added visibility from dawn to dusk.
New color options also are available for the 570 Premium and Trail, 570 Ride Command Edition, Sportsman 850 Premium and Ultimate Trail, Sportsman XP 1000 Ultimate Trail, Sportsman XP 1000 High Lifter Edition, Scrambler XP 1000 S and Sportsman XP 1000 S.
The 2024 Sportsman lineup starts at $6,999 US MSRP and will begin shipping to dealers this early fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/sportsman/
GENERAL
Polaris GENERAL is the industry's most versatile crossover side-by-side, capable of tackling tough trails, while also knocking out tasks around the property. For 2024, the GENERAL 1000 receives a new Premium trim offering that provides both style and performance enhancements. Featuring 14" wheels with 27" Coronado tires, and FOX® Podium QS3® shocks that riders can adjust between soft, medium and firm based on terrain changes, the new Premium trim will deliver a smooth ride over rugged terrain, while LED headlights provide greater visibility at morning and night. These upgrades will help riders knock out more tasks and hit the trails confidently in the GENERAL 1000.
Additionally, new colorways on the GENERAL 1000 model include Ghost Gray and Volcanic Orange. The Premium and Ultimate trim levels for the GENERAL XP will feature new colors and graphics in Matte Silver Quartz and Polaris Blue.
The 2024 GENERAL lineup starts at $17,499 US MSRP and will begin shipping to dealers this summer. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/general/
RZR
Polaris RZR, the No. 1 sport side-by-side brand, receives fresh new colors and graphics across its lineup, helping riders make a bold statement when hitting the trails. The 2024 RZR Trail and RZR Trail S are now available in Storm Blue on the Sport trim and two-tone Storm Blue with White Lightning on the Ultimate. Both Sport and Ultimate trim levels now receive the same upgraded steering wheel offered in the fully-redesigned 2024 RZR XP that provides a sportier feel while driving on trails. New for 2024, the RZR Trail and Trail S Sport level feature electric power steering and LED headlights standard, providing riders easier steering input on tight trail corners and enhanced visibility. Additionally for 2024, the RZR Trail S Ultimate trim now features Walker Evans Racing® shocks, while the Sport trim moved to ZF Sachs shocks, both offering riders plush suspension performance against the rugged terrain.
For 2024, the RZR Pro XP Sport and Premium models feature Walker Evans Racing® shocks, while the Ultimate will continue to be equipped with FOX® Live Valve shocks with DYNAMIX active suspension. Both the Premium and Ultimate trim received a refresh with new graphics on the Super Graphite colorway.
Lastly and by consumer demand, the Wide Open lineup of RZR Pro R and RZR Turbo R receives refreshed color options for 2024. For the first time since launching, the RZR Pro R Ultimate is available in an all-new Matte Onyx Black with Lifted Lime accents or Matte Heavy Metal, while the Premium trim level is offered in Matte Heavy Metal. The 2024 RZR Turbo R also welcomes vibrant new colors like Velocity Blue with Green Burst accents and Military Tan with Orange Burst accents.
The 2024 RZR lineup starts at $15,999 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/rzr/
RANGER
In addition to the newly launched Extreme Duty RANGER XD 1500, the Polaris RANGER lineup receives a variety of rider-inspired upgrades and quality refinements for 2024. RANGER SP 570 gets new color options, while the NorthStar Edition gets exclusive tailgate badging and new 25" 8-ply Pro Armor X-Terrain tires for added durability and enhanced puncture resistance.
Additionally, Polaris expands the color options for the RANGER 1000 Premium which will now be offered in the sleek Granite Grey color and graphics, while the XP 1000 will be featured in two new options: Desert Sand and Super Graphite with orange burst accents. Furthermore, the RANGER XP 1000 NorthStar Ultimate model boasts connectivity features such as vehicle health, issue diagnostics, and maintenance reminders enabled by RIDE COMMAND+.
The 2024 RANGER lineup starts at $11,699 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/ranger/
Youth
Dedicated to inspiring the next generation of riders, Polaris Off Road delivers the industry's largest and most varied lineup of youth offerings. For 2024, the Polaris ORV Youth lineup receives a refresh with eye-catching new colors and graphics. This lineup continues to provide industry-leading safety features that give parents peace of mind and help instill confidence in growing riders, including pin code start, adjustable speed limiter, geofencing, helmet aware technology and industry-exclusive safety gear kit.
Specifically, the 2024 RZR 200 EFI is now offered in Storm Gray and a new graphic pattern with bright red accents. The Outlaw 70 EFI ATV is offered in Velocity Blue with either Lifted Lime or Fierce Fuchsia accents, while the Outlaw 110 EFI is now offered in both Bright White with Polaris Blue and Bright White with Radiant Green details.
The 2024 Polaris Youth lineup starts at $2,999 US MSRP and will begin shipping to dealers this winter. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/shop-by-use/youth/
Polaris XPEDITION
The Polaris XPEDITION, which recently launched in May 2023, is the first-of-its-kind adventure side-by-side, combining the all-terrain capabilities of traditional side-by-sides with comfort and cargo capabilities typically associated with overlanding at the highest level. With a host of standard features and optional configurations to accommodate the greatest range of outdoor pursuits and enable consumers to keep chasing the wild, the 2024 Polaris XPEDITION XP and ADV are the most adaptable, comfortable and capable adventure machine on the market.
The 2024 Polaris XPEDITION lineup starts at $28,999 US MSRP and is currently shipping to dealers. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/polaris-xpedition/
To learn more about the Polaris ORV 2024 lineup and to stay up to date on testing and demo opportunities, please visit https://offroad.polaris.com/en-us/ or join the conversation and follow on FacebookSM, InstagramSM, YouTubeSM and TwitterSM. Walker Evans Racing® is a registered trademark of Walker Evans Enterprises Incorporated; FOX® is a registered trademark of Fox Factory Inc.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.wflx.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ | 2023-07-31T11:52:21 | 1 | https://www.wflx.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ |
The cutting-edge platform empowers B2B SaaS start-ups to reduce churn, increase upsell, and boost NRR
WILMINGTON, Del., July 31, 2023 /PRNewswire/ -- ZapScale, a new-age customer success platform, is making waves in the industry by offering an unrivalled one-day onboarding experience along with the ability to track 150 customer data points for a comprehensive 360-degree view of customer health. This ground-breaking feature sets ZapScale apart from its competitors.
The secret behind ZapScale's lightning-fast onboarding lies in its comprehensive toolkit. With a robust framework of 40 pre-built KPI-based health frameworks, 60 pre-designed playbooks to automate CS ops, and seamless native integrations with all popular tools, ZapScale empowers businesses to gain complete visibility over customer data. With deep customer health insights, ZapScale's customers have seen an improvement in retention and increase in upsell opportunities.
Manasij Ganguli, Founder and CEO of ZapScale, shares his personal motivation for creating this game-changing platform: "ZapScale was born out of my passion to empower B2B SaaS start-ups with an efficient and effective CS platform. Having faced numerous customer success challenges in my previous start-up, which I successfully sold in 2019, I realized the critical need for a solution that could streamline, optimize, and accelerate CS operations.
For small to mid-sized businesses that have limited time and resources, implementing a CS platform has historically been a daunting task, taking weeks, if not months, to set up essential elements like customer health, playbooks, and integrations. ZapScale has addressed this challenge by offering a user-friendly and efficient implementation process, eliminating waste of time and resources. Now, businesses can seamlessly focus on their customers right from day 1."
ZapScale eliminates the traditional barriers and time-consuming processes associated with implementing CS platforms using key in-built features that facilitate custom mapping, support custom fields, and require no unique key to integrate applications, ensuring a tailored yet quick integration experience.
ZapScale is swiftly gaining traction in the market, with 30+ global companies already using the customer success platform. Starting at $249 per month, with a one-month free trial, ZapScale is helping businesses significantly improve their customer success initiatives.
For more information about ZapScale and to schedule a demo, visit www.zapscale.com.
Contact:
Nikita Kalra
Marketing Head, ZapScale
nikita@zapscale.com
Logo: https://mma.prnewswire.com/media/2097823/ZS_Logo.jpg
View original content:
SOURCE ZapScale | https://www.wbrc.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ | 2023-07-31T11:52:25 | 1 | https://www.wbrc.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ |
Pitstick brings product, operations, and value-based care expertise to leading behavioral health provider
SARATOGA SPRINGS, N.Y., July 31, 2023 /PRNewswire/ -- aptihealth, the leading tech-driven behavioral healthcare provider built for higher acuity care, today announced that Regina Pitstick has joined the organization as Senior Vice President of aptihealth Medical Group.
Most recently, Pitstick was VP Advocacy Product & Innovation for the Employer and Individual segment at UnitedHealth Group, where she drove the company's product strategy and vision, focused on delivering a seamless, personalized patient experience. Responsible for product development initiatives, Pitstick's leadership and experience fueled successful long-range strategies, broader market penetration and deeper engagement for over 15M consumers.
"Regina brings more than twenty years of extremely relevant experience in the healthcare industry to aptihealth—including a deep skillset in digital health start-ups, product development, operations, process improvement and value-based care," said Tim Koehler, President and Chief Operating Officer of aptihealth. "Regina's patient-centered approach, insightful understanding of the health care landscape, innovate approach, and impeccable ability to execute strategic initiatives will greatly enhance our medical group. She's ideal for this critical role at aptihealth as we continue to pursue our mission of becoming the nation's preeminent provider of behavioral health services."
Pitstick joins aptihealth at a time of significant growth, having served nearly 15,000 patients for leading national and regional health plans. aptihealth expects to more than double its patients in 2023, with a majority covered by value-based care contracts.
"The value that aptihealth is providing to health plans, physicians groups, health systems and higher-acuity patients simply can't be underestimated," indicated Pitstick. "Whether it's the company's commitment to engaging new patients at any point of care, to their proprietary screening and assessment tools, to their proven ability to improve outcomes and decrease the overall cost of care, it's not hyperbole to state that aptihealth is changing the behavioral healthcare game. I'm thrilled to have the opportunity to help aptihealth continue to improve its care model, meet its strategic goals, and intelligently achieve its considerable opportunities for growth."
About aptihealth
aptihealth is improving higher acuity behavioral healthcare for populations who need it most—one patient at a time. The company's virtual-first model and proprietary screening, assessment, and treatment programs give members fast, convenient access to precise, personalized care. Headquartered in Saratoga Springs and employing over 150, aptihealth has raised over $70 million in funding from leading international private equity firms. The company's care program and data insights are driving breakthroughs in mental health understanding, treatment, outcomes, and cost reduction. Learn more at: www.aptihealth.com.
View original content to download multimedia:
SOURCE aptihealth | https://www.wflx.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ | 2023-07-31T11:52:28 | 0 | https://www.wflx.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ |
BEIJING, July 31, 2023 /PRNewswire/ -- SANY Group ("SANY") has announced the 2023 employee stock ownership plan (ESOP). This is the fourth consecutive year that SANY has launched the ESOP, which gives employees an opportunity to own shares in the company through the setting up of incentive funds. The 2023 ESOP has set up a fund size of around 590 million yuan (USD 82 million) with a share repurchase price planned at 16.13 yuan per share (USD 2.24). The capital will be from the incentive funds accrued following relevant provisions of the group.
SANY has always focused on improving employee benefits and adhering to the principle of "growing together, pursuing common development, and sharing achievements." By establishing a comprehensive incentive and restraining mechanism, it aims to inspire employees' enthusiasm and creativity and align the interests of shareholders, the listed company, and individuals. This encourages all parties to join efforts to boost SANY's long-term development.
SANY's annual ESOP aims to share the fruits of the group's achievements with employees. The number of employees awarded with stock ownership incentives is growing annually, and the proportion of mid-level and key position employees is increasing year by year:
- 2020: SANY awarded 8.31 million shares to 2,264 employees, 71.52 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2021: SANY awarded 7.54 million shares to 4,205 employees, 91.33 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2022: SANY awarded 20.5 million shares to 6,996 employees, 94.26 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2023: SANY is awarding 36.62 million shares to 7,131 employees, 95.69 percent were employees in mid-level management, key positions, and core business (technical) positions.
The source of shares for the 2023 ESOP is the shares that have already been repurchased by SANY's special account. It does not exceed 36.62 million shares in total and is within one percent of SANY's current total capital stock.
In the meantime, SANY Renewable Energy (SH688349) released an announcement relating to exercising of the second exercise period of the 2020 stock option incentive plan, with 16.0368 million granted options to be exercised, with a three-year restricted period. The subsidiary is committed to becoming a global leader of clean energy equipment and services, and contributing to reaching the goals of carbon peaking and carbon neutrality.
View original content to download multimedia:
SOURCE SANY Group | https://www.wflx.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ | 2023-07-31T11:52:34 | 1 | https://www.wflx.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ |
The Avocados From Mexico® Chocolate Dulce De Leche Cupcake will be available at Sprinkles bakeries nationwide for one week beginning July 31
DALLAS, July 31, 2023 /PRNewswire/ -- Talk about a perfect pairing! Avocados From Mexico®, the number one selling avocado brand in the U.S., is making National Avocado Day even better by partnering with renowned dessert bakery chain Sprinkles for a delicious collaboration – a limited-edition cupcake featuring fresh Mexican avocados.
The Avocados From Mexico® Chocolate Dulce De Leche Sprinkles cupcake is a delectable banana cupcake that's studded with pecans and generously filled with a soft dulce de leche core. And to top it all off? A zesty frosting that blends rich cream cheese and chocolate made with fresh Mexican avocados for a delightful, creamy finish.
"The new Avocados From Mexico Chocolate Dulce De Leche cupcake features the highest quality and best-tasting ingredients," said Sprinkles Vice President, Culinary, Charles Craig. "By blending fresh avocado and smooth cream cheese alongside the banana and dulce de leche cupcake, we were able to elevate all the ingredients resulting in a cupcake that is out-of-this world. We can't wait for fans to try it!"
Beginning on July 31, National Avocado Day, consumers can make their week better by enjoying Avocados From Mexico in cupcake form — available at Sprinkles nationwide through August 6.
"Avocados From Mexico make everything better, and we're so proud that our avocados will get to shine in a unique way on National Avocado Day," said Kelly Burke, Director of Brand Marketing at Avocados From Mexico. "Our brand is known for bringing the good times with great tasting avocados. We are excited to partner with a beloved brand like Sprinkles to spark good times in a new way with everyone's favorite sweet treat."
"Sprinkles Cupcakes has always taken an innovative approach to classic desserts, and this new collaboration with Avocados From Mexico is no exception," said Sprinkles CMO, Michelle Wong. "Avocados From Mexico was an obvious choice for their quality and taste, and we can't wait for our guests to discover our latest cupcake, starring this beloved fruit."
To learn more about Avocados From Mexico, visit https://avocadosfrommexico.com, Facebook (facebook.com/avocadosfrommexico), Instagram (@avocadosfrommexico) or Twitter (@AvosFromMexico). #MakeItBetter #AFMxSprinkles
About Avocados From Mexico
Avocados From Mexico is a wholly-owned subsidiary of the Mexican Hass Avocado Importers Association (MHAIA), formed for the purpose of advertising, promotion, public relations and research for all stakeholders of Avocados From Mexico. Under agreements, MHAIA and the Association of Avocado Exporting Producers & Packers of Mexico (APEAM) have combined resources to fund and manage Avocados From Mexico, with the intent to provide a focused, highly- effective and efficient marketing program in the United States. Avocados From Mexico is headquartered in Irving, Texas.
About Sprinkles
Sprinkles offers premium cupcakes, cakes and cookies that are baked fresh in small batches throughout the day and handcrafted with only the finest ingredients. Sprinkles opened its first bakery in Beverly Hills in 2005, drawing long lines of loyal cupcake fans and celebrity endorsements. Sprinkles prides themselves in being passionate innovators and since debuting the world's first Cupcake ATM, the brand has introduced layer cakes, cookies and brownies, launched a national shipping platform and has grown to over 70 bakeries and ATMs coast-to-coast. Sprinkles launched domestic and international franchising in 2022. For additional information on Sprinkles, follow @sprinklescupcakes on social and visit www.sprinkles.com.
CONTACT: Ana Ambrosi, aambrosi@avocadosfrommexico.com
View original content to download multimedia:
SOURCE Avocados From Mexico | https://www.wflx.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ | 2023-07-31T11:52:40 | 1 | https://www.wflx.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ |
SHENZHEN, China, July 31, 2023 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company" or "Taoping"), today announced that the board of directors of the Company approved a one-for-ten reverse stock split of the Company's issued and outstanding ordinary shares, no par value (the "Ordinary Shares"). Beginning August 1, 2023, the Company's Ordinary Shares will be trading on a split-adjusted basis under the same symbol "TAOP" but with new CUSIP number, G8675V 127.
As a result of the share consolidation, each ten Ordinary Shares outstanding will automatically combine and convert to one issued and outstanding Ordinary Share without any action on the part of shareholders who hold their shares in brokerage accounts or "street name". Shareholders holding certificates of Ordinary Shares are expected to receive instructions from the Company's transfer agent, Transhare Corporation, regarding procedures for exchanging share certificates. All outstanding options, warrants and other rights to purchase the Company's Ordinary Shares will be adjusted proportionately as a result of the reverse stock split. No fractional shares will be issued as a result of the reverse stock split, and instead, all such fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share.
The reverse stock split is intended to increase the per share trading price of the Ordinary Shares to satisfy the $1.00 minimum bid price requirement for continued listing on the NASDAQ Stock Market. Following the reverse stock split the Company will have approximately 1.86 million Ordinary Shares issued and outstanding, exclusive of shares issuable under outstanding options and warrants. The reverse stock split will not affect the number of total authorized Ordinary Shares of the Company.
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
Safe Harbor Statement
This press release contains "forward-looking statements" that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, such as statements regarding our estimated future results of operations and financial position, our strategy and plans, and our objectives or goals, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should," or "will" or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by, these forward-looking statements. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including: our potential inability to achieve or sustain profitability or reasonably predict our future results due to our limited operating history of providing smart cloud services, the effects of the global Covid-19 pandemic, the emergence of additional competing technologies, changes in domestic and foreign laws, regulations and taxes, uncertainties related to China's legal system and economic, political and social events in China, the volatility of the securities markets; and other risks including, but not limited to, those that we discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the "SEC") available on the SEC's website at www.sec.gov, including the Company's most recent Annual Report on Form 20-F as well as in our other reports filed or furnished from time to time with the SEC. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.
View original content to download multimedia:
SOURCE Taoping Inc. | https://www.wflx.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ | 2023-07-31T11:52:46 | 1 | https://www.wflx.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ |
This Launch Marks the Latest Expansion of the Brand's Complexion Offerings as it Doubles Down on The Skincare-Meets-Makeup Hybrid Category
NEW YORK, July 31, 2023 /PRNewswire/ -- TULA Skincare, the leading clinically proven probiotic extract powered skincare brand has announced the expansion of its complexion offerings to include concealer.
After learning that TULA's customers were looking for a skin brightening eye treatment along with a concealer, the brand created a state-of-the-art clean skincare-makeup hybrid that delivers skin-boosting benefits with high-performance medium-to-full coverage.
Available in a 20-shade range, the dermatologist-tested, Radiant Skin Brightening Serum Concealer is infused with TULA's unique Rainbow Seabright™ Elixir. This clinically-proven serum-like formula instantly conceals dark circles and discoloration for longwearing, crease-proof results, while brightening the appearance of skin over time. Additional ingredients include TULA's S6Pro Complex® - a US patent pending super six blend of prebiotics and probiotic extracts to help soothe skin, improve skin smoothness and maintain skin balance, along with eye peptides and tea leaf caffeine to help improve the look of dark circles, skin texture, and eye bags. The Radiant Skin Brightening Serum Concealer can be paired with the brand's Radiant Skin Brightening Serum Skin Tint or Filter Primer Blurring & Moisturizing Primer to help build one's complexion wardrobe, or spot conceal for a no-makeup, makeup look.
"Expanding our complexion category to include a concealer was a natural next step for us, especially knowing the strong desire our customers have had for an eye treatment with brightening benefits." said TULA Skincare CEO, Savannah Sachs. " We are excited to have another offering for our glow getters that will surely be a staple in their skincare and beauty routines."
To mark the launch, TULA will be executing a multi-channel launch campaign across its digital platform, and organic social, paid media, and influencer channels. Efforts will include launching a custom "shade finder" on tula.com to help customers find their perfect match concealer shade, highlighting content speaking to the "no-makeup, makeup" and makeup-skincare hybrid trends across TikTok and Instagram, and partnering with a curated set of influencers and providing them with an early access link exclusively for their followers to purchase the concealer prior to launch. In addition to tula.com, the concealer will launch in Ulta Beauty stores nationwide and online and will be featured in an upcoming issue of the Ulta Beauty Magazine, with in-store complexion events planned in the coming months in multiple doors.
TULA's Radiant Skin Brightening Serum Concealer will be available for purchase on July 31 on tula.com, and will retail for $32.
About TULA Skincare
TULA is a doctor-founded skincare brand built on clinically proven formulas powered by probiotic extracts. We believe that the same types of ingredients which are good for your body are also great for your skin. We focus on being healthy, not perfect and on empowering everyone to feel confident in their skin.
Media Contact: Zoe Jeans at Bux + Bewl Communications: zoe@buxandbewl.com
View original content to download multimedia:
SOURCE TULA Skincare | https://www.wflx.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ | 2023-07-31T11:52:53 | 1 | https://www.wflx.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ |
Launch demonstrates companies' commitment to bringing complex generic medicines to the market to help increase patient access
PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application (ANDA) approved by the U.S. Food and Drug Administration (FDA). Breyna, a drug-device combination product, is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD) and will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths.
Viatris Head of North America Jose Cotarelo said: "We are excited to bring Breyna to the U.S. market for the many Americans living with asthma and COPD. This launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain. Being the first to bring an FDA-approved generic version of Symbicort to patients is a true example of how access is the cornerstone of our mission to empower people worldwide to live healthier at every stage of life."
The indications for Breyna include asthma in patients six years of age and older, and the maintenance treatment of airflow obstruction and reducing exacerbations in patients with COPD, including chronic bronchitis and/or emphysema. Breyna is not indicated for the relief of acute bronchospasm. The 160 mcg/4.5 mcg is the only strength indicated for the treatment of COPD. COPD is a term used to describe a certain kind of chronic lung disease and is characterized by breathlessness; it affects more than 16 million Americans. Asthma causes swelling of the airways resulting in difficulty breathing, and approximately 25 million Americans have the chronic condition.
Milton Boyer, CEO of Kindeva Drug Delivery, added: "The launch of Breyna represents a significant milestone as it is the first FDA-approved generic version of Symbicort in the U.S., one of the most prescribed complex drug-device combination products to treat asthma and COPD. We are pleased for Viatris as well as the many Kindeva colleagues who have worked tirelessly to leverage our complex drug-delivery expertise for this important respiratory product — supporting a persistent need to continue bringing more quality medicines for asthma and COPD to patients."
To further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply. The program offers $30/month or up to $360 per year with 12 refills annually. The program will be available in August.
About Breyna
Breyna is indicated for the treatment of asthma in patients 6 years and older not adequately controlled on a long-term asthma-control medication such as an inhaled corticosteroid (ICS) or whose disease warrants initiation of treatment with both an ICS and long-acting beta2-adrenergic agonists (LABA). Breyna 160 mcg/4.5 mcg dosage is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, and Breyna 160 mcg/4.5 mcg is also indicated to reduce exacerbations of COPD. Breyna is NOT indicated for the relief of acute bronchospasm.
Important Safety Information
Breyna is contraindicated in the primary treatment of status asthmaticus or other acute episode of asthma or COPD where intensive measures are required, and in hypersensitivity to any of the ingredients in Breyna. Use of long-acting beta2-adrenergic agonists (LABA) as monotherapy (without inhaled corticosteroids [ICS]) for asthma is associated with an increased risk of asthma-related death. Available data from controlled clinial trials also suggest that use of LABA as monotherapy increases the risk of asthma-related hospitalization in pediatric and adolescent patients. These findings are considered a class effect of LABA. When LABA are used in fixed dose combination with ICS, data from large clinical trials do not show a significant increase in the risk of serious asthma-related events (hospitalizations, intubations, death) compared to ICS alone. Breyna is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms. Breyna should not be initiated in patients during rapidly deteriorating episodes of asthma or COPD. Patients who are receiving Breyna should not use additional formoterol or other LABA for any reason. Localized infections of the mouth and pharynx with Candida albicans has occurred in patients treated with Breyna. Patients should rinse the mouth after inhalation of Breyna. Lower respiratory tract infections, including pneumonia, have been reported following the administration of ICS. Due to possible immunosuppression, potential worsening of infections could occur. A more serious or even fatal course of chickenpox or measles can occur in susceptible patients. It is possible that systemic corticosteroid effects such as hypercorticism and adrenal suppression may occur, particularly at higher doses. Particular care is needed for patients who are transferred from systemically active corticosteroids to ICS. Deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available ICS. Caution should be exercised when considering administration of Breyna in patients on long-term ketoconazole and other known potent CYP3A4 inhibitors. As with other inhaled medications, paradoxical bronchospasm may occur with Breyna. Immediate hypersensitivity reactions may occur, as demonstrated by cases of urticaria, angioedema, rash, and bronchospasm. Excessive beta-adrenergic stimulation has been associated with central nervous system and cardiovascular effects. Breyna should be used with caution in patients with cardiovascular disorders especially coronary insufficiency, cardiac arrhythmias, and hypertension. Long-term use of ICS may result in a decrease in bone mineral density (BMD Assessment of BMD is recommended prior to initiating Breyna and periodically thereafter. ICS may result in a reduction in growth velocity when administered to pediatric patients. Glaucoma, increased intracolular pressure, and cataracts have been reported following the administration of ICS, including budesonide, a component of Breyna. Close monitoring for glaucoma and cataracts is warranted in patients with a change in vision or history of increased intraocular pressure. In rare cases, patients on ICS may present with systemic eosinophilic conditions. Breyna should be used with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, and in patients who are unusually responsive to sympathomimetic amines. The most common adverse reactions ≥3% reported in asthma clinical trials included nasopharyngitis, headache, upper respiratory tract infection, pharyngolaryngeal pain, sinusitis, influenza, back pain, nasal congestion, stomach discomfort, vomiting, and oral candidiasis. The most common adverse reactions ≥3% reported in COPD clinical trials included nasopharyngitis, oral candidiasis, bronchitis, sinusitis, and upper respiratory tract infection. Breyna should be administered with caution to patients being treated with MAO inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents. Beta-blockers may not only block the pulmonary effect of beta-agonists, such as formoterol, but may produce severe bronchospasm in patients with asthma. ECG changes and/or hypokalemia associated with nonpotassium-sparing diuretics may worsen with concomitant beta-agonists. Use caution with the coadministration of Breyna.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
About Kindeva Drug Delivery
Kindeva Drug Delivery is a global contract development manufacturing organization focused on drug-device combination products. Kindeva Drug Delivery develops and manufactures products across a broad range of complex drug-delivery formats, including injectables (autoinjector, intradermal, microneedle), pulmonary & nasal, and transdermal patches. Its service offering spans early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Kindeva Drug Delivery serves a global client base from its nine manufacturing and research and development facilities located in the U.S. and U.K. For more information, please visit www.kindevadd.com.
Forward-Looking Statements
This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements that the launch of Breyna demonstrates the companies' commitment to bringing complex generic medicines to the market to help increase patient access; Breyna will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths; this launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain; to further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply; and, the program will be available in August. Factors that could cause or contribute to such differences include, but are not limited to: the possibility that the Company may be unable to realize the intended benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with acquisitions, divestitures, or its global restructuring program, within the expected timeframe or at all; impairment charges or other losses related to the divestiture or sale of businesses or assets; the Company's failure to achieve expected or targeted future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by COVID-19; actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris' ability to bring new products to market, including but not limited to "at-risk" launches; Viatris' or its partners' ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings; any significant breach of data security or data privacy or disruptions to our information technology systems; risks associated with international operations; the ability to protect intellectual property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes in Viatris' or its partners' customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; failure to execute stock repurchases consistent with current expectations; stock price volatility; and the other risks described in Viatris' filings with the Securities and Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC's Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this release other than as required by law.
View original content to download multimedia:
SOURCE Viatris Inc. | https://www.wflx.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ | 2023-07-31T11:52:59 | 1 | https://www.wflx.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ |
New nuclear unit now serving customers with clean, reliable energy 24/7
ATLANTA, July 31, 2023 /PRNewswire/ -- Georgia Power declared today that Plant Vogtle Unit 3 has entered commercial operation and is now serving customers and the State of Georgia. The new unit represents a long-term investment in the state's clean energy future and will provide reliable, emissions-free energy to customers for decades to come.
"The Plant Vogtle 3 & 4 nuclear expansion is another incredible example of how Georgia Power is building a reliable and resilient energy future for our state," said Kim Greene, chairman, president and CEO of Georgia Power. "It is important that we make these kinds of long-term investments and see them through so we can continue providing clean, safe, reliable and affordable energy to our 2.7 million customers. Today's achievement is a testament to our commitment to doing just that, and it marks the first day of the next 60 to 80 years that Vogtle Unit 3 will serve our customers with clean, reliable energy."
Vogtle Unit 3 is the first newly-constructed nuclear unit in the U.S. in over 30 years and can power an estimated 500,000 homes and businesses. Once all four units are online, the Plant Vogtle site will be the largest generator of clean energy in the nation and support continued growth in Georgia as more industries, businesses and families come to the state.
"Today is a historic day for the State of Georgia, Southern Company, and the entire energy sector, as we continue transforming the way we power the lives of millions of Americans," said Chris Womack, president and CEO of Southern Company. "With Unit 3 completed, and Unit 4 in the final stages of construction and testing, this project shows just how new nuclear can and will play a critical role in achieving a clean energy future for the United States. Bringing this unit safely into service is a credit to the hard work and dedication of our teams at Southern Company and the thousands of additional workers who have helped build that future at this site, as well as all of the partners who have helped make this day a reality."
Nuclear energy is the only zero-emission baseload energy source available today, offering high reliability, and efficient operations around the clock. Nuclear energy currently provides approximately 25% of Georgia Power's overall energy mix, including the existing units at Plant Vogtle and Georgia's other nuclear facility at Plant Hatch in Baxley, Georgia.
"The Vogtle expansion is an American energy success story and would not be possible without the support of strong public and private partners like our partners at North America's Building Trades Unions," said Tom Fanning, chairman of the Board of Directors for Southern Company. "We continue to appreciate their support and those who have stood with us at the local, state and federal levels to complete this new clean energy source to serve electric customers. Providing leadership in our industry and a commitment to safety and quality are in Southern Company's DNA. Today's milestone at the Vogtle expansion site underscores this legacy, and I couldn't be prouder of the dedication our teams have shown in seeing Unit 3 through to completion."
The final stages of construction and testing continue at Vogtle Unit 4, with the unit projected to be placed in service during the late fourth quarter 2023 or the first quarter of 2024. The unit completed hot functional testing in May, in significantly less time than Unit 3 as the team continues leveraging best practices and learnings from the earlier unit. The Vogtle site has also received nuclear fuel for Unit 4, with a total of 157 fuel assemblies necessary for the safe and reliable startup of the unit.
Also, last week, Georgia Power announced the receipt of the 103(g) finding from the Nuclear Regulatory Commission (NRC) for Vogtle Unit 4. This finding was confirmed in an official letter received by Southern Nuclear and signifies that the new unit has been constructed and will be operated in conformance with the Combined License and NRC regulations. No further NRC findings are necessary in order for Southern Nuclear to load fuel or begin the startup sequence for the new unit.
The new Vogtle units are an essential part of Georgia Power's commitment to delivering clean, safe, reliable and affordable energy to its 2.7 million customers. Southern Nuclear will operate the new units on behalf of the co-owners: Georgia Power, Oglethorpe Power, MEAG Power and Dalton Utilities.
About Georgia Power
Georgia Power is the largest electric subsidiary of Southern Company (NYSE: SO), America's premier energy company. Value, Reliability, Customer Service and Stewardship are the cornerstones of the company's promise to 2.7 million customers in all but four of Georgia's 159 counties. Committed to delivering clean, safe, reliable and affordable energy, Georgia Power maintains a diverse, innovative generation mix that includes nuclear, coal and natural gas, as well as renewables such as solar, hydroelectric and wind. Georgia Power focuses on delivering world-class service to its customers every day and the company is recognized by J.D. Power as an industry leader in customer satisfaction. For more information, visit www.GeorgiaPower.com and connect with the company on Facebook (Facebook.com/GeorgiaPower), Twitter (Twitter.com/GeorgiaPower) and Instagram (Instagram.com/ga_power).
Cautionary Note Regarding Forward-Looking Statements
Certain information contained in this release is forward-looking information based on current expectations and plans that involve risks and uncertainties. Forward-looking information includes, among other things, statements concerning the projected in-service date for Plant Vogtle Unit 4 and the future operations of Plant Vogtle Units 3 and 4. Georgia Power cautions that there are certain factors that can cause actual results to differ materially from the forward-looking information that has been provided. The reader is cautioned not to put undue reliance on this forward-looking information, which is not a guarantee of future performance and is subject to a number of uncertainties and other factors, many of which are outside the control of Georgia Power; accordingly, there can be no assurance that such suggested results will be realized. The following factors, in addition to those discussed in Georgia Power's Annual Report on Form 10-K for the year ended December 31, 2022, and subsequent securities filings, could cause actual results to differ materially from management expectations as suggested by such forward-looking information: the ability to control costs and avoid cost and schedule overruns during the development, construction, and operation of facilities or other projects, including Plant Vogtle Unit 4, which includes components based on new technology that only within the last few years began initial operation in the global nuclear industry at this scale, due to current and/or future challenges which include, but are not limited to, changes in labor costs, availability and productivity, challenges with the management of contractors or vendors, subcontractor performance, adverse weather conditions, shortages, delays, increased costs, or inconsistent quality of equipment, materials, and labor, contractor or supplier delay, the impacts of inflation, delays due to judicial or regulatory action, nonperformance under construction, operating, or other agreements, operational readiness, including specialized operator training and required site safety programs, engineering or design problems or any remediation related thereto, design and other licensing-based compliance matters, challenges with start-up activities, including major equipment failure, or system integration, and/or operational performance, continued challenges related to the COVID-19 pandemic or future pandemic health events, continued public and policymaker support for projects, environmental and geological conditions, delays or increased costs to interconnect facilities to transmission grids, and increased financing costs as a result of changes in market interest rates or as a result of project delays; the ability to overcome or mitigate the current challenges, or challenges yet to be identified, at Plant Vogtle Unit 4, that could further impact the cost and schedule for the project; legal proceedings and regulatory approvals and actions related to construction projects, such as Plant Vogtle Unit 4, including Georgia Public Service Commission approvals and U.S. Nuclear Regulatory Commission ("NRC") actions; under certain specified circumstances, a decision by holders of more than 10% of the ownership interests of Plant Vogtle Unit 3 and 4 not to proceed with construction; the notices of tender by Oglethorpe Power Corporation and the City of Dalton of a portion of their ownership interests in Plant Vogtle Units 3 and 4 to Georgia Power, including related litigation; the ability to construct facilities in accordance with the requirements of permits and licenses (including satisfaction of NRC requirements), to satisfy any environmental performance standards and the requirements of tax credits and other incentives, and to integrate facilities into the Southern Company system upon completion of construction; the inherent risks involved in operating and constructing nuclear generating facilities; the ability of counterparties of Georgia Power to make payments as and when due and to perform as required; the direct or indirect effect on Georgia Power's business resulting from cyber intrusion or physical attack and the threat of cyber and physical attacks; catastrophic events such as fires, earthquakes, explosions, floods, tornadoes, hurricanes and other storms, droughts, pandemic health events, political unrest, wars or other similar occurrences; the potential effects of the continued COVID-19 pandemic; and the direct or indirect effects on Georgia Power's business resulting from incidents affecting the U.S. electric grid or operation of generating or storage resources. Georgia Power expressly disclaim any obligation to update any forward–looking information.
View original content to download multimedia:
SOURCE Georgia Power | https://www.wflx.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ | 2023-07-31T11:53:06 | 1 | https://www.wflx.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ |
- Revenue of RMB9,908 Million in the Second Quarter, Up 6.7% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 39.5% - Revenue of RMB18,871 Million in the First Half, Up 6.3% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 27.9% - Net Profit Attributable to Owners of the Company for the First Half Increased 14.6% to RMB 5,313 Million
- Diluted Earnings per Share (EPS) for the First Half Increased 20.9% to RMB1.79
- Adjusted Non-IFRS Net Profit Attributable to Owners of the Company for the First Half Increased 18.5% to RMB5,095 Million
- Adjusted Non-IFRS Diluted EPS for the First Half Increased 18.5% to RMB1.73[1]
- Free Cash Flow Achieved RMB2,926 Million for the First Half, Turned Positive and Grew Strongly
SHANGHAI, July 31, 2023 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its financial results for the first half ending June 30, 2023 ("Reporting Period").
This release provides a summary of the results and is not intended to be a comprehensive report. For additional information, please refer to the 2023 Interim Report and other relevant announcements published on the websites of the Shanghai Stock Exchange (www.sse.com.cn) and the Stock Exchange of Hong Kong (www.hkexnews.hk), and the designated media for dissemination of the relevant information. Investors are advised to exercise caution and be aware of the investment risks in trading Company shares.
All financial information disclosed in this press release is prepared based on International Financial Reporting Standards (IFRS), in currency of RMB.
The 2023 Interim Report of the Company has not been audited.
Second Quarter 2023 Financial Highlights
Revenue grew 6.7% year-over-year to RMB9,908 million, excluding COVID-19 commercial projects, revenue grew strongly by 39.5%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 2.6% year-over-year to RMB7,034 million, excluding COVID-19 commercial projects, revenue grew strongly by 51.6%. Adjusted non-IFRS gross profit grew 12.9% year-over-year to RMB3,216 million, with a gross profit margin of 45.7%.
- WuXi Testing revenue grew 23.6% year-over-year to RMB1,638 million and adjusted non-IFRS gross profit grew 36.2% year-over-year to RMB640 million, with a gross profit margin of 39.1%.
- WuXi Biology revenue grew 17.5% year-over-year to RMB656 million and adjusted non-IFRS gross profit grew 21.3% year-over-year to RMB 271 million, with a gross profit margin of 41.4%.
- WuXi ATU revenue grew 22.9% year-over-year to RMB389 million and adjusted non-IFRS gross profit was RMB(16) million, with a gross profit margin of (4.2)%
- WuXi DDSU revenue declined 17.9% year-over-year to RMB176 million and adjusted non-IFRS gross profit grew year-over-year 5.2% to RMB63 million, with a gross profit margin of 35.8%. Meanwhile, we received the first royalty income from customers in the second quarter, which is a breakthrough for DDSU.
Unit: RMB million
- IFRS gross profit increased 18.1% year-over-year to RMB4,030 million. Gross profit margin was 40.7%[2]
- Adjusted non-IFRS gross profit increased 16.4% year-over-year to RM4,177 million. Adjusted non-IFRS gross margin was 42.2%.
- Net profit attributable to owners of the Company increased 5.1% year-over-year to RMB3,145 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 22.4% year-over-year to RMB2,753 million.
First-Half 2023 Financial Highlights
Revenue grew 6.3% year-over-year to RMB18,871 million, excluding COVID-19 commercial projects, revenue grew strongly by 27.9%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 3.8% year-over-year to RMB13,467 million, excluding COVID-19 commercial projects, revenue grew strongly by 36.1%. Adjusted non-IFRS gross profit grew 14.9% year-over-year to RMB6,103 million, with a gross profit margin of 45.3%.
- WuXi Testing revenue grew 18.7% year-over-year to RMB3,091 million and adjusted non-IFRS gross profit grew 26.1% year-over-year to RMB1,168 million, with a gross profit margin of 37.8%.
- WuXi Biology revenue grew 13.0% year-over-year to RMB1,233 million and adjusted non-IFRS gross profit grew 15.1% year-over-year to RMB511 million, with a gross profit margin of 41.5%.
- WuXi ATU revenue grew 16.0% year-over-year to RMB714 million and adjusted non-IFRS gross profit was RMB(40) million, with a gross profit margin of (5.7)%.
- WuXi DDSU revenue declined 24.9% year-over-year to RMB342 million and adjusted non-IFRS gross profit declined 26.2% year-over-year to RMB103 million, with a gross profit margin of 30.1%. Meanwhile, DDSU achieved a breakthrough in receiving the first royalty income from customers.
Unit: RMB million
- IFRS gross profit increased 17.6% year-over-year to RMB7,556 million. Gross profit margin was 40.0%[3].
- Adjusted non-IFRS gross profit increased 15.7% year-over-year to RMB7,855 million. Adjusted non-IFRS gross margin was 41.6%.
- Net profit attributable to owners of the Company increased 14.6% year-over-year to RMB 5,313 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year to RMB5,095 million.
- Diluted EPS increased 20.9% year-over-year to RMB1.79, while adjusted diluted non-IFRS EPS increased by 18.5% year-over-year to RMB1.73.
- Free cash flow achieved RMB2,926 million, turned positive and grew strongly year-over-year.
First-Half 2023 Business Operation Highlights
- As an industry innovation enabler, we grow together with our customers. In the first half of 2023, we added over 600 new customers, and in total we served more than 6,000 active customers over the past 12 months. Backlog grew 25% year-over-year excluding COVID-19 commercial projects. We continued to optimize our cross-platform synergies to better serve our customers worldwide, strengthen our unique competitive advantage as a fully integrated Contract Research, Development and Manufacturing Organization (CRDMO) and Contract Testing, Development and Manufacturing Organization (CTDMO) platform, and provide one-stop services for our customers from discovery to development and manufacturing. The diversified revenue streams from customers across regions ensure the stability and resilience of the Company's financial performance.
- WuXi Chemistry: Integrated CRDMO Business Model Drives Steady Growth, with Continued Expansion in New Modalities (WuXi TIDES)
- In the past 12 months, we successfully synthesized and delivered more than 420,000 new compounds to customers, which grew 20% year-over-year. Through our chemistry drug discovery services, we enabled our customers to accelerate their research while generating opportunities for our downstream business units. In the past 12 months, 120 molecules have transitioned from R to D&M, representing a year-on-year growth of 21%. Through our "follow-the-customer" and "follow-the-molecule" strategies, we established trusted partnerships with our global customers, supporting the sustainable growth of our CRDMO business.
- We continued executing our "long-tail" strategy. Demand from "long-tail" customers in discovery services of small molecule and new modalities continued to grow, with the number of new customers growing 17% year-over-year.
- In the first half of 2023, D&M services revenue grew 2.1% year-over-year to RMB9.67 billion. Excluding COVID-19 commercial projects, D&M services revenue grew strongly by 54.5%.
- In the first half of 2023, we added 583 molecules to our D&M pipeline. To date, our D&M pipeline consists of 2,819 molecules, including 56 commercial projects, 59 in phase III, 301 in phase II and 2,403 in phase I and pre-clinical stages, among which, 8 commercial and phase III projects were added in the first half of 2023.
- In the first half of 2023, TIDES revenue grew 37.9% year-over-year to RMB1.33 billion. As of June 30, 2023, backlog of TIDES grew strongly by 188% year-over-year. We expect revenue growth from TIDES business to exceed 70% in 2023.
- The number of TIDES D&M customers increased 25% year-over-year to 121, and the number of TIDES molecules increased 46% year-over-year to 207.
- WuXi Testing: Lab Testing Services Drive Steady Growth, Clinical Business Fully Recovered
- The Company provides a full range of laboratory testing services for our customers, including drug metabolism and pharmacokinetics (DMPK), toxicology, and bioanalysis for drug development testing, as well as medical device testing. We provide customers with high-quality services, realize "one report for global submission," and enable customers to save time, reduce costs and increase efficiency.
- H1 2023 revenue from drug safety evaluation services grew 24% year-over-year. We maintained our industry leadership position in Asia Pacific for drug safety evaluation services that meet global regulatory requirements. In the first half of 2023, new lab testing facilities in Qidong and Suzhou began operations as scheduled, ensuring the business growth to accelerate in the second half of 2023.
- Moreover, we continued to enhance capabilities related to new modalities, with comprehensive coverage such as target protein degradation, nucleic acids, conjugates, and cell and gene therapies (CGT), etc.
- SMO revenue grew strongly by 53.9% in Q2 2023 and 34.3% in H1 2023, maintaining a leadership position in China. In the first half of 2023, SMO supported 25 new drug approvals for customers.
- In the first half of 2023, clinical CRO enabled our customers to obtain 8 IND approvals and submit 3 NDA filings.
- WuXi Biology: Strong Contribution from New Modalities; Early Discovery Screening Platform Continued to Generate Downstream Opportunities
- WuXi ATU: CTDMO Business Model Drives Growth
- WuXi DDSU: the First Year to Receive New Drug Application (NDA) Approval of New Drugs Developed for Customers; Breakthrough to Receive the First Royalty Income
Our Commitment to ESG
As an industry innovation enabler, a trusted partner and a contributor to the global healthcare industry, the Company is committed to environmental protection and sustainability, and to being a good global corporate citizenship.
Our outstanding ESG performance has been recognized by major global ESG rating agencies, including MSCI, S&P Global, Sustainalytics, CDP and EcoVadis. In June 2023, we received the fourth "Silver" medal recognition from EcoVadis for our Couvet site in Switzerland.
By the first half of 2023, our carbon emission intensity, energy consumption intensity and water use intensity reduced by 20.1%, 18.4%, and 31.6%, respectively, as compared to the baseline year 2020.
As we continue to advance our sustainability strategy, we embrace our shared responsibility to be good stewards of the environment.
Management Comment
Dr. Ge Li, Chairman and CEO of WuXi AppTec, said, "We continued to achieve steady growth of revenue, net profit, and free cash flow in the first half of 2023. Our revenue increased 6.3% year-over-year to RMB18.87 billion, or 27.9% if excluding COVID-19 commercial projects. Our adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year, outpacing the revenue growth rate, and our free cash flow achieved RMB2.93 billion, as a result of the Company's pursuit of operational excellence and productivity."
"The Company's performance in the first half of 2023 demonstrated that WuXi AppTec's unique CRDMO and CTDMO business models can effectively meet the growing demands from customers worldwide and continue to drive solid growth for the Company. In 2023, we aim to deliver a 5-7% revenue growth, increase adjusted non-IFRS gross profit by 13-14%, and expand free cash flow by 750-850%. We remain committed to prioritizing our customers' needs and enhancing our capacity and capabilities as we support our customers' efforts to bring groundbreaking therapies to patients around the world. Together, we can realize our vision that 'every drug can be made and every disease can be treated'."
About WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com
Forward-Looking Statements
This press release may contain certain "forward-looking statements" which are not historical facts, but instead are predictions about future events based on our beliefs as well as assumptions made by and information currently available to our management. Although we believe that our predictions are reasonable, future events are inherently uncertain and our forward-looking statements may turn out to be incorrect. Our forward-looking statements are subject to risks relating to, among other things, the ability of our service offerings to compete effectively, our ability to meet timelines for the expansion of our service offerings, our ability to protect our customers' intellectual property, unforeseeable international tension, competition, the impact of emergencies and other force majeure. Our forward-looking statements in this press release speak only as of the date on which they are made, and we assume no obligation to update any forward-looking statements except as required by applicable law or listing rules. Accordingly, you are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. All forward-looking statements contained herein are qualified by reference to the cautionary statements set forth in this section. All information provided in this press release is as of the date of this press release and are based on assumptions that we believe to be reasonable as of this date, and we do not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Use of Non-IFRS and Adjusted Non-IFRS Financial Measures
We provide non-IFRS gross profit and non-IFRS net profit attributable to owners of the Company, which exclude share-based compensation expenses, issuance expenses of convertible bonds, fair value gain or loss from derivative component of convertible bonds, foreign exchange-related gains or losses, amortization of intangible assets acquired in business combinations, non-financial assets impairment, etc. We also provide adjusted non-IFRS net profit attributable to owners of the Company and earnings per share, which further exclude realized and unrealized gains or losses from our venture capital investments and joint ventures. Neither is required by, or presented in accordance with IFRS.
We believe that the adjusted financial measures used in this press release are useful for understanding and assessing our core business performance and operating trends, and we believe that management and investors may benefit from referring to these adjusted financial measures in assessing our financial performance by eliminating the impact of certain unusual, non-recurring, non-cash and non-operating items that we do not consider indicative of the performance of our core business. Such adjusted non-IFRS net profit attributable to owners of the Company, the management of the Company believes, is widely accepted and adopted in the industry the Company is operating in. However, the presentation of these adjusted non-IFRS financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with IFRS. You should not view adjusted results on a stand-alone basis or as a substitute for results under IFRS, or as being comparable to results reported or forecasted by other companies.
For more information, please contact:
Ms. Ruijia Tang (for investors)
IR Director
Email: tang_ruijia@wuxiapptec.com
Mr. Davy Wu (for media)
PR Director
Email: davy_wu@wuxiapptec.com
View original content:
SOURCE WuXi AppTec | https://www.wflx.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ | 2023-07-31T11:53:12 | 0 | https://www.wflx.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ |
GUANGZHOU, China, July 31, 2023 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that it has published its 2022 Environmental, Social and Governance ("ESG") report, outlining the Company's progress and performance in key ESG areas.
The report provides a comprehensive review of Yatsen's ESG initiatives and developments, including corporate governance, research and development, employee rights protection, human capital development, environmental sustainability and social responsibility, among others.
To view the report in full, please visit the ESG section on the Yatsen Investor Relations website. Alternatively, please click here for the English version and here for the Chinese version of the 2022 report.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the mission of creating an exciting new journey of beauty discovery for consumers around the world. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands, including Perfect Diary, Little Ondine, Abby's Choice, Galénic, DR.WU (its mainland China business), Eve Lom, Pink Bear and EANTiM. The Company's flagship brand, Perfect Diary, is one of the leading color cosmetics brands in China in terms of retail sales value. The Company primarily reaches and engages with customers directly, both online and offline, with an expansive presence across all major e-commerce, social and content platforms in China.
For more information, please visit http://ir.yatsenglobal.com/.
For investor and media inquiries, please contact:
In China:
Yatsen Holding Limited
Investor Relations
E-mail: ir@yatsenglobal.com
The Piacente Group, Inc
Hui Fan
Tel: +86-10-6508-0677
E-mail: yatsen@thepiacentegroup.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: yatsen@thepiacentegroup.com
View original content:
SOURCE Yatsen Holding Limited | https://www.wflx.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ | 2023-07-31T11:53:18 | 0 | https://www.wflx.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ |
Leveraging artificial intelligence, Mumbai-based IT services firm Yodaplus is catalyzing industry transformations, from nutraceuticals to retail, by streamlining business operations and boosting decision-making capabilities.
MUMBAI, India, July 31, 2023 /PRNewswire/ -- Yodaplus, a Mumbai-based IT services firm, is at the forefront of empowering organizations worldwide with advanced technological capabilities. Today, the company sheds light on the evolving global landscape of Artificial Intelligence (AI) and its growing adoption within its service portfolio.
With its wide range of services and deep industry knowledge, Yodaplus has been a game changer – enabling organizations to focus on their core operations and achieve sustainable growth. And now, by integrating AI into services, Yodaplus helps businesses navigate the complex digital transformation landscape more efficiently, creating a competitive edge.
AI continues to transform business operations globally, powering automation, analytics, decision-making, and enhancing user experiences. This ultimately delivers safer and more effective products to meet the growing global demand.
Yodaplus is known for its expansive roster of clients - from development banks and blockchain companies to EdTech startups and HRMS providers. With such a diverse clientele, embracing AI is more necessary than a choice, and Yodaplus has promptly addressed this need.
"As we navigate the digital age, the integration of AI into our service offerings has become an undeniable necessity," commented Vishrut Srivastava, MD, Yodaplus. "AI is here to stay, poised to make our lives more efficient and free mankind from the burden of mundane tasks. At Yodaplus, we are committed to embracing AI to drive growth and innovation for our clients while we continue to explore new horizons in this transformative technological landscape."
In line with this commitment, Yodaplus has developed an AI engine transforming the global nutraceutical supply chain. Addressing the complexities of generating differentiated nutraceutical label claims necessitates a well-mapped global database and the application of AI. To solve this problem, Yodaplus developed an AI-driven smart labels function via the NutrifyGenie AI engine.
NutrifyGenie uses sophisticated algorithms that facilitate simplified and precise decision-making, authenticating label claim validation and enabling real-time regulatory compliance. This feature provides users with pre-made labels, including correct dosage values for nutraceutical products, significantly expediting product development.
Enabling companies to effortlessly commercialize their innovations in essential markets fulfills the continuously increasing demand for nutraceutical products. As the nutraceutical industry continues to grow, Yodaplus's AI engine will play a crucial role in accelerating the new product development process and helping businesses bring innovative and differentiated products to market faster than ever before.
Not just that, the company has also recently deployed advanced invoice parsing for a retail giant. This smart solution facilitates operations by accurately extracting and collating relevant information from invoices, thus automating a previously laborious task. Furthermore, Yodaplus uses sophisticated AI tools to assist an asset management client in conducting comprehensive financial records analysis, rendering them outstanding financial decision-making capabilities.
About Yodaplus
An ever-evolving, highly specialized technology solutions company, Yodaplus offers an array of services designed to address the unique needs of businesses globally, extending beyond its Mumbai base to the US, UK, UAE, and Singapore. The company's mission, steered by MD Vishrut Srivastava, is dedicated to providing top-tier IT services and aims to propel businesses toward unprecedented growth and success. With this commitment, Yodaplus becomes your duly trusted tech partner.
For more information about Yodaplus, please visit www.yodaplus.com.
Press Contact:
Amit Pareek
Senior Marketing Manager
amitp@yodaplus.com
Photo: https://mma.prnewswire.com/media/2163861/Vishrut_Srivatava_MD_Yodaplus.jpg
Logo: https://mma.prnewswire.com/media/2144978/4185052/Yodaplus_Logo.jpg
View original content:
SOURCE Yodaplus Technologies | https://www.wflx.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ | 2023-07-31T11:53:24 | 1 | https://www.wflx.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ |
The cutting-edge platform empowers B2B SaaS start-ups to reduce churn, increase upsell, and boost NRR
WILMINGTON, Del., July 31, 2023 /PRNewswire/ -- ZapScale, a new-age customer success platform, is making waves in the industry by offering an unrivalled one-day onboarding experience along with the ability to track 150 customer data points for a comprehensive 360-degree view of customer health. This ground-breaking feature sets ZapScale apart from its competitors.
The secret behind ZapScale's lightning-fast onboarding lies in its comprehensive toolkit. With a robust framework of 40 pre-built KPI-based health frameworks, 60 pre-designed playbooks to automate CS ops, and seamless native integrations with all popular tools, ZapScale empowers businesses to gain complete visibility over customer data. With deep customer health insights, ZapScale's customers have seen an improvement in retention and increase in upsell opportunities.
Manasij Ganguli, Founder and CEO of ZapScale, shares his personal motivation for creating this game-changing platform: "ZapScale was born out of my passion to empower B2B SaaS start-ups with an efficient and effective CS platform. Having faced numerous customer success challenges in my previous start-up, which I successfully sold in 2019, I realized the critical need for a solution that could streamline, optimize, and accelerate CS operations.
For small to mid-sized businesses that have limited time and resources, implementing a CS platform has historically been a daunting task, taking weeks, if not months, to set up essential elements like customer health, playbooks, and integrations. ZapScale has addressed this challenge by offering a user-friendly and efficient implementation process, eliminating waste of time and resources. Now, businesses can seamlessly focus on their customers right from day 1."
ZapScale eliminates the traditional barriers and time-consuming processes associated with implementing CS platforms using key in-built features that facilitate custom mapping, support custom fields, and require no unique key to integrate applications, ensuring a tailored yet quick integration experience.
ZapScale is swiftly gaining traction in the market, with 30+ global companies already using the customer success platform. Starting at $249 per month, with a one-month free trial, ZapScale is helping businesses significantly improve their customer success initiatives.
For more information about ZapScale and to schedule a demo, visit www.zapscale.com.
Contact:
Nikita Kalra
Marketing Head, ZapScale
nikita@zapscale.com
Logo: https://mma.prnewswire.com/media/2097823/ZS_Logo.jpg
View original content:
SOURCE ZapScale | https://www.wflx.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ | 2023-07-31T11:53:31 | 0 | https://www.wflx.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ |
China imposes curbs on drone exports, citing Ukraine and concern about military use
By JOE McDONALD
AP Business Writer
BEIJING (AP) — China has imposed restrictions on exports of long-range civilian drones, citing Russia’s war on Ukraine and concern drones might be converted to military use. Chinese leader Xi Jinping’s government is friendly with Moscow but says it is neutral in the 18-month-old war. It has been stung by reports both sides might be were using Chinese-made drones for reconnaissance and possibly attacks. The Ministry of Commerce said controls take effect Tuesday to prevent use of drones for “non-peaceful purposes.” It said exports still will be allowed but didn’t say what restrictions would apply. China is a leading developer and exporter of drones. | https://kion546.com/ap-colorado/2023/07/31/china-imposes-curbs-on-drone-exports-citing-ukraine-and-concern-about-military-use/ | 2023-07-31T11:53:36 | 0 | https://kion546.com/ap-colorado/2023/07/31/china-imposes-curbs-on-drone-exports-citing-ukraine-and-concern-about-military-use/ |
Elvina Kalieva 2023 Livesport Prague Open 2021 Odds
Elvina Kalieva's round of 32 match in the Livesport Prague Open 2021 will be versus Linda Noskova. Kalieva is +4000 to win this tournament at Tennis Club Sparta Praha.
Find all the latest odds for the 2023 Livesport Prague Open 2021 and place your bets with a new user bonus from BetMGM.
Kalieva at the 2023 Livesport Prague Open 2021
- Next Round: Round of 32
- Tournament Dates: July 28 - August 6
- Venue: Tennis Club Sparta Praha
- Location: Prague, Czechia
- Court Surface: Hard
Watch live sports without cable! Sign up today for a free trial to Fubo!
Kalieva's Next Match
Kalieva will meet Noskova in the round of 32 on Tuesday, August 1 at 5:00 AM ET, after getting past Tayisiya Morderger 6-2, 6-3 in the qualification final.
Kalieva is listed at +375 to win her next matchup against Noskova. Check out the latest odds for the entire field at BetMGM.
Want to bet on Kalieva? Head to BetMGM using our link for a bonus bet special offer for new players!
Kalieva Stats
- Kalieva defeated Morderger 6-2, 6-3 on Sunday in the qualifying round.
- In five tournaments over the past year, Kalieva is yet to win a title, and her overall record is 3-5.
- Kalieva has a record of 2-3 on hard courts over the last 12 months.
- In her eight matches over the past year, across all court surfaces, Kalieva has averaged 18.6 games.
- On hard courts, Kalieva has played five matches over the past 12 months, and she has totaled 20.8 games per match while winning 49.0% of games.
- Over the past year, Kalieva has been victorious in 12.5% of her return games and 28.6% of her service games.
- Kalieva has claimed 50% of her service games on hard courts and 11.1% of her return games over the past 12 months.
Not all offers available in all states, please visit BetMGM for the latest promotions for your area. Must be 21+ to gamble, please wager responsibly. If you or someone you know has a gambling problem, contact 1-800-GAMBLER.
© 2023 Data Skrive. All rights reserved. | https://www.wflx.com/sports/betting/2023/07/28/elvina-kalieva-livesport-prague-open-2021-betting-odds/ | 2023-07-31T11:53:37 | 0 | https://www.wflx.com/sports/betting/2023/07/28/elvina-kalieva-livesport-prague-open-2021-betting-odds/ |
Dispute over Persian Gulf gas field poses early challenge to Saudi-Iranian rapprochement
By NICK EL HAJJ
Associated Press
DUBAI, United Arab Emirates (AP) — An escalating dispute over a gas field in the Persian Gulf poses an early challenge to a Chinese-brokered agreement to reconcile regional rivals Saudi Arabia and Iran. Saudi Arabia and neighboring Kuwait jointly claim the offshore Al-Durra gas field. Iran says it has rights to the field, which it refers to as Arash. The two sides held talks in Iran in March but were unable to agree on a border demarcation. A spokesman for Iran’s Foreign Ministry said on Monday it will not tolerate any infringement on its rights to the field, echoing remarks by Iran’s oil minister the previous day. Last week, Kuwait’s oil minister said his country would commence drilling and production without waiting for a deal. | https://kion546.com/ap-colorado/2023/07/31/dispute-over-persian-gulf-gas-field-poses-early-challenge-to-saudi-iranian-rapprochement/ | 2023-07-31T11:53:42 | 1 | https://kion546.com/ap-colorado/2023/07/31/dispute-over-persian-gulf-gas-field-poses-early-challenge-to-saudi-iranian-rapprochement/ |
French daredevil who climbed towers around world believed to have fallen to his death in Hong Kong
By KANIS LEUNG
Associated Press
HONG KONG (AP) — Hong Kong police say a French man apparently has fallen to his death from a high-rise residential building. Local media outlets identified the dead man as daredevil Remi Lucidi. Police on Monday said the body of the 30-year-old man was found on a patio in the city’s upscale Mid-Levels area. He was thought to have engaged in extreme sports, without identifying him. Officers said he apparently fell from a rooftop of the building, and no suicide note was found at the scene. The cause of his death would have to be verified by an autopsy, they added. | https://kion546.com/ap-colorado/2023/07/31/french-daredevil-who-climbed-towers-around-world-believed-to-have-fallen-to-his-death-in-hong-kong/ | 2023-07-31T11:53:48 | 1 | https://kion546.com/ap-colorado/2023/07/31/french-daredevil-who-climbed-towers-around-world-believed-to-have-fallen-to-his-death-in-hong-kong/ |
DUBAI – An escalating dispute over a gas field in the Persian Gulf poses an early challenge to a Chinese-brokered agreement to reconcile regional rivals Saudi Arabia and Iran.
Saudi Arabia and neighboring Kuwait jointly claim the offshore Al-Durra gas field. Iran says it has rights to the field, which it refers to as Arash. The two sides held talks in Iran in March but were unable to agree on a border demarcation.
A spokesman for Iran’s Foreign Ministry, Nasser Kanaani, said the country would not tolerate any infringement on its rights, echoing remarks by the country's oil minister the previous day.
“We have expressed our readiness to engage in dialogue with the Kuwaiti side," Kanaani told reporters Monday. “But if there is no interest in mutual utilization of this joint field, the Islamic Republic of Iran has naturally put the exploration and utilization of the resources on its agenda.”
Kuwait's oil minister told Sky News Arabia last week that his country would commence drilling and production without waiting for a deal.
Saudi Arabia has sided with Kuwait, saying the two countries have exclusive ownership of the field, and has called on Iran to return to negotiations.
Saudi Arabia and Iran, which have backed opposite sides in conflicts across the Middle East and accused each other of destabilizing the region, formally restored diplomatic relations in April following a seven-year freeze. They have since reopened embassies and welcomed senior officials on visits.
But they continue to back opposite sides in Yemen's civil war, which is ongoing despite a 15-month cease-fire. Saudi Arabia is also in negotiations with the United States over potentially normalizing relations with Israel, which Iran's leaders have said should be wiped off the map.
“Any step in the direction toward normalization of ties with this aggressive regime will only serve to give it more leeway to commit more atrocities against the Palestinian nation," Kanaani, the Iranian Foreign Ministry spokesman, said.
It's unclear whether the dispute over the gas field, which goes back to the 1960s, will escalate beyond rhetoric. But tensions are already high in the Persian Gulf, where the U.S. is building up military forces in response to what it says is Iran's unlawful seizure of oil tankers and harassment of commercial vessels.
Saudi Arabia and Kuwait agreed last year to jointly develop the gas field. Kuwait said at the time that they aimed to produce 1 billion cubic feet of natural gas and 84,000 barrels of liquefied gas per day. Iran denounced the agreement as illegal and said it should be included in any such plans. | https://www.wsls.com/business/2023/07/31/dispute-over-persian-gulf-gas-field-poses-early-challenge-to-saudi-iranian-rapprochement/ | 2023-07-31T11:53:52 | 1 | https://www.wsls.com/business/2023/07/31/dispute-over-persian-gulf-gas-field-poses-early-challenge-to-saudi-iranian-rapprochement/ |
First Alert Weather: West wind pattern returns to the Suncoast
SARASOTA, Fla. (WWSB) - A shift in the Suncoast winds and a good amount of moisture will combine with a bit of upper air energy to produce good rain chances for the west coastal regions of Florida.
The most likely chances for showers will fall in the late morning and early afternoon. At that point, the rain chance will be close to 50%. After that, most of the rain activity will be moving to inland locations.
This type of enhanced west wind pattern will be around for the first half of the work week. Tomorrow, some slightly drier air will move in. While the timing and motion of the rain will be the same as today, the overall coverage will probably be reduced.
Our pattern will return to a more easterly wind by the end of the week. This should alter the timing of storms to be centered more toward the late afternoon and early evenings. This pattern is more typical of August rain patterns.
The afternoons will be warm and humid all week, with daytime high temperatures running several degrees above the average.
The tropics are somewhat active but the direction of movement of the storms which look to develop are away from the United States and toward the open ocean.
Copyright 2023 WWSB. All rights reserved. | https://www.mysuncoast.com/2023/07/31/first-alert-weather-west-wind-pattern-returns-suncoast/ | 2023-07-31T11:53:52 | 0 | https://www.mysuncoast.com/2023/07/31/first-alert-weather-west-wind-pattern-returns-suncoast/ |
Georgia man electrocuted after jumping into lake
ATLANTA (WANF/Gray News) - A Georgia man is dead after jumping into Lake Lanier Thursday evening, WANF reports.
The Forsyth County Sheriff’s Office said 24-year-old Thomas Shepard Milner jumped into the lake from his family’s dock near Dove Trail and was electrocuted when he entered the water.
A family friend told investigators they heard Milner scream for help and tried to get him out of the water using a ladder.
When that didn’t work, neighbors stepped in to help and took a boat out to Milner, the sheriff’s office said. The person in the boat jumped in the water to pull Milner out but reported feeling a burning sensation, which they immediately recognized as an electric shock.
After swimming to shore and turning off the power box near the dock, the person returned to the water to pull Milner back to shore, according to investigators.
Witnesses told authorities Milner’s uncle administered CPR until emergency medical crews got to the scene. The 24-year-old was rushed to Northside Forsyth Hospital. He died from his injuries the next day.
Milner’s mother, Martha Milner, told WANF her son was gentle and kind and loved the lake.
“Shepard was known for his quirkiness, his humor and his dedication,” she said.
According to Martha Milner, the dock at their lake property was less than three years old and outfitted with electricity by a licensed electrician.
Boaters like Chris Morris were saddened to hear about the death on Sunday.
“It’s a freak accident,” he said.
It is unclear why the water was electrified.
The investigation remains ongoing.
Copyright 2023 WANF via Gray Media Group, Inc. All rights reserved. | https://www.mysuncoast.com/2023/07/31/georgia-man-electrocuted-after-jumping-into-lake/ | 2023-07-31T11:53:53 | 0 | https://www.mysuncoast.com/2023/07/31/georgia-man-electrocuted-after-jumping-into-lake/ |
ATLANTA – A new reactor at a nuclear power plant in Georgia has entered commercial operation, becoming the first new American reactor built from scratch in decades.
Georgia Power Co. announced Monday that Unit 3 at Plant Vogtle, southeast of Augusta, has completed testing and is now sending power to the grid reliably.
At its full output of 1,100 megawatts of electricity, Unit 3 can power 500,000 homes and businesses. Utilities in Georgia, Florida and Alabama are receiving the electricity.
A fourth reactor is also nearing completion at the site, where two earlier reactors have been generating electricity for decades. The Nuclear Regulatory Commission on Friday said radioactive fuel could be loaded into Unit 4, a step expected to take place before the end of September. Unit 4 is scheduled to enter commercial operation by March.
The third and fourth reactors were originally supposed to cost $14 billion, but are now on track to cost their owners $31 billion. That doesn’t include $3.7 billion that original contractor Westinghouse paid to the owners to walk away from the project. That brings total spending to almost $35 billion.
The third reactor was supposed to start generating power in 2016 when construction began in 2009.
Vogtle is important because government officials and some utilities are again looking to nuclear power to alleviate climate change by generating electricity without burning natural gas, coal and oil.
In Georgia, almost every electric customer will pay for Vogtle. Georgia Power, the largest unit of Atlanta-based Southern Co., currently owns 45.7% of the reactors. Smaller shares are owned by Oglethorpe Power Corp., which provides electricity to member-owned cooperatives, the Municipal Electric Authority of Georgia and the city of Dalton. Oglethorpe and MEAG plan to sell power to cooperatives and municipal utilities across Georgia, as well in Jacksonville, Florida, and parts of Alabama and the Florida Panhandle.
Georgia Power’s 2.7 million customers are already paying part of the financing cost and elected public service commissioners have approved a monthly rate increase of $3.78 a month for residential customers as soon as the third unit begins generating power. That could hit bills in August, two months after residential customers saw a $16-a-month increase to pay for higher fuel costs.
Commissioners will decide later who pays for the remainder of the costs of Vogtle, including the fourth reactor. | https://www.wsls.com/business/2023/07/31/first-american-nuclear-reactor-built-from-scratch-in-decades-enters-commercial-operation-in-georgia/ | 2023-07-31T11:53:54 | 0 | https://www.wsls.com/business/2023/07/31/first-american-nuclear-reactor-built-from-scratch-in-decades-enters-commercial-operation-in-georgia/ |
ROANOKE, Va. – Police responded to reports of a shooting on King George Avenue SW at about 9 a.m. Sunday.
When they arrived, they found a man in a car with a fatal gunshot wound.
This is the fifth shooting this week alone, and one local activist is saying it’s time to take action.
In 2004, Rita Joyce experienced what she says is a mother’s nightmare, when she lost her son to gun violence.
Now 19 years later, she says we’re seeing more violence than ever.
“That’s somebody’s child. I don’t care how old they are; it’s somebody’s child. So, I’m heartbroken right now. I’m just so broken because I know what the family is having to go through,” Joyce said.
Roanoke saw five shootings in the span of seven days, three of which were deadly.
Joyce is the founder of FEDUP, a gun violence activist group in Roanoke, and works with the families of the victims.
“When you hear another mother say, ‘Rita, if he owed money or whatever I could have paid it. They didn’t have to do my son like that.’ That is very crushing for me. And having to hear another mother feel that pain. She knew she could call me because she knew I’d been through it,” Joyce said.
Joyce says it’s time to confront gun manufacturers with lawmakers.
“We’ve gotta hit them in the pocket. We’ve gotta say if you’re gonna allow our young kids to be able to order guns online and to put them in possession where they can use them to take a life,” she said.
She says the latest shootings alone show something needs to change.
“We are not as a society looking at gun violence as a pandemic. Why? Why? Tell me why? Because of the society of people it’s affecting? Is that why?” Joyce said.
Joyce believes it will take the whole city to make a change.
“It’s gonna take all of us to say, ‘Let’s break the cycle.’ If you see someone hurting, let’s talk to them. But we have to be better about seeking out and figuring out why is this continuing to happen,” she said.
In all five shootings this week, there have been no suspects identified or arrested. | https://www.wsls.com/news/local/2023/07/31/im-heartbroken-right-now-local-activist-reacts-to-weekend-of-violence-in-roanoke/ | 2023-07-31T11:53:54 | 0 | https://www.wsls.com/news/local/2023/07/31/im-heartbroken-right-now-local-activist-reacts-to-weekend-of-violence-in-roanoke/ |
Lawsuit alleges flight attendants served too much alcohol to passenger that groped woman, her daughter
(CNN) - A passenger is suing Delta Airlines, claiming flight attendants overserved alcohol to a man who became drunk while on board and groped a mother and her teenage daughter.
The alleged incident happened during an international flight last summer.
The suit claims the flight attendants ignored the mother’s pleas for them to stop serving alcohol to the man and that the passenger was making them feel unsafe.
The plaintiffs in the case said during the nine-hour flight from New York to Greece, the man made obscene gestures and sexually assaulted the 16-year-old girl sitting next to him.
When the plane landed in Greece, the man was allowed to walk free despite the mother’s request that authorities arrest him in Athens.
Delta has not commented on the suit but says the airline has zero tolerance for passengers who engage in inappropriate or unlawful behavior.
Copyright 2023 CNN Newsource. All rights reserved. | https://www.mysuncoast.com/2023/07/31/lawsuit-alleges-flight-attendants-served-too-much-alcohol-passenger-that-groped-woman-her-daughter/ | 2023-07-31T11:53:54 | 1 | https://www.mysuncoast.com/2023/07/31/lawsuit-alleges-flight-attendants-served-too-much-alcohol-passenger-that-groped-woman-her-daughter/ |
Japanese court sentences ‘Joker’ to 23 years for stabbing passenger, setting a fire on a Tokyo train
By MARI YAMAGUCHI
Associated Press
TOKYO (AP) — A Japanese court has sentenced a man to 23 years in prison for stabbing a passenger and setting a fire on a Tokyo express train while dressed in a Joker costume on Halloween two years ago. The court found Kyota Hattori guilty of attempted murder for stabbing and seriously injuring a male passenger in his 70s and of spraying lighter fluid in the train car and then lighting it to try to kill others. During the trial, Hattori told the court he was so shocked when he learned that his girlfriend had married someone else only six months after they broke up that he decided to carry out the attack so he could end his life by receiving the death penalty. | https://kion546.com/ap-colorado/2023/07/31/japanese-court-sentences-joker-to-23-years-for-stabbing-passenger-setting-a-fire-on-a-tokyo-train/ | 2023-07-31T11:53:54 | 0 | https://kion546.com/ap-colorado/2023/07/31/japanese-court-sentences-joker-to-23-years-for-stabbing-passenger-setting-a-fire-on-a-tokyo-train/ |
WATCH: Concertgoer throws drink at Cardi B; she hurls microphone at them
Published: Jul. 31, 2023 at 6:58 AM EDT|Updated: 53 minutes ago
LAS VEGAS (CNN) - Cardi B hurled her microphone at a fan during a concert in Las Vegas on Saturday.
The rapper was performing her song “Bodak Yellow” when a concertgoer threw a drink at her.
In seconds, Cardi B threw her microphone into the crowd as the song continued to play.
Security guards rushed to the stage.
More security guards are then seen flocking to the person in the crowd as she watched from the stage before continuing with her set.
There’s no word on what happened to the fan or if any charges will be filed.
Copyright 2023 CNN Newsource. All rights reserved. | https://www.mysuncoast.com/2023/07/31/watch-concertgoer-throws-drink-cardi-b-she-hurls-microphone-them/ | 2023-07-31T11:53:55 | 0 | https://www.mysuncoast.com/2023/07/31/watch-concertgoer-throws-drink-cardi-b-she-hurls-microphone-them/ |
BEIRUT – Lebanon's embattled central bank governor stepped down Monday under a cloud of investigation and blame for his country's economic crisis as several European countries probe him for alleged financial crimes.
Riad Salameh, 73, ended his 30-year tenure atop the central bank as tearful employees took photos and a band played celebratory music with drums and trumpets.
In that same building, his four vice governors, led by incoming interim governor Wassim Mansouri, quickly pivoted to urge fiscal reforms for the cash-strapped country.
“We are at a crossroads,” Mansouri said at a news conference. “There is no choice, if we continue previous policy ... the funds in the Central Bank will eventually dry up.”
Seventy-three-year-old Riad Salameh kicked off his tenure as central bank governor in 1993, three years after Lebanon’s bloody 15-year civil war came to an end. It was a time when reconstruction loans and aid was pouring into the country, and Salameh was widely celebrated at the time for his role in Lebanon's recovery.
Now, he leaves his post a wanted man in Europe, accused by many in Lebanon of being a main culprit in the country's financial downfall since late 2019.
It was a steep fall for a leader whose policies were once hailed for keeping the currency stable. Later, many financial experts saw him as setting up a house of cards that crumbled as the country's supply of dollars dried up on top of decades of rampant and corruption and mismanagement from Lebanon's ruling parties.
The crisis has pulverized the Lebanese pound and wiped out the savings of many Lebanese, as the banks ran dry of hard currency.
With the country's banks crippled and public sector in ruins, Lebanon for years has run on a cash-based economy and relied primarily on tourism and remittances from millions in the diaspora.
Mansouri said previous policies that permitted the Central Bank to spend large sums on money to prop up the Lebanese state is no longer feasible. He cited years of spending billions of dollars to subsidize fuel, medicine, and wheat and more to keep the value of the Lebanese pound stable.
Instead, Mansouri proposed a six-month reform plan that included passing long awaited reforms such as capital controls, a bank restructuring law, and the 2023 state budget.
“The country cannot continue without passing these laws,” Mansouri explained. “We don't have time, and we paid a heavy price that we cannot pay anymore.”
The reforms Mansouri mentioned are among those the International Monetary Fund set as conditions on Lebanon in April 2022 for a bailout plan, though he did not mention the IMF. None have been passed.
France, Germany, and Luxembourg are investigating Salameh and his associates over myriad financial crimes, including illicit enrichment and the laundering of $330 million. Paris and Berlin issued Interpol notices to the central bank chief in May, though Lebanon does not hand over its citizens to foreign countries.
Salameh has repeatedly denied the allegations and insisted that his wealth comes from his previous job as an investment banker at Merrill Lynch, inherited properties, and investments. He has criticized the probe and said it was part of a media and political campaign to scapegoat him.
In his final interview as governor, Salameh said on Lebanese television that the responsibility for reforms lies with the government.
“Everything I did for the past 30 years was to try to serve Lebanon and the Lebanese,” he said. “Some -- the majority -- were grateful, even if they don’t want to say so. And there are other people, well may God forgive them.”
Salameh's departure adds another gap to crisis-hit Lebanon’s withering and paralyzed institutions. The tiny Mediterranean country has been without a president nine months, while its government has been running in a limited caretaker capacity for a year. Lebanon has also been without a top spy chief to head its General Security Directorate since March.
Lebanese officials in recent months were divided over whether Salameh should stay in his post or whether he should step down immediately in the remaining months of his tenure.
Caretaker Economy Amin Salam wanted the latter, given that the central bank chief had a “legal question mark.”
“I cannot explain anyone holding on to a person while a nation is failing unless there is something wrong or hidden," Salam told The Associated Press. | https://www.wsls.com/news/world/2023/07/31/lebanons-central-bank-governor-ends-30-year-tenure-under-investigation-during-dire-economic-crisis/ | 2023-07-31T11:53:55 | 0 | https://www.wsls.com/news/world/2023/07/31/lebanons-central-bank-governor-ends-30-year-tenure-under-investigation-during-dire-economic-crisis/ |
BEIJING, July 31, 2023 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced the launch of its 36Kr Media Lab in Silicon Valley, an initiative to embrace the large language models (LLM) revolution taking place in the content creation industry and optimize the application of artificial intelligence (AI) for the new economy sector.
36Kr Silicon Valley Media Lab's first project leveraging LLM, "Empty Office," will experimentally explore scenarios where AI can think and work as humans, enhancing content production efficiency and reducing costs. Through "Empty Office," 36Kr is also building innovative media solutions that will transform traditional video, graphic and text communications into avant-garde dialogues between customized AI characters and audiences. These network-based dialogues will be naturally and seamlessly driven by real-time data generation, and available anytime, anywhere.
At the same time, 36Kr Silicon Valley Media Lab continues to focus on tailoring its LLM to the new economy sector. By utilizing dedicated financial and business datasets, including enterprises' financial results, news, market dynamics and knowledge repositories, among other resources, to train its LLM to thoroughly understand and analyze business information, 36Kr has developed a model that keenly grasps the business nuances to generate accurate analysis and interpretation. 36Kr Silicon Valley Media Lab constantly maintains its database, serving as the reference foundation to ensure that its fact-based model produces rigorous and up-to-date business and financial analysis.
Furthermore, 36Kr's professionally-training, fine-tuning capability enables its LLM-empowered "Empty Office" to quickly and efficiently create informative content for the new economy sector. For instance, in the case of a business event, such as a new product launch, an AI agent can instantly extract relevant data from the database, automatically perform a comprehensive analysis, and issue reports within just seconds. This top-speed response gives 36Kr's business and financial-focused media platform an unrivaled edge.
Mr. Dagang Feng, Co-chairman and CEO of 36Kr, commented, "The launch of 36Kr Silicon Valley Media Lab is a testament to our AI technology acumen and vision as well as our commitment to extending media's boundaries. By integrating pioneering AI technology into content creation, 36Kr will constantly elevate the efficiency and quality of content production alongside the rapid advancement of the LLM, fostering a superior content ecosystem encompassing business, finance and technology, further turbocharging the evolution of the New Economy. As we adopt and develop more AI tools amid the technology's rapid advancement, we are strategically positioning the Company to break new ground and ultimately drive long-term growth for our business."
About 36Kr Holdings Inc.
36Kr Holdings Inc. is a prominent brand and a pioneering platform dedicated to serving New Economy participants in China with the mission of empowering New Economy participants to achieve more. The Company started its business with high-quality New Economy-focused content offerings, covering a variety of industries in China's New Economy with diverse distribution channels. Leveraging traffic brought by high-quality content, the Company has expanded its offerings to business services, including online advertising services, enterprise value-added services, and subscription services, to address the evolving needs of New Economy companies and upgrading needs of traditional companies. The Company is supported by a comprehensive database and strong data analytics capabilities. Through diverse service offerings and significant brand influence, the Company is well-positioned to continuously capture the high growth potential of China's New Economy.
For more information, please visit: http://ir.36kr.com.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's goal and strategies; the Company's future business development, results of operations and financial condition; relevant government policies and regulations relating to our business and industry; the Company's expectations regarding the use of proceeds from this offering; the Company's expectations regarding demand for, and market acceptance of, its services; the Company's ability to maintain and enhance its brand; the Company's ability to provide high-quality content in a timely manner to attract and retain users; the Company's ability to retain and hire quality in-house writers and editors; the Company's ability to maintain cooperation with third-party professional content providers; the Company's ability to maintain relationships with third-party platforms; general economic and business conditions in China; possible disruptions in commercial activities caused by natural or human-induced disasters; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.
For investor and media inquiries, please contact:
In China:
36Kr Holdings Inc.
Investor Relations
Tel: +86 (10) 8965-0708
E-mail: ir@36kr.com
The Piacente Group, Inc.
Jenny Cai
Tel: +86 (10) 6508-0677
E-mail: 36Kr@tpg-ir.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: 36Kr@tpg-ir.com
View original content:
SOURCE 36Kr Holdings Inc. | https://www.mysuncoast.com/prnewswire/2023/07/31/36kr-launches-silicon-valley-media-lab-empower-content-ecosystem-with-llm-based-ai-technology/ | 2023-07-31T11:53:56 | 1 | https://www.mysuncoast.com/prnewswire/2023/07/31/36kr-launches-silicon-valley-media-lab-empower-content-ecosystem-with-llm-based-ai-technology/ |
Thanks to Brenda Arnette for sending us today’s Picture of the Day.
Want to see your pictures featured on air and online? You can send your pictures here through Pin It.
Thanks to Brenda Arnette for sending us today’s Picture of the Day.
Want to see your pictures featured on air and online? You can send your pictures here through Pin It.
Copyright 2023 by WSLS 10 - All rights reserved. | https://www.wsls.com/station/2023/07/31/july-31-2023-picture-of-the-day/ | 2023-07-31T11:53:56 | 0 | https://www.wsls.com/station/2023/07/31/july-31-2023-picture-of-the-day/ |
Kimberly Palmer: How to stay safe from financial scams
By KIMBERLY PALMER of NerdWallet
While there’s no way to guarantee you’ll completely avoid financial scams, there are steps you can take to reduce your chances of falling for one. Scammers tend to contact you first, create a false sense of urgency and then ask you to send money or share personal information. A good strategy to protect yourself is to verify the identity of anyone who contacts you and claims to be your bank by hanging up and placing a call to a confirmed number yourself. If you do come into contact with scammers, consider reporting them to the authorities and following up with your bank to attempt to recoup any losses. | https://kion546.com/ap-colorado/2023/07/31/kimberly-palmer-how-to-stay-safe-from-financial-scams/ | 2023-07-31T11:54:01 | 1 | https://kion546.com/ap-colorado/2023/07/31/kimberly-palmer-how-to-stay-safe-from-financial-scams/ |
40 million ways Trump’s campaign is morphing into his legal defense
Analysis by Stephen Collinson, CNN
(CNN) — The fateful clash between former President Donald Trump’s legal imbroglio and the 2024 election is deepening amid new signs his GOP poll-topping campaign is partly designed to bankroll his defense and beat criminal charges.
News that Trump’s leadership PAC, which raises most of its money from small-dollar donations, has spent more than $40 million on attorneys’ fees for himself and associates emerged as he tightens his grip on the GOP race – a New York Times/Siena College poll released Monday finds Trump with a monumental advantage over the rest of the GOP pack – and ramps up claims that President Joe Biden wants him arrested so he can’t pull off a stunning White House comeback.
While many of Trump’s rivals are still wary of openly criticizing his legal morass for fear of alienating his supporters, some are becoming more vocal after the ex-president was hit by new charges in the classified documents case last week and as he predicts new indictments are coming soon in the special counsel’s investigation into efforts to overturn the 2020 election and in another probe by a district attorney focusing on a similar bid in Georgia. The federal grand jury in Washington is next expected to meet on Tuesday.
Former New Jersey Gov. Chris Christie – who is seeking to turn the New Hampshire primary into a referendum on how Trump’s legal woes could jeopardize GOP hopes among more moderate and crucial suburban voters – slammed Trump on CNN’s “State of the Union” on Sunday as a billionaire who was using contributions to pay his legal fees.
“This is a guy who’s putting himself before the country. You can’t put America first with Donald Trump, because it’s Trump first,” Christie told Kasie Hunt, saying the ex-president and his associates had acted like “the Corleones with no experience.”
“I want voters to listen to this. It is most likely that by the time we get on the debate stage (on) August 23, the front-runner will be out on bail in four different jurisdictions: Florida, Washington, Georgia, and New York,” Christie said.
Another candidate, former South Carolina Gov. Nikki Haley, demonstrated the dancing on a political pin head that Trump is forcing his opponents to do as they seek to exploit his plight while also trying to avoid angering the GOP base, much of which appears to believe Trump’s claim he’s a victim of political persecution. Haley, who served in Trump’s Cabinet as ambassador to the United Nations, warned on CBS’s “Face the Nation” that new accusations in the case of classified documents her old boss hoarded at his Florida resort were “incredibly dangerous to our national security” – if they were true. But she added that the American people didn’t trust the Justice Department and hinted she might pardon Trump if she won the White House.
Florida Gov. Ron DeSantis is also edging closer to criticizing Trump over the case, though he’s also treading carefully in order to avoid further damaging his recently wilting campaign. “If the election becomes a referendum on what document was left by the toilet at Mar-a-Lago, we are not going to win,” DeSantis told ABC News during a campaign swing through Iowa on Friday.
The growing turbulence in the Republican race comes as Biden tries to boost his appeal to voters. The administration, for instance, launched a beta website Sunday for a new income-driven federal student loan payments system finalized after the Supreme Court struck down his student debt forgiveness initiative. And the pace of campaigning by Vice President Kamala Harris is increasing. As the Republican candidates gathered in Iowa on Friday, Harris flew into the state to highlight the overturning of a constitutional right to an abortion – part of Democrats’ efforts to make the conservative majority Supreme Court’s decision last year detrimental to GOP hopes in 2024.
The vice president also went to Florida earlier this month to attack DeSantis over new educational standards in the Sunshine State that she claims will teach kids that some enslaved people “benefited” from skills they acquired. DeSantis accused her of misleading voters by seizing on one line of a much broader curriculum about the entire topic of slavery – but it’s a line that’s sparked some public spats between him and Black Republican lawmakers, ensuring it remains in the news.
Legal net tightens while Trump creates new echo of first impeachment
Trump’s legal struggles still dominate the Republican race. In an unexpected move worsening his legal position, Smith brought new charges on Thursday against Trump, his aide Walt Nauta and a third co-defendant, Carlos De Oliveira, in the case alleging the former commander in chief mishandled classified documents after leaving the White House. The charges included allegations that Trump and his employees attempted to delete Mar-a-Lago security footage sought by the grand jury. Trump and Nauta have already pleaded not guilty to earlier counts brought against them in the case.
Despite Trump’s legal woes, no rival Republican has shown much sign of narrowing his double-digit lead in national primary polls. And Trump showed at a Republican Party dinner featuring most of the major candidates in Iowa on Friday and in a raucous rally in Erie, Pennsylvania, the next night, that he will be very hard for them to stop. The former president accused Smith and the Biden administration of trying to make it illegal to question the result of an election and branded investigations into his conduct as “election interference” to keep him from a White House return.
His attitude threatens to tarnish the faith of his supporters in yet another American presidential election as he seeks to become only the second president to win a non-consecutive second term and readies a hardline agenda reflecting his authoritarian tendencies. There is no evidence of widespread fraud in the 2020 election and Trump’s claims otherwise were rejected by his own Justice Department.
Trump also said Saturday the probes into his behavior were intended to cover up “crimes” by the current president and his son, Hunter, following the collapse last week of a plea deal for Hunter Biden on tax charges that would have also resolved a felony gun charge. There is no evidence of wrongdoing by the president, but Trump’s GOP allies in the House are making noise about an impeachment inquiry to probe their claims that Biden and his son used his influence as vice president to enrich themselves.
And Trump’s now calling on Congress to halt all aid to Ukraine until Biden cooperates with congressional investigations – an echo of the conduct that led to his first impeachment, when he used the prospect of military aid to try to coerce Ukrainian President Volodymyr Zelensky into opening an investigation into the former vice president and eventual Democratic nominee.
Fundraising for a legal defense
The extent to which Trump’s 2024 campaign has merged with his legal defense as he faces multiple criminal charges was laid bare in news about his PAC’s expenditures, which are expected to be reported to the Federal Election Commission on Monday. The PAC, Save America, has spent more than $40 million on legal fees since the start of this year, a source familiar with the matter told CNN, which is more than double the amount the group spent on legal fees in all of 2022.
PACs and political parties have a Monday deadline to file midyear disclosure reports that will offer a glimpse into the financial health and spending of some groups used to support presidential candidates.
Trump’s team is strongly defending the expenditures as an integral part of the ex-president’s larger political project.
“In order to combat these heinous actions by Joe Biden’s cronies and to protect these innocent people from financial ruin and prevent their lives from being completely destroyed, the leadership PAC contributed to their legal fees to ensure they have representation against unlawful harassment,” Trump campaign spokesman Steven Cheung told CNN. The details of the spending on legal fees by Trump’s PAC were first reported by The Washington Post.
Both Nauta and De Oliveira are being represented by attorneys paid for by Trump’s operation.
As the costs mount, Trump’s team is also creating a legal defense fund, two sources familiar with the planning told CNN, adding that the entity will be called the Patriot Legal Defense Fund Inc., and will be led by Trump associate and adviser Michael Glassner. It will cover the bills of some of Trump’s current and former aides and employees. The development was first reported by The New York Times.
Ohio Republican Sen. J. D. Vance wrote on Twitter on Sunday that attacks on Trump for using fundraising dollars for legal fees were “lame” and said the strategy alleviated the burden on some of the president’s associates. “I have good friends who did nothing wrong who had their legal fees paid by Save America PAC. Would you rather they throw all of their employees under a bus?” Vance wrote.
Trump and allied fundraising operations send out multiple emails a day to supporters, and the ex-president has frequently used indictments and other twists in his legal saga to boost his campaign coffers. On Sunday, for instance, the Trump campaign and Save America sent out a joint appeal that told supporters: “While my primary opponents continue to take cheap swipes at me as the Department of Justice plots ways to throw me in JAIL for up to 561 YEARS, I am asking YOU to stand with me at this pivotal moment in the election.”
The new counts in the classified documents case are just a portion of the legal jeopardy Trump faces. He’s due to go on trial in Manhattan in March on more than 30 counts related to business fraud arising from a payment to an adult film actress before the 2016 election. The former president says he has received a target letter from Smith regarding the investigation into the aftermath of the 2020 election, which is a step often followed by criminal charges. And Trump is expected to learn by the end of August whether he or associates will face charges in Fulton County, Georgia, stemming from alleged attempts to overturn the result of the 2020 election in the crucial swing state.
Fulton County District Attorney Fani Willis over the weekend praised increased security measures around the local courthouse as charging decisions approach, and indicated her investigation had all but wrapped up.
“The work is accomplished,” Willis told CNN affiliate WXIA at a back-to-school event. “We’ve been working for two-and-half years. We’re ready to go.”
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/cnn-opinion/2023/07/31/40-million-ways-trumps-campaign-is-morphing-into-his-legal-defense/ | 2023-07-31T11:54:07 | 0 | https://kion546.com/cnn-opinion/2023/07/31/40-million-ways-trumps-campaign-is-morphing-into-his-legal-defense/ |
WALLOPS ISLAND, Va. – A resupply mission to the International Space Station takes off from Wallops Island Tuesday, August 1, 2023.
Launch time is expected to be around 8:30 in the evening.
It will be live streamed here.
With it being so close to sunset, there’s potential for the rocket’s vapor trail to be seen from the Carolinas to New England.
This includes our part of Southwest and Central Virginia.
The trail starts narrow and then expands as it rises into a thinner portion of Earth’s atmosphere.
The forecast as of Sunday evening showed 80% odds of favorable weather for a successful launch. The only thing that could prevent that is a field of cumulus clouds.
48-Hour Weather Forecast 🌤️
— NASA Wallops (@NASA_Wallops) July 30, 2023
The Wallops Range weather office continues to keep weather at 80% favorable, with a slight chance of cumulus clouds being the main concerns for Tuesday's Antares launch window. https://t.co/KNSoHlWiKg
You can live stream the launch here, so you know when to go outside and look toward the Southeast horizon.
If you get any pictures or video of the rocket’s vapor trail, send them through Pin It here. | https://www.wsls.com/weather/2023/07/31/next-wallops-island-rocket-launch-potentially-visible-in-parts-of-the-eastern-us/ | 2023-07-31T11:54:12 | 1 | https://www.wsls.com/weather/2023/07/31/next-wallops-island-rocket-launch-potentially-visible-in-parts-of-the-eastern-us/ |
HOUSTON, July 31, 2023 /PRNewswire/ -- AutomationEdge, a leading Hyperautomation platform has announced strategic partnership with eAlliance Corp, a cutting-edge Hyperautomation solutions provider.
The partnership will enable eAlliance Corp to provide AutomationEdge solutions such as CogniBot - a conversational AI platform, DocEdge - an intelligent document processing platform, Intelligent Service Desk Ticket Data Analysis, IT Process Automation (ITPA) and RPA. This collaboration will empower AutomationEdge and eAlliance Corp to help customers innovate with automation to move the needle on the top and bottom line.
AutomationEdge, along with its Hyperautomation platform, has also build the ready automation solutions across industries. It will help customers achieve faster Go-To-Market for automation projects with lower cost. It is empowering 250+ customers globally in Healthcare, Banking, Insurance, Financial Services and other industries.
For over 20 years, eAlliance Corp has been delivering technology solutions to businesses worldwide across industries. It has been a trusted advisor to its customer in innovation, strategy and execution of automation solutions. Through this partnership, eAlliance will be able to offer innovative business process automation solutions to customers focusing on key enterprise domains such as finance & accounting, customer service, procurement, human resources, cash applications and more.
About AutomationEdge
AutomationEdge is a leading Hyperautomation platform across the globe with end-to-end automation capabilities. With its platforms working together as one solution, it has enabled seamless process automation for global enterprises.
AutomationEdge has already delivered its innovative solutions to large multinational organizations like American Express, Smart Dubai Government, Wipro, AccentCare, Danone, University of Maryland Medical System, Aspen Pharmacare, Oman LNG, Mashreq Bank, HDFC Bank, and Genpact, to name a few.
For more details, contact sales or request a demo.
About eAlliance Corp
eAlliance Corp is a professional services firm with big company expertise and small company relationships, taking pride in agility and real-time responsiveness. eAlliance Corp is a trusted name in the Hyperautomation industry, offering comprehensive services and solutions to help businesses achieve their automation goals with ease. Founded in 2002 in Chicago, IL, staffed with resources in the US and India possessing vast experience and leadership in business and technology.
For more details, visit website.
For media inquiries, please contact:
Rahul Wandile
Media Relations – AutomationEdge
rahul.wandile@automationedge.com
www.automationedge.com
Follow AutomationEdge on: Twitter, Facebook, LinkedIn, and YouTube
View original content:
SOURCE AutomationEdge | https://www.mysuncoast.com/prnewswire/2023/07/31/automationedge-ealliance-corp-announced-partnership-hyperautomation-solutions/ | 2023-07-31T11:54:12 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/automationedge-ealliance-corp-announced-partnership-hyperautomation-solutions/ |
Bursting the Beanie Baby bubble
By Nicole Mowbray, CNN
(CNN) — If you were a child – or even an adult — in the nineties, it’s probable you had a collection of Beanie Babies. In fact, it’s possible you still do. Perhaps you’re hoping (like me) one of them will turn out to be worth a fortune one day.
Invented by toy impresario (and subsequent convicted tax evader) Ty Warner, an initial nine bean-filled plushies — including the first-ever Beanie Baby, Legs the Frog, as well as Chocolate the Moose and Brownie the Bear — were released at a New York toy fair in 1993, to limited success.
Warner was undeterred. His eponymous toy company released more than 20 new designs in 1994, and the poseable toys, which were sold through local gift shops rather than big chain stores, quickly became an unbridled phenomenon. A poll conducted by USA Weekend magazine in 1998 found that, at that time, 64% of Americans owned at least one Beanie Baby.
The tale of the so-called Beanie boom and the man who created it all has made it to the small screen in the form of “The Beanie Bubble” movie. Starring Zach Galifianakis, Sarah Snook and Elizabeth Banks, the film debuted on streaming service Apple TV+ last week.
Selling for around $5 each in the 1990s, the limited-edition collectible plush toys — each ticketed with a heart-shaped swing tag bearing its name, date of birth and a short personal poem — became highly sought after due to the company’s policy of discontinuing or “retiring” characters at random.
This strategy fueled a demand for rare or scarce Beanie Babies as people clamored to buy soon-to-be extinct toys, causing them to become instantly highly valuable. An underground black market began, with adults trading and bidding for the toys. Shoppers would queue overnight for rare editions or characters about to be discontinued, some even traveling internationally to get their hands on a specific Beanie. People stole them from stores. “Dealers” were enlisted to track pieces down and Beanie experts sprung up, specializing in storage and display solutions, authenticating purchases, or predicting and valuing the next big thing.
A Beanie preservation industry was spawned too, to protect their “future investments” — Perspex containers to protect bears from dust, tiny plastic sleeves to keep swing tags in immaculate condition.
Fuelling a cultural hysteria
It’s a phenomenon examined in great depth in Zac Bissonnette’s 2015 book, “The Great Beanie Baby Bubble: Mass Delusion and the Dark Side of Cute,” which inspired the movie.
“The idea for the book came to me in 2010,” the Florida-based author told CNN during a phone interview. “While at college in Massachusetts, I visited an auction house looking for furniture. There, I saw five enormous plastic containers full of Beanie Babies complete with a detailed hand-written inventory. It was clear that whoever had built this collection had done so under the belief that they would one day be of high value. As it was, the whole collection sold for about $50.”
Interest piqued, Bissonnette set about looking into the Beanie phenomenon. “As someone who was interested in financial markets, I wanted to know how this had happened,” he explained. “I started looking into the creator of Beanies, Ty Warner. He had become a billionaire off of these things having done no rounds of investment, no advertising. All of his money was made selling Beanies at a $2.50 wholesale price. It’s a pretty rare thing in business.”
Bissonnette found that the launch of eBay in 1995 had only added to the resale fever. The auction house say that in 1997, six per cent of their total volume of sales — equating to $500m — come from the sales of secondhand Beanie Babies.
Very few collectors, however, were making huge profits. While some people made money quickly flipping newly-retired” Beanie Babies — for several hundred or even a few thousand dollars — to desperate collectors, most hung on to their lions and tigers and bears (oh my) in the hopes of a future windfall.
It was a bad move. In a 2019 piece about Bissonnette’s book, the Financial Times newspaper dubbed the Beanie Baby investment movement “perhaps, in terms of its sheer level of mass insanity, the greatest market bubble of all time,” adding that the plushies were “the dotcom stock of the soccer mom world in the second half of the 1990s.”
The end of an era
Indeed as the millennium rolled around, the Beanie bubble had well and truly burst, with stock sitting unsold on the shelves and the fever surrounding the release of a new bear well and truly gone. People surmise many reasons for this, from child collectors growing up and moving on, to market saturation (collectors only have room for so many stuffed toys), but the exact reason is unclear.
“1999 was kind of the end of the dream,” Bissonnette said. “Character ‘retirement’ announcements stopped creating a huge spike in demand. But the nature of bubbles is to burst. Beanie Baby mania was always a speculative fervor that didn’t make sense.”
One person for whom Beanie mania did make perfect sense, however, was the toys’ designer and inventor Ty Warner. In 1998 alone, Ty’s sales were reportedly $1.3 billion; Beanies are still being produced today and as of July 2023, Forbes states that Warner — who invested some of his Beanie wealth into a high-end hotel portfolio which includes the Four Seasons in New York and the Four Seasons Resort in Santa Barbara — is worth $6.1 billion.
Bissonnette said he is often contacted by Beanie Collectors desperate to know the value of their toys and explained that, while there is still a market for some Beanies that meet specific criteria, most were collected en masse globally and as such, aren’t as valuable as many resale sites claim. Serious collectors, however, do reportedly pay high prices for certain Beanies.
“Peanuts the Elephant in royal blue was only produced for a short time before it was changed to a lighter blue, so that one can be valuable,” he said. “But otherwise, it’s the early Beanies, the ones created before Ty started putting a star on the swing tag that are the ones usually worth something. The value is really what everyone wants to know.”
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/entertainment/cnn-style/2023/07/31/bursting-the-beanie-baby-bubble/ | 2023-07-31T11:54:13 | 0 | https://kion546.com/entertainment/cnn-style/2023/07/31/bursting-the-beanie-baby-bubble/ |
DUBAI, United Arab Emirates (AP) — An escalating dispute over a gas field in the Persian Gulf poses an early challenge to a Chinese-brokered agreement to reconcile regional rivals Saudi Arabia and Iran.
Saudi Arabia and neighboring Kuwait jointly claim the offshore Al-Durra gas field. Iran says it has rights to the field, which it refers to as Arash. The two sides held talks in Iran in March but were unable to agree on a border demarcation.
A spokesman for Iran’s Foreign Ministry, Nasser Kanaani, said the country would not tolerate any infringement on its rights, echoing remarks by the country’s oil minister the previous day.
“We have expressed our readiness to engage in dialogue with the Kuwaiti side,” Kanaani told reporters Monday. “But if there is no interest in mutual utilization of this joint field, the Islamic Republic of Iran has naturally put the exploration and utilization of the resources on its agenda.”
Kuwait’s oil minister told Sky News Arabia last week that his country would commence drilling and production without waiting for a deal.
Saudi Arabia has sided with Kuwait, saying the two countries have exclusive ownership of the field, and has called on Iran to return to negotiations.
Saudi Arabia and Iran, which have backed opposite sides in conflicts across the Middle East and accused each other of destabilizing the region, formally restored diplomatic relations in April following a seven-year freeze. They have since reopened embassies and welcomed senior officials on visits.
But they continue to back opposite sides in Yemen’s civil war, which is ongoing despite a 15-month cease-fire. Saudi Arabia is also in negotiations with the United States over potentially normalizing relations with Israel, which Iran’s leaders have said should be wiped off the map.
“Any step in the direction toward normalization of ties with this aggressive regime will only serve to give it more leeway to commit more atrocities against the Palestinian nation,” Kanaani, the Iranian Foreign Ministry spokesman, said.
It’s unclear whether the dispute over the gas field, which goes back to the 1960s, will escalate beyond rhetoric. But tensions are already high in the Persian Gulf, where the U.S. is building up military forces in response to what it says is Iran’s unlawful seizure of oil tankers and harassment of commercial vessels.
Saudi Arabia and Kuwait agreed last year to jointly develop the gas field. Kuwait said at the time that they aimed to produce 1 billion cubic feet of natural gas and 84,000 barrels of liquefied gas per day. Iran denounced the agreement as illegal and said it should be included in any such plans. | https://www.seattletimes.com/business/dispute-over-persian-gulf-gas-field-poses-early-challenge-to-saudi-iranian-rapprochement/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_business | 2023-07-31T11:54:14 | 0 | https://www.seattletimes.com/business/dispute-over-persian-gulf-gas-field-poses-early-challenge-to-saudi-iranian-rapprochement/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_business |
Impact "much bigger than a single project"
WAYNESBORO, Ga., July 31, 2023 /PRNewswire/ -- Bechtel, the engineering, procurement, and construction company brought in to complete construction on new Units 3 and 4 at the Vogtle nuclear power plant in Georgia, today issued the following statement from Brendan Bechtel, Bechtel Chairman and CEO, marking the start of commercial operations for Unit 3:
"We are extremely proud of Bechtel's part in achieving this milestone. Our team has been 100 percent committed to Vogtle's completion since being brought in to finish the project.
"Today's start of commercial operations for Vogtle Unit 3 gives the Southeast a major new source of clean, reliable, carbon-free baseload energy. And, as the first new nuclear unit built in the U.S. in more than 30 years, it helps put America back on the map as a leader in the global nuclear industry.
"Bechtel has supported the design and construction of 150 nuclear plants worldwide. We know firsthand how Vogtle Units 3 and 4 go a long way in restoring America's muscle memory in nuclear construction, including the workforce and domestic supply chains required to build America's largest nuclear power plant. Vogtle Unit 3 comes online at a pivotal time when energy security concerns and the need to cut carbon emissions are driving growth in the world's nuclear fleet.
"Plant Vogtle will generate more carbon-free electricity yearly than any other energy facility currently operating in the country. Its completion reinforces that the United States is the responsible partner of choice for new nuclear energy around the world, and maintains U.S. interests in ensuring strong safety, security, and non-proliferation standards. This is why Vogtle's impact is much bigger than a single project.
"Thank you to the thousands of skilled craft professionals, union partners, engineers, project managers, procurement experts, suppliers, subcontractors, and everyone who made this day possible. And thank you to Georgia Power and Southern Nuclear for the opportunity to bring this project over the finish line. We look forward to doing the same with Unit 4 in the coming months."
Background
In 2017, Bechtel was brought in by Georgia Power and Southern Nuclear to take over construction of Vogtle Units 3 and 4, bringing extensive experience supporting the design and construction of 150 nuclear plants worldwide. Vogtle Units 3 and 4 are the first Westinghouse AP1000 units to ever be built in the U.S.
Bechtel has completed more than 76,000 megawatts of new nuclear generation capacity and has designed, built, or performed engineering and/or construction services on more than 80% of nuclear plants in the United States. Today, the company leads efforts in designing and constructing advanced nuclear plants, critical to global efforts to achieve net zero carbon emissions.
Bechtel partnered with North America's Building Trades Unions (NABTU) to build Plant Vogtle Units 3 and 4. At peak, Bechtel and NABTU had a combined 9,000 workers on site.
About Bechtel
Bechtel is a trusted engineering, construction, and project management partner to industry and government. Differentiated by the quality of our people and our relentless drive to deliver the most successful outcomes, we align our capabilities to our customers' objectives to create a lasting positive impact. Since 1898, we have helped customers complete more than 25,000 projects in 160 countries on all seven continents that have created jobs, grown economies, improved the resiliency of the world's infrastructure, increased access to energy, resources, and vital services, and made the world a safer, cleaner place.
Bechtel serves the Energy; Infrastructure; Manufacturing & Technology; Mining & Metals; and Nuclear, Security & Environmental markets. Our services span from initial planning and investment through start-up and operations. www.bechtel.com
Contact:
Amanda Meixel
ammeixel@bechtel.com
M: 1-706-360-5526
P: 1-703-429-6313
View original content to download multimedia:
SOURCE Bechtel | https://www.mysuncoast.com/prnewswire/2023/07/31/bechtel-commercial-operations-vogtle-unit-3-is-an-important-milestone-us-nuclear-industry/ | 2023-07-31T11:54:18 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/bechtel-commercial-operations-vogtle-unit-3-is-an-important-milestone-us-nuclear-industry/ |
‘Barbenheimer’ box office success has reawakened America’s moviegoing muscle
PARAMOUNT PICTURES, ANGEL STUDIOS, WALT DISNEY PICTURES, UNIVERSAL PICTURES, WARNER BROS. PICTURES, CNN
By Eva Rothenberg, CNN
(CNN) — It’s a tale of two movies and a box office triumph: “Barbie” and “Oppenheimer” maintained incredible momentum into their second weekends.
“Barbie” wore several hats this weekend, with domestic “Barbie” impressing with $93 million in gross revenue and international “Barbie” bringing in around $122 million, making it the No. 1 release worldwide.
It is the largest domestic second weekend performance ever for Warner Bros., which produced the movie. (CNN and Warner Bros. are both owned by Warner Bros. Discovery.)
“Oppenheimer” also had a blowout weekend, with a domestic total of $46 million, according to estimates from media analytics company Comscore, bringing its worldwide total to almost half a billion dollars. Universal, which distributed the movie, estimated Oppenheimer will be Nolan’s biggest non-superhero film of all-time in 40 regions, and his biggest film ever in 28.
Crucially, these numbers reflect that not only is there high energy and excitement for movies, but an appetite for the movie theater experience.
“Barbenheimer was never going to happen on your TV, it’s just not,” said Michael O’Leary, president and CEO of the National Association of Theater Owners in the United States. “You have to go into the theater to experience it.”
Repeat viewings are also fueling box office earnings. Midwest-based chain B&B Theaters estimated that across its 55 theaters, more than 2,100 people saw “Barbie” both opening weekend and this weekend, and almost 500 returned to see “Oppenheimer.”
According to O’Leary, there has always been a strong movie theater culture in the United States – we need look no further than “Hollywood” being interchangeable with “the movie industry.”
But after the pandemic ravaged theaters and public screenings, people are now looking forward to “sitting in a theater with world-class projection and sound systems, having an immersive experience alongside other people,” he said.
“Barbie” and “Oppenheimer” will trigger more and more people going to the movies by reminding them “the best of what the theatrical experience can be. It’s a reawakening,” he added.
O’Leary expects the movies to perform well for weeks to come, noting there’s been a rise over the past several years in very strong holdover weekends. That could be partly due to energetic word-of-mouth stoked by social media.
“At their core, consumers want to go see a compelling story, they want to be entertained,” he said. “If stories resonate with people… they tell other people.”
The overwhelming appreciation for these creative projects means that the ongoing Writers Guild of America and actors union SAG-AFTRA strikes could be a dark cloud over the these financial successes, according to some analysts.
“There’s pressure to resolve (these labor disputes) because the possibility of revenue is built on the foundation of having movies and actors to promote them,” said Paul Dergarabedian, senior media analyst at Comscore. “For now we have high-profile films, but that pool will be drying out.”
The production limbo caused by a lack of negotiations on the part of studios are leading to a ripple effect where the release dates for those projects will also be postponed. According to Boxoffice Pro chief analyst Shawn Robbins, this means that in the second half of 2023 and throughout 2024, theater chains will need “to keep a weather eye on the horizon for problems beyond their control.”
“While it’s important to celebrate the good times right now and realize they can be a barometer for the future, it’s just as important to recognize the fight for equality by so many who play a part in creating the content we see on our screens, large and small,” he added.
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/money/cnn-business-consumer/2023/07/30/barbenheimer-box-office-success-has-reawakened-americas-moviegoing-muscle-2/ | 2023-07-31T11:54:19 | 1 | https://kion546.com/money/cnn-business-consumer/2023/07/30/barbenheimer-box-office-success-has-reawakened-americas-moviegoing-muscle-2/ |
"I don't think it's caught up to me yet — how much my life has changed," says Emma Hardyman, singer of the 2023 Tiny Desk Contest-winning band Little Moon. The Utah-based band recently wrapped up the Tiny Desk Contest On The Road tour, headlining eight sold-out shows across the country. While on the road, Hardyman caught up with NPR to reflect on the life-changing win and also share the story behind Little Moon's winning song, "Wonder Eye."
Hardyman tells NPR the song was written during the time her mother-in-law was in hospice care. The melody came to Hardyman as she and her husband Nathan Hardyman, who is also part of Little Moon, drove from Utah to Idaho to visit his mother.
During this difficult time, Emma and Nathan Hardyman were also in the process of leaving the Mormon church in which they had grown up.
"And pretty quickly, just because of the circumstances, I realized that this song, this melody, was about death," says Emma Hardyman, who wrote the structure of the song before asking Nathan Hardyman to write the lyrics.
The couple were also observing the disintegration of many of the building blocks their Mormon belief systems were built on. "I've grieved past versions of myself throughout my whole life," Emma Hardyman shares.
"I really love where Mormonism brought me," Emma Hardyman says. "It introduced me to teachings that are supposed to love everybody, that are supposed to incorporate everybody. [But] it couldn't follow me to how much I wanted to take [those teachings] seriously," she adds, noting that many of the Little Moon band members are queer. She says Mormonism didn't align with how she wants to treat people 'without conditions.'
Emma Hardyman also shares that she had many self-doubts about herself as an artist when she and Nathan Hardman met — but that he believed in her from their very first date. And in "Wonder Eye," the two even find peace in not having all the answers. Emma sings: "Is there a knowledge that is found not in knowing?" as she's met with the warm hums of the band.
Copyright 2023 NPR. To see more, visit https://www.npr.org. | https://www.wvasfm.org/2023-07-31/the-power-and-heartbreak-behind-the-song-that-won-the-tiny-desk-contest | 2023-07-31T11:54:19 | 1 | https://www.wvasfm.org/2023-07-31/the-power-and-heartbreak-behind-the-song-that-won-the-tiny-desk-contest |